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n Nano, 10−9
p Pico, 10−12
µ Micro, 10−6
Taxa
At Arabidopsis thaliana (thale cress)
Cr Catharanthus roseus
Nb Nicotiana benthamiana
Os Oryza sativa (asian rice)
Pfu Pyrococcus furiosus
Ps Pseudomonas syringae
Pto Pseudomonas syringae pv. tomato
Sl Solanum lycopersicon (tomato)
Xcc Xanthomonas campestris pv. campestris
Col-0 Columbia (At ecotype)
Ler Landsberg erecta (At ecotype)
Units
×g Multiple of standard gravity (∼ 9.5 ms−2)
Å Ångstrom
AU Arbitrary units
g Gram
h Hour
L Liter
M Molar
m Meter
min Minute
RLU Relative light units
rpm Revolutions per minute
RU Response units (SPR)
s Second
U Units (enzymatic activity)
°C Degrees Celsius
CHAPTER 1
INTRODUCTION
1.1 Fundamentals of innate immunity
1.1.1 Life is immunity
Primal battlegrounds Life thrives on death – this biological paradigm succinctly de-
scribes why even the earliest and simplest of life forms on earth have evolved mechanisms
to hold off would-be predators. Primal ecosystems such as marine water are dominated
by parasitic agents; bacteriophage titres reach 5 ×107 mL−1 (Danovaro et al., 2008). To
deal with this challenge, prokaryotes use the CRISPR/Cas system to degrade invading
bacteriophage DNA (Garneau et al., 2010) - a very early form of an immune system that
is present in ∼90 % of archaea and ∼40 % of bacteria (Horvath and Barrangou, 2010).
Conceptually similar mechanisms include the prokaryotic use of restriction-modification
(RM) systems, which encode specific methyl transferases to epigenetically mark domestic
DNA as self and restriction endonucleases to cleave invading DNA that has not been
properly modified and is thus classified as non-self (Kobayashi, 2001). This dichotomy
of self against non-self, of host against pathogen, thus forms the very basis of the biologi-
cal concept of immunity, which is retained from the simplest nucleic acids interacting
with each other to complex multicellular eukaryotes.
Evolution of immunity Advancing along the tree of life presents an ever-increasing
variety of strategies to cope with the assault of harmful organisms, and higher organ-
isms often combine them to increase the efficiency of the immune response. Immunity
mechanisms can be broadly categorized as being either innate or adaptive, based on
whether they function as genetically preformed (and thus, inherited) systems or include
responsive elements that allow fine-tuning to the specific nature of challenging pathogens,
respectively. Conceptually, these strategies tie together by providing a layering effect:
preformed systems do not require prior contact with the pathogen to be effective, while
adaptive systems can be more specific (Cooper and Alder, 2006). This enhanced speci-
ficity allows adaptive immune responses to be both more finely tailored to the exact nature
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of the pathogen and to incur higher metabolic costs, as their induction can be more tightly
regulated (Iwasaki and Medzhitov, 2010). Arguably the most striking example of this
concept is the vertebrate adaptive immune system, which uses somatic hypermutations
and recombinations to achieve a far higher variety of very specific defence mechanisms
than what could reasonably be encoded genetically (Tonegawa, 1983, McBlane et al.,
1995). Additionally, the vertebrate adaptive immune system can create a specific im-
munity ’memory’ which enhances the efficiency of subsequent responses to the same
pathogen (Ahmed and Gray, 1996). In vertebrates, the innate and adaptive immune
systems are efficiently integrated; beside providing defensive actions by itself, the innate
immune system provides signals to the adaptive immune system which help to efficiently
regulate immune responses (Fearon and Locksley, 1996). Recently, the critical impor-
tance of the innate immune system for animal health has gained increasing recognition
(Kawai and Akira, 2010), and it has been shown that polymorphism in a single gene
encoding for an innate immunity receptor is a significant factor in the development of
human disease (Hawn et al., 2003). It should be noted that while the vertebrate adaptive
immune system is the classical and most well-studied example of adaptive immunity, even
evolutionarily ancient systems like the previously mentioned CRISPR/Cas system can
provide some adaptive flexibility outside of the more rigid genetic framework generally
classified as innate immunity (Westra et al., 2014).
Constitutive adaptations Organisms have evolved unspecific, constitutive biological
adaptations as a first line of defence against potential pathogens. These include anatomical
or physiological barriers to pathogen entry and survival, but due to their generalized nature,
their effectiveness against any single type of pathogen is naturally limited, and successful
pathogens evolved strategies to circumvent these defences (e.g. bacteriophages which
can circumvent microbial cell envelopes or animal gut pathogens which survive passage
through the stomach). Additionally, due to their constitutive presence, there is a strong
need to balance the extent of these adaptations against the physiological needs of a healthy
organism – resistant hosts are ecologically less competitive than non-resistant hosts in
the absence of pathogens (Schmid-Hempel and Ebert, 2003), as immunity always has
physiological tradeoffs (Eichmann and Schäfer, 2015).
Regulated immunity Stepping up in efficiency from purely unspecific, constitutive
defences introduces the need for regulation. The basis of all regulated biological im-
munity functions – recognizing a present need to functionally activate dormant defence
mechanisms – is mediated by receptors. The innate immune system genetically encodes
receptor proteins for various molecular signals that alert the organism to a pathogen’s
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presence. The detection of these ’danger signals’ can be either direct (e.g. recognizing
molecular features that are only present in the pathogen) or indirect (e.g. recognizing the
pathogen’s actions). Once a signal is detected, the receptor provides input into a complex
signalling network which can ultimately lead to an immune response (Tena et al., 2011).
The multitude of negative feedback elements in immunity signalling emphasizes the
critical importance of a well-regulated immune system (Akira et al., 2006), and some of
the most intuitively drastic effects of immunity misregulation are apparent in the impact
of human autoimmune diseases (Sakaguchi et al., 2008).
1.1.2 Danger signals as the basis of innate immunity
Pattern recognition A recurring theme of danger perception that occurs in innate
immunity of higher organisms is that of molecular patterns (Medzhitov and Janeway,
1997). These perception systems are an evolutionary ancient part of innate immunity
and are, in different forms, present in both plants and animals (Nürnberger et al., 2004,
Ronald and Beutler, 2010). Although the general concept of pattern recognition is
conserved in higher organisms, the specific perception systems seem to rather be a case
of convergent evolution (Ausubel, 2005, Zipfel and Felix, 2005). Classically, such
patterns have been defined as widely conserved, often simple molecular features (e.g.
short peptide epitopes, carbohydrates, and small molecule ligands) that are recognized by
corresponding pattern recognition receptors (PRRs).
MAMPs vs. DAMPs Patterns that are inherently specific to microbial life are excellent
templates by which higher organisms can unequivocally detect the presence of microbes;
these have been termed microbe-associated molecular patterns (MAMPs; also called
PAMPs for pathogen-associated molecular patterns). Perception of MAMPs originating
from microbial pathogens thus constitutes direct danger signals, as defined previously.
Conversely, patterns which are endogenous in nature but only arise as a consequence of
pathogen action (’modified self’) have been classified as damage-associated molecular
patterns (DAMPs), and thus constitute indirect danger signals. Pattern recognition in
context of plant innate immunity is discussed in detail in section 1.4.1.
Effectors Besides these simple molecular patterns, other signals of danger include the
perception of specific pathogen proteins which act as virulence factors and have been
termed effectors. Effector perception systems have been the basis of the classical gene-for-
gene hypothesis in plant immunity (Flor, 1971; for details, also see section 1.4.2.1), and
have been described as a distinct branch of innate immunity (effector-triggered immunity,
ETI) that can be contrasted with the previously described PRR-mediated immunity
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(PAMP-triggered immunity, PTI; Jones and Dangl, 2006). Although the bulk of research
on effector perception systems has been conducted on plants, emerging evidence shows
that similar effector perception systems exist in animals (Stuart et al., 2013). Effectors
in context of plant innate immunity are discussed in detail in section 1.4.2.
Classification of danger signals Although the terms introduced in this section are
widely used for classification purposes, there is ongoing debate whether such rigid
classifications are appropriate, as a growing number of molecular examples are being
discovered which defy these conventions (Boller and Felix, 2009, Thomma et al., 2011,
Cook et al., 2014). Examples of specific danger signals and detailed discussion of their
perception systems are provided in later sections describing the relevant concepts in the
context of plant innate immunity (section 1.4).
1.2 Microbial plant pathogens and plant diseases
The dawn of phytopathology In 1861, the population of Ireland was still feeling
the impact of the calamity which would enter history books as the "Great Famine"
of 1845 (Klinkowski, 1970) – a widespread outbreak of potato late blight, caused by
Phytophotora infestans infection. This demonstration of the direct and drastic effect that
plant disease can have on human culture contrasts the stark lack of knowledge about the
origins of plant diseases at the time. It was only in 1861 that Anton de Bary, impressed
by the recent events, demonstrated the causal link between microbial pathogens and the
devastating potato disease (Bary, 1861). In stating that the oomycete caused the disease
(he was describing it as a fungus at the time), he was rebuffing earlier reports which only
mention fungal infection as a consequence of a prior existing disease (Corda, 1847).
Environmental factors to pathogenicity Plants are in the distinctly precarious posi-
tion of not being able to evade harmful organisms through motility. In addition to this
rather direct effect, the sessile lifestyle has other disadvantages: being forced to endure
adverse abiotic environmental conditions (which might be favourable to pathogenesis)
without possibility of avoidance puts additional strain on a plant’s immune system. The
causal interplay between environment, host and pathogen in the development of disease is
therefore an early and central paradigm of plant pathology; host susceptibility to disease
is a combination of multiple factors, with the actual presence of the pathogen being only
one among others (’disease triangle’, Scholthof, 2007).
Plant microbiomes Plants influence their own biotic environment by providing micro-
bial habitats. The phyllosphere and rhizosphere are ecological niches rich in microbial
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life (Vorholt, 2012, Philippot et al., 2013). Although environmentally quite different,
there is significant overlap in microbial taxonomic distribution between these compart-
ments (Bai et al., 2015). There is vivid two-way interaction between plants and their
associated microbial communities, with distinct impacts on plant health (Hardoim et al.,
2008, Berendsen et al., 2012, De Coninck et al., 2014); plants actively influence the
composition of their microbiomes, e.g. through the secretion of metabolic compounds
into the rhizosphere (Badri et al., 2013, Bulgarelli et al., 2013). The extent to which
diverse factors such as soil type and plant identity influence the composition of root
microbiomes is an emerging topic in plant science (Lundberg et al., 2012, Bulgarelli
et al., 2012).
Friend or foe? As MAMPs are a significant danger signal to plants (section 1.1.2), the
question arises if and how the plant immune system can discriminate between beneficial
and harmful microbes. In at least some cases, there is clear mechanistic similarity between
the establishment of microbial symbiosis and pathogenicity (exemplified e.g. by legume-
rhizobia interactions, Oldroyd et al., 2011). An increasing amount of data indicates that
active suppression of the plant immune system by the putative symbiont is an important
factor in establishment of symbiotic relationships (Liang et al., 2013), indicating that
functional co-evolution of plants and symbiotic microorganisms has closer mechanistic
ties to pathogenicity and the suppression plant innate immunity than thought previously
(Zamioudis and Pieterse, 2012, Gourion et al., 2015, Cook et al., 2014).
Entry sites, attack vectors and pathogen synergy Animal action can facilitate mi-
crobial entry into plant tissues. Below the ground, nematodes infect roots and through
this process transmit microbial plant pathogens (Powell, 2012), while above the ground,
artificial lesions such as those occurring during herbivory or punctation by aphids have
similar effects (Stout et al., 2006); these synergies between different classes of pathogens
put additional strain on plant immunity. However, natural openings often suffice. A
prime entry point for foliar bacterial pathogens is through stomata (Underwood et al.,
2007). Far from being just passive gates of entry, active regulation and manipulation
of stomatal opening is turning out to be a intense battleground between plants and their
bacterial pathogens (Montillet and Hirt, 2013); while plants actively close their stomata
in response to MAMP perception, pathogens have evolved virulence mechanisms to open
them (Melotto et al., 2006), notably the use of specialized phytotoxins which manipulate
plant hormonal signalling such as coronatine in Pseudomonas syringae and fusicoccin in
various fungi (Melotto et al., 2008). Similarly, filamentous pathogens such as Sclerotinia
sclerotiorum use stomata to aid hyphae extension through plant tissue and use oxalate as
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a virulence factor to induce stomatal opening (Stotz and Guimaraes, 2004). Secondary
effects of pathogen invasion may also include general impairment of stomatal function
due to plant defence responses and/or epidermal cell death (Mur et al., 2013), as has
been observed for the interaction between powdery mildew and barley (’stomatal lock
open’, Prats et al., 2006).
Crop disease Securing future food supply in a situation of a globally growing human
population hinges heavily on effective agriculture which aims to minimize crop yield loss.
Although total reduction in crop yield is affected roughly similarly by weeds, animal
pests, and fungal/bacterial pathogens (9.4 %, 10.1 %, and 9.9 %, respectively), crop
protection measures taken in current agricultural practise are less effective for the control
of fungal/bacterial pathogens than for the other two groups (33.8 % efficacy compared
to 42.4 % efficacy for animal pests and 70.6 % efficacy for weeds, respectively; Oerke
and Dehne, 2004). Efforts to battle microbial plant pathogens in agricultural settings are
aggravated by the fact that they evolve quickly and that current agriculture heavily relies
on a narrow range of globally distributed crop plants of limited genetic diversity, often
planted in monoculture settings (Strange and Scott, 2005). In recent years, there has
been a remarkable increase in strongly virulent fungal disease outbreaks both in plant
and animal hosts, which has already led to an unprecedented amount of host extinction
events; this emerging fungal threat is probably aided by ubiquitous pathogen dispersal
through an ever more globalized economy (Fisher et al., 2012). As mentioned before,
environmental factors also strongly influence the outbreak of plant disease; global climate
change might therefore pose further risks to food security as pathogens stand ready to
exploit environmental changes to their benefit (Gregory et al., 2009).
1.3 Pseudomonas syringae, a model bacterial plant pathogen
1.3.1 Emergence as a model
The ’prime’ bacterial plant pathogen In 2012, the journal Molecular Plant Pathology
carried out a survey among its contributors, collecting 458 votes to determine which
bacterial plant pathogen they consider ’the most scientifically and economically impor-
tant’, with first place going to Pseudomonas syringae pathovars (Mansfield et al., 2012).
While certainly subjective, this anecdote serves to illustrate the perceived importance of
P. syringae as a plant pathogen.
Historical discoveries for origins of pathogenicity The mentioned voting among
scientists was surely influenced by the fact that many ground-breaking discoveries about
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interactions of the plant immune system with bacterial pathogens were using P. syringae as
a model organism. The hrp gene cluster, which forms the type III (three) secretion system
(TTSS or T3SS), an important mechanism for effector delivery (and thus, pathogenicity)
in many bacterial pathogens that infect eukaryotic organisms (Galán and Wolf-Watz,
2006), was elucidated in P. syringae pathovars (Lindgren et al., 1986, He et al., 1993).
Subsequently, P. syringae has become a prime model organism for large-scale studies
of secreted effector repertoires (Guttman et al., 2002, Jamir et al., 2004, Chang et
al., 2005) and their workings in plant innate immunity (Tao et al., 2003), e.g. through
repression of MAMP signalling (Li et al., 2005, Block et al., 2008, Guo et al., 2009) or
being recognized as danger signals themselves (ETI, see section 1.4.2 for a more detailed
look).
P. syringae genomes In 2003, the genome of P. syringae pv. tomato (Pto) DC3000
was sequenced (Buell et al., 2003), which greatly aided the exploration of its effector
secretome (Collmer et al., 2002). Since then, many other pathovars have been added
to this list (Joardar et al., 2005, Feil et al., 2005), culminating in the possibility of a
large-scale effort in comparative genomics among the different pathovars to elucidate
their respective effector and phytotoxin secretomes and thus, the origins of differences in
pathogenicity (Baltrus et al., 2011).
1.3.2 P. syringae lifestyle and pathogenicity
Ice, rain, and clouds An early and curious discovery about P. syringae was the fact that
liquid cultures of some strains of the bacterium freeze at surprisingly high temperatures
(−1.8 to −3.8 °C), due to induction of ice nucleation by intact P. syringae cells (Maki
et al., 1974). Unlikely as it seems, the identification of the outer membrane proteins
responsible for this phenomenon (Wolber et al., 1986) has revolutionized the artificial
snow-making industry and prompted discussions about the ecology of ski pistes (Rixen
et al., 2003). Since then, P. syringae strains have been found to be abundant in distinctly
non-agricultural habitats such as pristine snow and even tropospheric clouds (Amato
et al., 2007), which is remarkable for a species known primarily as a plant pathogen
(Morris et al., 2007). The life-cycle of P. syringae has since been shown to be inherently
linked to earth’s water cycle, and environmentally isolated strains show striking similarity
to agriculturally relevant pathogen strains (Morris et al., 2008). These circumstances
contribute to the bacterium’s success as a plant pathogen by providing ecological reser-
voirs independent of plant life and aiding in its wide distribution (Monteil et al., 2013).
Water status of an infected plant also seems critical for virulence of P. syringae (Beattie,
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2011), which can use mechanisms such as the production of extracellular polysaccharides
to enhance its chances of survival in the apoplast (Fett and Dunn, 1989,Yu et al., 1999).
Interestingly, resistant plants can correspondingly use ETI mechanisms to induce physio-
logical adaptations which actively dehydrate the leaf environment around the invading
pathogen (Freeman and Beattie, 2009). The importance of the aquatic aspect of P.
syringae lifestyle and ecology is increasingly gaining recognition (Morris et al., 2013).
A successful plant pathogen The taxon P. syringae as a whole has an excessively large
host distribution compared to other bacterial plant pathogens; P. syringae pv. syringae
alone was determined to infect more than 80 host species (Hirano and Upper, 2000).
P. syringae occurs mainly as a epiphytic leaf pathogen (Hirano and Upper, 1990). Not
all strains are pathogenic; some have adapted to the life as a leaf commensal by losing
key virulence factors such as the T3SS and effector genes (Mohr et al., 2008), and
strains lacking the canonical T3SS have recently been described to be abundant in non-
agricultural habitats (Diallo et al., 2012). In pathogenic P. syringae, host specificity and
range varies widely among the different pathovars, and there is ongoing discussion on the
rearragement of different pathovars into various P. syringae subspecies (O’Brien et al.,
2011); also, pathovar designation often does not follow phylogeny (Sawada et al., 1999).
As a crop pathogen, P. syringae has a global economic impact by infecting important crop
species; a non-exhaustive listing in typical horticultural literature includes apples, beets,
beans, cabbage, cucumbers, flowers, oats, olives, peas, tobacco, tomato, and rice (Horst,
2013). The topicality of P. syringae as a virulent plant pathogen is highlighted by recent
developments like the epidemic spreading of a new and aggressive disease phenotype,
’bleeding canker disease’ of European horse chestnut trees, which is caused by P. syringae
pv. aesculi (Green et al., 2010). Historically, one of the best-studied disease phenotypes
caused by P. syringae is the ’bacterial speck disease’ of tomato, caused by Pto DC3000
(Louws et al., 2001). Interestingly, this strain can also infect the model plant Arabidopsis
thaliana (Preston, 2000). By deleting a single effector gene from Pto DC3000, virulence
on the tobacco model Nicotiana benthamiana can be established (Wei et al., 2007). The
molecular determinants which lead to either resistance or susceptibility to this disease
phenotype in various tomato cultivars and in Arabidopsis have since become a prime
pathway for mechanistic studies on ETI and plant hormone signalling in context of
immunity (Xin and He, 2013).
Determinants of P. syringae host specificity Host specificity of P. syringae can be in-
terpreted on two different levels (Heath, 2000). On the first level, some plant species are
susceptible to a certain pathovar of P. syringae while others are not (’nonhost resistance’).
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On the second level, different cultivars of a single, generally susceptible host species are
(atypically) resistant to some strains of a generally pathogenic pathovar (’host resistance’).
The presence or absence of specific effectors (or combinations thereof) has been identified
as a key determinant for the divergent host specificity of the various P. syringae pathovars,
and resistance (R) protein polymorphisms (which are, in Arabidopsis, highly abundant;
Clark et al., 2007) in different plant species or cultivars can explain differential recogni-
tion of certain effectors, and thus, presence or absence of effective resistance (Lindeberg
et al., 2009). Dissecting P. syringae genomes by multi-locus sequencing typing (MLST)
suggests four main clades, with designated pathovars scattered among them (Sarkar
and Guttman, 2003), and effector screens have been performed for members of each
clade (Cunnac et al., 2009). Examples from closely related strains of bean pathovars
gylcinea and phaseolicola show that differential effector arsenals can explain some, but
not all, of the quantitative differences in cross-pathogenicity on the corresponding hosts
(Baltrus et al., 2012). Evolutionary host shifts in pathovar lineages appear to correspond
to conserved type three effector (T3E) repertoires; for example, the Pla106 strain (patho-
var lachrymans, the causative agent of cucumber angular leaf spot disease) shares much
of its T3E suite with two tomato pathogens, hinting to similar virulence strategies and
making shifts between cucumber and tomato host systems more likely (Baltrus et al.,
2011). Artificially engineering effectors originating from various pathovars into naturally
non-pathogenic strains might lead to new insight into host specificity (Mohr et al., 2008).
Evolutionary and functional aspects of effector repertoires are discussed in further detail
in section 1.5.1.
P. syringae phytotoxins In addition to proteinacious virulence factors such as effectors,
P. syringae pathovars are remarkable for exhibiting a variety of phytotoxins to increase
their pathogenicity (Hwang et al., 2005). A particularly interesting example is coronatine
(COR), a hybrid molecule consisting of the polyketide coronafacic acid (CFA) and the
isoleucine-derived coronamic acid (CMA). The CFA moiety is structurally similar to jas-
monates (JAs; Weiler et al., 1994), and coronatine was shown to target COR-insensitive 1
(COI1; Feys et al., 1994, Xie et al., 1998), a key component in JA perception (Sheard
et al., 2010), in order to activate JA-dependent signalling and consequently suppress
salicylic acid (SA)-dependent defence responses due to interference with physiological
JA/SA hormonal crosstalk (Brooks et al., 2005). In addition to its detrimental effects
on phytohormone-regulated immunity signalling, coronatine directly interferes with the
regulation of stomatal closure, re-opening stomata that have been closed in response to
MAMP signalling to facilitate bacterial entry into plant tissues (Melotto et al., 2006).
Two other notable phytotoxins specific to P. syringae, syringomycin and syringopeptin
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(Gross and DeVay, 1977, Ballio et al., 1991)), are lipopeptides that function similarly to
detergents to form pores in plant plasma membranes (Lavermicocca et al., 1992), which
facilitates the release of nutrients to the bacterium (Hutchison and Gross, 1997). Taking
a wide view on the origins of pathogenicity leads to the conclusion that P. syringae’s
unique arsenal of phytotoxins contributes significantly to its success as a broad-spectrum
plant pathogen (Bender et al., 1999, Geng et al., 2014).
1.4 Danger perception systems in plants
An evolutionary view on danger perception As stated previously (section 1.1.2),
danger perception is a universal feature of innate immunity and a prerequisite for adequate
and efficient defence responses. Observing the cladistic distributions of danger signals
in pathogens and their corresponding perception systems in plants highlights some
evolutionary aspects of plant innate immunity (Boller and Felix, 2009). While the
microbial molecular features responsible for pattern recognition (MAMPs) are usually
broadly conserved among pathogens and phylogenetically ancient, both widely and
narrowly conserved MAMP perception systems exist in plants (figure 1.1), indicating that
there is continuing evolution of new perception systems for these ancient danger signals.
Conversely, both microbial effectors and their corresponding perception systems in plants
are usually more narrowly conserved. Genetic innovations which lead to new virulence
factors in pathogens and new perception systems in plants have therefore been described
as an ’evolutionary arms race’, with important implications to pathogen host range and
adaptation (Schulze-Lefert and Panstruga, 2011). It should be noted again that the
historical distinction between MAMPs and effectors, while conceptually convenient, is
subject to dissolution as more and more examples are being discovered which cannot be
constrained by this rigid dichotomy (Thomma et al., 2011, also note the ’mixed shape’
in figure 1.1, B). The following sections keep the classical MAMP/effector nomenclature
for mechanistic descriptions, while section 1.4.3 describes some of the current challenges
to this classification in more detail.
1.4.1 Pattern-triggered immunity
1.4.1.1 Structural variety of PRR families
Animal PRRs Although the general concept of pattern recognition is similar in plant
and animal innate immunity, some of the molecular features and functionality of PRRs
are different in both systems. The most intensely studied mammalian PRRs belong to the
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Fig. 1.1 Evolutionary aspects of danger perception in plants. A, Highly simplified, schematic
representation of danger perception systems in a plant cell. Greyscale, host-derived components;
red, pathogen-derived components (labels are given in figure). B, Relative conservation of danger
signals and their corresponding perception systems. Meaning of symbols is the same as for
(A), and number of symbols was chosen arbitrarily for illustrative purposes. The fluency of the
MAMP/effector designation is symbolized by the mixed-form ’drop’ shape. Pane (B) is modified
from Boller and Felix, 2009.
class of toll-like receptors (TLRs) which act as prototypical MAMP receptors (Song and
Lee, 2012) through extracellular leucine-rich repeat (LRR) domains, containing 19-25
LRRs each, and transduce danger signals into the cytoplasm using intracellular Toll-IL-1
Receptor (TIR) domains (Akira and Takeda, 2004). Interestingly, TLRs are in a way
atypical LRR-domain receptors as most TLRs (with the exception of TLR5, which is
involved in flagellin recognition; Hayashi et al., 2001) do not recognize proteinaceous
ligands and do not bind their ligands on the concave surface of the ectodomain (as
common in LRR-domain receptors; Kang and Lee, 2011, Yoon et al., 2012). Not all
TLRs are functionally located at the cell surface; several perceive signals such as foreign
nucleic acids within endosomes (Werling et al., 2009). A common theme in TLR-
mediated pattern recognition is dimerization of TLRs (Brodsky and Medzhitov, 2007),
which leads to signalling activation intracellularly and can increase the possible variety
of perceived MAMP signals extracellularly through heterodimerization of ectodomains
(O’Neill and Bowie, 2007). Recent advances demonstrate a role of other types of PRRs
in animal immunity as well, among them C-type lectin receptors (CLRs), nucleotide-
binding oligomerization domain (NOD)-like receptors (NLRs) and RIG-I-like receptors
(RLRs), and there is active crosstalk between TLRs, these other PRRs, and various other
’adaptor’-type proteins to orchestrate immune responses (Kawai and Akira, 2011).
LRR-RLKs Similarly to the situation in the animal system, the classical plant PRRs
were described as leucine-rich-repeat containing receptor-like kinases (LRR-RLKs),
making comparisons to animal TLRs immediately tempting. However, the similarity
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is mostly limited to using the same basic biochemical modules (LRRs) for pattern
recognition, as both the structures of the LRR domains and the specific MAMP epitopes
being recognized are significantly different in animal and plant systems, hinting to
a case of convergent evolution (Nürnberger et al., 2004). The adaptability of the
extracellular LRR domain to a wide variety of signals makes LRR-RLKs prototypical
plasma membrane receptors, and consequently, they fulfil signalling functions not only in
the context of innate immunity but also in developmental processes such as brassinosteroid
(BR) signalling, stomatal patterning, and floral abscission (Diévart and Clark, 2004,
Wu et al., 2015).
LRR-RLKs Plant LRR-RLKs also differ significantly from animal TLRs in their
intracellular domains. While animal TLRs use TIR domains (both as cytoplasmic domain
of the PRR and in various cytoplasmic adaptor proteins) to initiate signalling, LRR-RLK
cytoplasmic domains are classical kinases, and form a monophyletic group together with
several cytoplasmic animal receptor kinases, dubbed the RLK/Pelle family, or interleukin-
1 receptor associated kinase (IRAK)/Pelle in animals (Shiu and Bleecker, 2001). While
animals have few members of this family, it expanded vastly during plant evolution, with
the Arabidopsis genome encoding for 600 proteins that contain this type of kinase domain
(Shiu and Bleecker, 2003). Interestingly, while only a small subset of RLK/Pelle family
members have been characterized as ’non-RD’ kinases (due to the lack of a conserved
arginine immediately preceding the catalytic aspartate in the activation loop; Johnson
et al., 1996, Nolen et al., 2004), this subgroup is relatively common in characterized
immunity-related PRRs. PRR subfamilies do not form a distinct clade, hinting that the
biological PRR function has likely evolved multiple times in different groups of kinases,
and thus, similar functional requirements might explain similar subsequent changes to
the otherwise highly conserved RD motif (Dardick et al., 2012).
LRR-RLPs Like LRR-RLKs, LRR-receptor like proteins (LRR-RLPs) contain ex-
tracellular LRR domains for ligand binding and a single-pass transmembrane domain
(Fritz-Laylin et al., 2005), and fulfil roles as receptors in immunity and developmental
pathways (Wang et al., 2008). However, instead of a kinase domain, the intracellular
portion of RLPs consists of a much shorter cytoplasmic domain. This poses obvious
implications for signalling, and indeed RLP function has been fundamentally linked to
that of adaptor proteins which can provide kinase function (Gust and Felix, 2014), a
prime example of which is SOBIR1 (SUPPRESSOR OF BIR1-1/ EVERSHED), which
has been shown to interact with a variety of LRR-RLPs in tomato (Liebrand et al., 2013).
Importantly, this interaction is ligand-independent, indicating a fundamental necessity
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of the interaction that makes the label ’bimolecular receptor kinase’ for an RLP/adaptor
complex appropriate (Gust and Felix, 2014).
LysM domain PRRs While the LRR domains of LRR-RLKs and LRR-RLPs show re-
markable adaptability to peptide ligands, there are various types of PRRs with other types
of ectodomains, enabling perception of danger signals corresponding to other molecular
classes. Particularly well-studied are lysine motif (LysM) domain PRRs. The LysM
domain is evolutionary ancient and occurs in bacteriophages, prokaryotes, and eukaryotes;
the conserved function of LysM is binding of microbial structural carbohydrates such as
bacterial peptidoglycan and fungal chitin via their N-acetylglucoasmine (GlcNAc) moi-
eties (Buist et al., 2008, Mesnage et al., 2014). In plants, PRRs containing extracellular
LysM domains fulfil functions in immunity- and symbiosis-related signalling (Gust et al.,
2012). Apart from their extracellular domain, LysM domain PRRs exhibit a variety of
protein topologies. LysM-RLKs are similar to LRR-RLKs and have cytoplasmic kinase
domains for signalling, while LsyM-RLPs do not. In contrast to LRR-RLPs, LysM-RLPs
also lack transmembrane and cytoplasmic domains altogether, being instead connected
to the plant plasma membrane via glycophosphatidylinositol (GPI) anchors (Gust et al.,
2012). Dimerization of LysM domain PRRs has emerged as a central theme to signalling
in response to microbial cell envelope MAMPs (Liu et al., 2012, Hayafune et al., 2014),
and differences in perception among plant species are currently being elucidated (Shinya
et al., 2012).
1.4.1.2 A model system for MAMP perception: flg22 and FLS2
The ’classical’ MAMP Arguably, the prime example of a MAMP (by virtue of being
the most clearly characterized and intensively studied) is flg22, an active epitope of
bacterial flagellin (Felix et al., 1999). As a structural protein and main component of the
bacterial flagellum (Samatey et al., 2001), flagellin (FliC) is relatively conserved among
mobile microbes and an important factor contributing to their ecological fitness, and —in
case of pathogens— virulence, both in plant and in animal systems (Tans-Kersten et al.,
2001, Taguchi et al., 2010, Josenhans and Suerbaum, 2002). Therefore, bacteria can-
not easily avoid detection by losing flagellin altogether without incurring major fitness
penalties, a theme that recurs in other MAMPs as well and makes them ideal templates
for danger recognition. Interestingly, both Agrobacterium and commensalistic Rhizo-
bium have evolved a variant of flagellin that retains functionality yet manages to avoid
an immune response (Felix et al., 1999), and studies using Xanthomonas campestris
pv. campestris (Xcc) show that single amino-acid polymorphisms of the epitope can
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lead to quantitatively altered magnitudes of flg22 perception (Sun et al., 2006). Sim-
ilar results have been obtained in the animal system, as it has been demonstrated that
certain strains of human pathogenic bacteria exhibit mutations that render their flagellin
versions undetectable, along with complementary mutations that restore motility function
(Andersen-Nissen et al., 2005).
FLS2 Flagellin perception is widespread among plant phyla, and presence of in both an-
giosperms and gymnosperms indicates an evolutionary ancient perception system (Albert
et al., 2010b). Genetic analysis led to the identification of Flagellin-sensing 2 (FLS2)
as necessary for flg22 perception (Gómez-Gómez and Boller, 2000) and induction of
plant defences in response to flg22 stimulation (Zipfel et al., 2004); subsequently, after
previous indications that the FLS2 ectodomain is crucial for flg22 perception (Gómez-
Gómez et al., 2001), a physical interaction between flg22 and FLS2 was demonstrated,
establishing a direct ligand-receptor relationship (Chinchilla et al., 2006). Elucidation
of the crystal structure of the flg22-FLS2 ectodomain complex gave further insights into
the structural requirements of flg22 perception, and demonstrated the vital necessity of a
co-receptor, Brassinosteroid-insensitive 1 (BRI1)-associated kinase 1 (BAK1), for flg22
binding (Sun et al., 2013a; the role of BAK1 as a co-receptor is described in detail in
section 1.4.1.5). FLS2 binds flg22 with high sensitivity, leading to experimental difficul-
ties in the discovery of other MAMPs due to contamination issues (Mueller et al., 2012);
as a consequence, there has been intense controversy on whether FLS2 may be involved
in the recognition of several fundamentally unrelated peptide epitopes (Lee et al., 2011,
Danna et al., 2011, Segonzac et al., 2012, Lee et al., 2012).
Other flagellin epitopes and receptors Although flagellin is conserved as a MAMP
in plant and animal immunity, different flagellin epitopes have emerged as template
for danger signaling in these two kingdoms of life (Zipfel and Felix, 2005). Animal
TLR5 senses a region composed of 13 amino acids within the conserved D1 domain of
the flagellin monomer, and certain mutations in this region abrogated both recognition
by TLR5 and bacterial motility function; single point mutations have a greater effect
on motility than on recognition, indicating bacteria’s challenges to evade detection by
mutating the epitope (Smith et al., 2003), although, as mentioned before, some pathogens
have adapted successfully (Andersen-Nissen et al., 2005). In contrast, the flg22 motif
responsible for plant recognition through FLS2 is located in an N-terminal fragment (Felix
et al., 1999) which has been deemed dispensable for animal recognition through TLR5,
and purified flg22 did not cause an immune response in human cell culture (Donnelly
and Steiner, 2002). Interestingly, flagellin harbors at least one more immunogenic
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epitope: flg28 was identified as being distinct from flg22 and is recognized by a yet-
unidentified PRR other than FLS2 that seems to be limited to Solanaceae species (a
putative ’FLS3’); furthermore, allelic variety in flagellin epitopes and their corresponding
receptors seems to significantly shape flagellin responses (Clarke et al., 2013). The
tomato (Solanum lycopersicum) orthologue of AtFLS2, SlFLS22, also recognizes flg22,
but exhibits some important differences in the characteristics of binding, as it additionally
recognized a shorter version of the epitope, flg15, which is unresponsive in Arabidopsis
(Robatzek et al., 2007). Rice (Oryza sativa) also has a functional FLS2 orthologue, as
expression of OsFLS2 in Arabidopsis fls2 mutants restored flg22 recognition; however,
in rice itself flg22 stimulation leads to much weaker responses (Takai et al., 2008). In
summary, emerging evidence points to a large variety of nuances in both MAMP and
receptor specificities for the model flg22/FLS2 pair that challenges the classical concept
of strongly conserved and monolithic MAMP/receptor systems.
1.4.1.3 Variety of MAMP perception
Proteinaceous MAMPs Since the initial description of immunogenic short peptide mo-
tifs derived from specific pathogen proteins, the search for other proteinaceous MAMPs
has been ongoing. Corresponding to the general evolutionary theory of MAMP recogni-
tion systems, large-scale genomic screens have been directed towards pathogen proteins
under strong negative selection due to their critical function for the ecological fitness of
the pathogen (McCann et al., 2012). However, many candidate MAMPs are still waiting
for identification of their cognate perception systems, while on the other hand, many
previously described PRRs detect unknown MAMPs (’orphan’ MAMPs/receptors, Boller
and Felix, 2009). Historically, the second proteinaceous MAMP to be characterized
in greater detail as part of an unequivocal ligand-receptor pair was elf18 (Kunze et al.,
2004), the N-terminally located active epitope of bacterial elongation factor Tu (EF-Tu),
with its cognate plant PRR EF-Tu receptor (EFR), an LRR-RLK (Zipfel et al., 2006).
EF-Tu is a highly conserved (Lathe and Bork, 2001), abundant (the most abundant
protein in E. coli, Pedersen et al., 1978), and functionally essential bacterial protein,
and thus perfectly fulfilling the classical definition of a MAMP template. EFR evolved
in Brassicacae, making it a relatively narrowly distributed PRR perceiving a widely
distributed MAMP; however, functional transfer of Arabidopsis EFR to tobacco and
tomato show that downstream components seem to be conserved (Lacombe et al., 2010).
Interestingly, recent studies showed that EF-Tu harbours another active epitope, EFa50,
which can trigger defence-responses in rice, hinting to another yet-uncharacterised EF-
Tu-perceiving PRR active in non-Brassicaceae (Furukawa et al., 2014). EFR shares
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significant structural and functional similarity with FLS2, and switching of FLS2/EFR
subdomains generally results in functional chimeric PRRs (Albert et al., 2010a). Beside
LRR-RLKs, other receptor families have been implicated in the perception of proteina-
ceous MAMPs. The LRR-RLP RLP23 (Albert et al., 2015) detects a conserved 20 amino
acid epitope present in Necrosis and ethylene-inducing peptide 1-like proteins (NLPs),
which is exceedingly widely distributed; the NLP20 motif has been found in NLPs from
bacteria, fungi, and oomycetes (Böhm et al., 2014a). This example provides another
illustration of the duality inherent in many danger signals: cytotoxic NLPs are both
important virulence factors for necrotrophic pathogens (Qutob et al., 2006, Ottmann
et al., 2009) and direct MAMP signals. Interestingly, in some cases, the amino acid
sequence of the recognized peptide epitope is not sufficient for detection, as plants have
evolved PRRs to specifically detect modified epitopes; Required for activation of Xa21
(RaxX) is a peptide MAMP from Xanthomonas species whose perception in rice by the
LRR-RLK XA21 depends on sulfation of a single tyrosine residue (Pruitt et al., 2015).
In summary, peptide ligands originating from pathogen proteins form the basis of a broad
variety of pattern recognition strategies in plant innate immunity.
Carbohydrate MAMPs Beside pathogen proteins, a second extensive class of molecules
functioning as MAMPs is that of pathogen carbohydrates, which often fulfil important
structural functions in microbial pathogens (T. J. Silhavy, D. Kahne and Walker,
2010, Bowman and Free, 2006). As noted before (section 1.4.1.1), PRRs containing
LysM domains are the prime example, recognizing bacterial peptidoglycan (Willmann
and Lajunen, 2011, Gust, 2015) and fungal chitin (Cao et al., 2014, Liu et al., 2012,
Hayafune et al., 2014). However, perception of carbohydrate patterns is not limited
to LysM domain PRRs. Receptor-like kinases with other types of extracellular lectin
domains (LecRLKs; Vaid et al., 2012) have been implicated in carbohydrate binding as
well (Singh and Zimmerli, 2013, De Schutter and Van Damme, 2015); comparisons
to the animal system (Dectin-1, a C-type lectin; Gantner et al., 2003) make them poten-
tial candidates for β -glucan perception, but the molecular identity of the corresponding
receptor in plants remains elusive (Fesel and Zuccaro, 2015).
Other MAMPs Bacterial lipopolysaccharide (LPS), a critical immunogenic compound
in the Gram-negative cell envelope (Erbs and Newman, 2012), is sensed by the B-type
lectin LecRLK lipooligosaccharide-specific reduced elicitation (LORE) in Brassicaceae;
the recognition is based on the lipid A moiety (Ranf et al., 2015). Other microbial
cell envelope components also fulfil the definition of a MAMP; fungal ergosterol has
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immunogenic properties in plants (Tugizimana et al., 2012), but its receptor remains
elusive (Klemptner et al., 2014).
1.4.1.4 DAMPs ... and *AMPs
Endogenous peptides DAMPs pose a second major class of danger signals that are
perceived via PRRs, and can be generally defined as host-derived molecules released
during host-pathogen interaction (Lotze et al., 2007). Early research into this molecular
class focused on plant-derived peptides. An 23 amino-acid peptide, Pep1, was described
as a potent elicitor of plant immunity and is generated from a precursor (proPep1) that is
induced by wounding, methyl jasmonate and ethylene signaling (Huffaker et al., 2006).
Concurrently, the receptor for this peptide was identified as the LRR-RLK Pep1 receptor 1
(PEPR1) (Yamaguchi et al., 2006). Pep1 is a member of a family of related DAMP
peptides, designated Pep1-Pep7. Interestingly, a second PRR, PEPR2, was found to
perceive Pep family ligands, and the differential receptor-ligand specificities have been
elucidated, with PEPR1 being the receptor for Pep1-6, and PEPR2 being a receptor for
Pep1 and Pep2 (Yamaguchi et al., 2010). The function of endogenous peptide DAMPs
seems to be that of an internal amplifier of defence responses, with functional integration
into MAMP perception and hormone signalling (Ma et al., 2012b, Tintor et al., 2013),
as well as a general mediator of herbivory defence widely conserved in range of plant
clades (Huffaker et al., 2013). These recent studies highlight that there is a certain
degree of fluency in classifying these endogenous peptides, as their release seems to be
more specifically regulated and functionally varied than thought initially (Bartels and
Boller, 2015), and may thus be functionally closer to cytokines than to true DAMPs.
Small-molecules for danger assessment Pathogen action can lead to the release of
small molecule ligands that would not circulate within the plant normally, making them
excellent DAMPs. Examples of this concept include the wall-associated kinase 1 (WAK1),
which perceives liberated cell wall components (Decreux and Messiaen, 2005, Brutus
et al., 2010), and Does not Respond to Nucleotides 1 (DORN1), a novel lectin-domain
receptor for extracellular ATP (Tanaka et al., 2010) unrelated to previously identified
animal ATP receptors (Choi et al., 2014).
Non-microbial pathogen signatures Pattern recognition is not limited to perception
of microbial or endogenous damage-associated signatures, although these have been
studied in most detail; it seems that for every interaction of a plant with another organism,
there are corresponding foreign patterns being recognized, as in the case of insect her-
bivory (herbivory-associated molecular patterns - HAMPs, Mithöfer and Boland, 2008,
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Acevedo et al., 2015), or plant-plant parasitism (parasite-associated molecular patterns -
ParAMPs, Kaiser et al., 2015; Markus Albert, personal communication).
1.4.1.5 BAK1, a central co-receptor in plant immunity
Brassinosteroid signalling The receptor-like kinase BRI1-associated kinase 1 (BAK1)
was first described for its role in brassinosteroid signalling as a modulator of Brassinosteroid-
Insensitive 1 (BRI1) activity (Li et al., 2002, Vert et al., 2005). Brassinosteroid signalling
by the BRI1/BAK1 complex has been shown to be mediated by sequential transphospho-
rylation events between the respective kinase domains (Wang et al., 2008). Subsequently,
elucidation of the BRI1 ectodomain crystal structure provided further hints towards BAK1
as a true co-receptor (Hothorn et al., 2011), a notion which was reinforced by the finding
that the BAK1 ectodomain is essential for complex formation (Jaillais et al., 2011) and
unequivocally confirmed through a dedicated BRI1/brassinolide/BAK1 co-crystal (Sun
et al., 2013b).
Immunity signalling BAK1 was first established as a component in plant immunity
due to its involvement in the containment of the cell-death response in a BR-independent
manner (Kemmerling et al., 2007). Concurrently, other studies highlighted its direct
role in PRR signalling by its ligand-dependent association with FLS2 and the fact that
bak1 plants are impaired in FLS2-mediated immunity, both in Arabidopsis and tobacco
(Chinchilla et al., 2007, Heese et al., 2007). Initial experiments included in these studies
hinted that the involvement of BAK1 might not be limited to FLS2, and indeed other PRRs
such as EFR and PEPR1 were found to interact rapidly with BAK1 and undergo transpho-
sphorylation in a ligand-dependent manner; (Schulze et al., 2010), demonstrating a
general role of BAK1 in MAMP recognition (Chinchilla et al., 2009). An FLS2/BAK1
ectodomain co-crystal structure demonstrated BAK1 has an active role in binding the
ligand, with the flg22 peptide acting as ’molecular glue’ between the BAK1/FLS2 LRR
domains (Sun et al., 2013a). Cogent to its central role in immunity signalling, BAK1
was found to be targeted by microbial effectors (Shan et al., 2008); this aspect is dis-
cussed in more detail in section 1.5.2. Focusing on BAK1 phosphorylation has provided
several mechanistic insights; the structural impact of activation-loop phosphorylation was
demonstrated (Yan et al., 2012) and the differential roles of BAK1 could be separated in
a phosphorylation-dependent manner by a novel mutant allele, bak1-5, which is impaired
in its PRR-mediated signalling functions but not in in BR signalling or cell death control
(Schwessinger et al., 2011).
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SERKs BAK1 is also known as SERK3, and part of a protein family named Somatic
Embryogenesis Receptor-like Kinases (SERKs) for their initially discovered role in em-
bryogenesis (Schmidt et al., 1997). The SERK family consists of five members and is
highly conserved among plant clades (Schwessinger and Rathjen, 2015). Although the
general protein architecture (4.5-5 LRR extracellular domain, single-pass transmembrane
domain, kinase domain) is conserved among SERKs, modular domain functions have di-
verged during evolution, explaining the wide variety of co-receptor functions that SERKs
are involved in (Li, 2010, Aan den Toorn et al., 2015). There is partial functional redun-
dancy among SERK proteins; for example, four out of the five members of the SERK
family – SERK1, SERK2, SERK3/BAK1, and SERK4/BKK1 (BAK1-like kinase 1) –
can function as co-receptors for BRI1 (He et al., 2007, Albrecht et al., 2008, Gou et al.,
2012). Recently, mathematical modelling of the BRI1/SERK interactome helped to put
these data into context by describing SERK action as differential modulators of physiolog-
ical output (Esse et al., 2013). Similarly, both SERK3/BAK1 and SERK4/BKK1 interact
with FLS2, EFR, and PEPR1/2 to provide co-receptor redundancy to PRR-mediated
immunity signalling (Roux et al., 2011), and the same proteins confer similar redundancy
to the cell-death control pathway (He et al., 2007). Although SERK5, an extremely close
homologue of SERK4, is not functional in the model Arabidopsis ecotype Col-0 due to a
natural mutation in the RD motif, recent studies using SERK5 in the Landsberg erecta
(Ler) ecotype demonstrate its interaction with BRI1 and subsequently, its function in BR
signalling (Wu et al., 2015).
1.4.1.6 PRR regulation networks
Positive regulation As the variety of identified PRRs is constantly increasing, subse-
quent mechanistic studies continue to unveil their extended interactoms and regulatory
networks (Böhm et al., 2014b). The botrytis-induced kinase 1 (BIK1) was initially
described as a plasma-membrane located regulatory kinase that modulates early responses
to pathogen infection (Veronese and Nakagami, 2006). Subsequently, BIK1 was shown
to associate with both FLS2 and BAK1 and to be involved in transphosphorylation events
following flg22 perception (Lu et al., 2010a); similar data has since been obtained for
other PRRs (Zhang et al., 2010, Liu et al., 2013a). Mechanistically, BIK1 works as
a positive regulator of PRR immunity and directly phosphorylates the Nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase Respiratory burst oxidase D (RBOHD)
to induce reactive oxygen species (ROS) production (Kadota et al., 2014). BIK1 is part
of a family of Receptor-like cytoplasmatic kinases (RLCKs) called PBS1-like (PBL)
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kinases; its homologues PBL1, PBL2, and PBS1 seem to be functionally additive (Zhang
et al., 2010, Liu et al., 2013b).
Negative regulation The use of FLS2 as a model PRR has revealed mechanisms for
signal attenuation after ligand perception, showing that FLS2 gets internalized after flg22
binding (Robatzek et al., 2006) and is a direct substrate for ubiquitination by two plant
u-box E3 ubiquitin (PUB) ligases, PUB12 and PUB13, which are activated by BAK1
transphosphorylation in the active receptor complex (Lu et al., 2011); another nega-
tive regulator is the kinase-associated protein phosphatase (KAPP) which interacts with
FLS2’s kinase domain (Gómez-Gómez et al., 2001). As a common co-receptor for multi-
ple PRRs, BAK1 is also a prime target for regulation. The BAK1-interacting receptor-like
kinase 1 (BIR1) was identified as a BAK1-dependent negative regulator in immunity and
cell death processes (Gao et al., 2009). Subsequently, a co-immunoprecipitation approach
using BAK1 yielded two novel interactors belonging to the same protein family, named
BIR2 and BIR3, which differentially regulate PRR complexes in a ligand-dependent
manner through BAK1 (Halter et al., 2014b, Halter et al., 2014a, Imkampe, 2015).
BAK1 is also the direct target of a phosphatase, protein Ser/Thr phosphatase type 2A
(PP2A), which constitutively associates with BAK1 (but not with FLS2 or BIK1) and
modulates its phosphorylation status (Segonzac et al., 2014); negative regulation of the
common co-receptor BAK1 is thus emerging as a prime element of PRR regulation and
underlines the importance of BAK1 as a central hub in MAMP signalling.
1.4.2 Effector-triggered immunity
1.4.2.1 Early models putting ETI into context of plant immunity
Going vertical The ’gene-for-gene’ hypothesis of plant defence (Flor, 1971) was one
of the earliest attempts to describe the genetic background of plant immunity, proposing
complementary genetic systems in host and pathogen leading to ’vertical’ resistance; i.e.,
resistance mediated by a single gene in host and pathogen each, following Mendelian
inheritance patterns, and thus leading to qualitative resistance effects (Plank, 1968). This
was contrasted with ’horizontal’ resistance, which was defined as being polygenic and non-
race specific (Parlevliet and Zadoks, 1977). According to this model, host genes leading
to immunity were termed resistance genes (R-genes) and the corresponding pathogen
genes being recognized by these R-genes were termed avirulence genes (Avr genes).
However, this model left an open question regarding pathogen evolution: How does the
pathogen benefit from the presence of an Avr gene? This problem was resolved by the
discovery that an Avr gene product of Xanthomonas campestris, AvrBs2, is necessary
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for full virulence (Kearney and Staskawicz, 1990); subsequently, an increasing number
of Avr genes was associated with virulence functions, and it became clear that virulence
and avirulence are indeed often two sides of the same coin, based on a single pathogen
protein (Swords et al., 1996, Vivian and Gibbon, 1997). Since then, the term ’effector’
has been used increasingly instead of ’Avr protein’ in order to reconcile virulence and
avirulence characteristics of the same protein under a more neutral term (Kjemtrup et al.,
2000).
Going ’Zig-Zag’ In an effort to unify the apparently two-sided nature of plant immunity
(MAMP/PAMP triggered immunity based on pattern recognition (PTI), broadly corre-
sponding to the historic ’horizontal’ resistance, and effector triggered immunity (ETI)
based on effector recognition, broadly corresponding to the historic ’vertical’ resistance),
the ’zig-zag’ model was introduced (Jones and Dangl, 2006). This model explains the
interplay of PTI and ETI as a staggered process in which PTI can be overcome by effector
virulence action to result in effector-triggered susceptibility (ETS), which can then in turn
be overcome through the evolution of novel R-genes against specific effectors, resulting
in ETI; the process would be repeated over and over in an ’evolutionary arms race’ (Jones
and Dangl, 2006, Boller and He, 2009). Importantly, this model defined quantitative
differences in magnitude of the defence response as a hallmark division between PTI
and ETI, with only ETI reaching the highest possible magnitude, exemplified by the
hypersensitive response (HR), a form of localized cell death (Heath, 2000).
1.4.2.2 ETI systems
Structural aspects Recognition events in early ETI studies using tobacco and tomato
pathosystems (Whitham et al., 1994, Salmeron et al., 1996) were soon found to be
linked to a distinct class of immune receptors, termed NB-LRR or NLR proteins for their
domain structure, which includes a nucleotide binding (NB) domain and a number of
LRRs (Bent, 1996, Meyers et al., 1999). NLR-like immune receptors exist in animals
and plants, but despite structural and functional similarity, they are likely a product of
convergent evolution (Bonardi and Dangl, 2012). In contrast to animal NLRs, plant
NLRs are numerous and highly polymorphic (Bakker et al., 2006, Guo et al., 2011); the
expanded role in plant immunity is likely caused by the increased need for specificity due
to lack of an adaptive immune system (Yue et al., 2012). Two major classes of NLRs in
plants have been defined by the presence of either a TIR domain or a coiled coil (CC)
domain at the N terminus adjacent to the NB domain, resulting in a tripartite domain
architecture of TIR/CC-NB-LRR domains; these classes are termed TNL and CNL,
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respectively (Takken and Goverse, 2012, Ma et al., 2012a). The crystal structures of
TIR and CC domains have been elucidated and, in an intriguing similarity to animal
TLR function, revealed self-association and homodimerization as a crucial element in
receptor activation; importantly, CNLs self-associate before, TNLs after effector-triggered
activation (Bernoux et al., 2011, Maekawa et al., 2011). Mechanistically, structural
data indicates that NLRs bind ADP in an autoinhibited, resting state and conformationally
change into the signalling-competent R proteins upon effector perception, exchange ADP
to ATP, and undergo further conformational changes initiating downstream signalling
which ultimately leads to defence gene activation in the nucleus and a HR response
(Takken and Goverse, 2012, Qi and Innes, 2013). Interestingly, downstream pathways
triggered by NLRs seem to be strongly conserved in the plant kingdom despite the high
degree of NLR polymorphism (Maekawa et al., 2012), and NLR proteins have been
implicated in immunity-related functions other than the recognition of pathogen effectors
(Bonardi et al., 2011).
Guards and decoys As many microbial effector proteins are secreted into the plant cell,
intracellular perception was defined as an important difference of ETI compared to the
generally membrane-bound PTI mechanisms (Jones and Dangl, 2006). Early work with
R-gene systems has therefore focused on dissecting intracellular recognition mechanisms
(Hammond-Kosack and Jones, 1996). The most immediately intuitive way of effector
recognition is direct, physical interaction with a plant receptor, and indeed this mode of
recognition has been observed in diverse host/pathogen systems such as rice blast (Jia
et al., 2000), bacterial wilt caused by Ralstonia solanacearum (Deslandes et al., 2003),
and flax rust (Dodds et al., 2006, Catanzariti et al., 2010). However, a large number
of effector / R-protein recognition pairs does not operate via direct physical interaction.
To explain this phenomenon, the ’guard’ hypothesis was introduced, which states that
the effector’s action on a virulence target is perceived indirectly by the R-protein, with
the R-protein thus acting as ’guard’ to a effector-targeted ’guardee’ (Van Der Biezen
and Jones, 1998, Dangl and Jones, 2001). As an example, the Arabidopsis protein
Resistance to Pseudomonas maculicola 1 (RPM1)-interacting protein 4 (RIN4), a multi-
faceted component in immunity regulation (Day et al., 2006, Liu et al., 2009), is targeted
by multiple P. syringae effectors via distinct molecular mechanisms (Kim et al., 2005b,
Kim et al., 2005a, Wilton et al., 2010, Sun et al., 2014). However, effector modification
of RIN4 is sensed by two classical R-proteins, RPM1 and Resistance to Pseudomonas
syringae protein 2 (RPS2), to induce ETI responses (Axtell and Staskawicz, 2003,
Mackey et al., 2003). In addition to dispensing with the need for direct interaction, the
guard model resolved another perceived internal contradiction of the original gene-for-
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gene hypothesis; namely, the fact that a single R-protein can detect multiple effectors
(Dangl and Jones, 2001). Intriguingly, recent studies demonstrated that a single NLR
R-protein can indeed directly interact with and recognize multiple effectors (Cesari et al.,
2013). However, the guard model posed some other conceptual problems: to avoid
virulence action by effectors, a guarded target should be under evolutionary pressure to
evade effector binding, which would in turn limit the use of guard proteins in effector
recognition. Thus, the ’decoy model’ was proposed as a refinement to the guard model;
in essence, it postulates that a guarded protein might have evolved to serve no other
intrinsic molecular function than to be bound by the effector and thus, serve as a danger
signal to the corresponding guarding R-protein (Hoorn and Kamoun, 2008, Khan et al.,
2016). This model implies that decoy proteins are effectively a molecular mimicry of
the effector’s original virulence target, and may have evolved either independently or
from these virulence targets by gene duplication. Interestingly, recent studies show that
molecular decoys could exist not only as dedicated proteins but rather as single functional
domains within R-proteins, such as NLRs carrying C-terminal WRKY domains which
mimic effector-targeted WRKY transcription factors (Le Roux et al., 2015, Sarris et al.,
2015). However, as the designation of a plant protein as decoy is by necessity based
on negative data (apparent lack of a molecular function of the guarded protein), there is
ongoing discussion whether the decoy designation is appropriately reflecting biological
reality (Block and Alfano, 2011).
1.4.2.3 The Pto-Prf system
Indirect recognition The classical P. syringae / tomato gene-for-gene resistance pair
avrPto / Pto (Ronald et al., 1992, Martin et al., 1993, Rommens et al., 1995), the
critical determinant for the resistance to bacterial speck disease in tomato (Scofield et
al., 1996), was described to be functionally dependent on another tomato gene, Pseu-
domonas resistance / fenthion sensitivity (Prf ), a member of the NB-LRR family with
an atypically long N-terminal extension (Salmeron et al., 1996). Initiation of ETI sig-
nalling in response to AvrPto perception was linked to direct physical interaction between
AvrPto and Pto, a serine-threonine kinase (Tang et al., 1996). Mutational analysis of Pto
showed that its kinase activity is not necessary for the interaction with AvrPto, but for
the Prf-dependent induction of HR; additionally, constitutively kinase-active Pto led to
Prf-dependent HR in the absence of AvrPto (Rathjen et al., 1999, Sessa et al., 2000).
These data strengthened the notion that Pto works in conjunction with Prf to form a
signalling-competent complex (Mucyn et al., 2006, Balmuth and Rathjen, 2007), a
model generally consistent with the previously described guard hypothesis (Xiao et al.,
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2003). In addition to AvrPto, a second sequence-unrelated P. syringae effector, AvrPtoB,
is also recognized through interaction with Pto (Kim et al., 2002, Dong et al., 2009).
Phosphorylation switches The structure of the AvrPto-Pto complex was resolved in
2007, demonstrating the mechanistic basis for effector perception through manipulation
of discreet phosphorylation residues on Pto (Xing et al., 2007). AvrPto acts as a kinase
inhibitor, and its interaction with the Pto P+1 loop occurs structurally similar to that of the
cAMP-dependent protein kinase A (PKA) with its pseudosubstrate peptide inhibitor PKI
(Bossemeyer et al., 1993), directly manipulating the activation segment of Pto; beside the
structural data, quantitative AvrPto-dependent inhibition of in vitro Pto autophosphoryla-
tion could be demonstrated (Xing et al., 2007), in clear contrast to previous postulations
that activation of Pto kinase activity by AvrPto recognition initiated ETI signalling (Tang
et al., 1999). However, mutational analysis showed that AvrPto-mediated inhibition of
kinase activity is not the signal trigger per se, as discreet point-mutated variants of Pto,
which were insensitive to kinase-inhibition by AvrPto, constitutively triggered HR (Xing
et al., 2007). This suggested a negative-regulatory function of Pto acting on Prf, which
could be abolished through disrupting the Pto P+1 loop by AvrPto binding; a notion
which gained further traction in subsequent studies linking negative regulation of Prf
by Pto-like kinases to Fen, a kinase structurally similar to Pto and required for fenthion
sensitivity in tomato (Mucyn et al., 2009).
Dimerization model of Pto-Prf function These findings could be substantiated in later
studies, which proposed refinements to the molecular function of the Pto/Prf complex.
The complex was found to be oligomeric, with at least two Prf molecules associating
with Pto; both Prf dimerization and Pto association were found to be mediated by the
previously mentioned atypical, extended N-terminal domain of Prf (Gutierrez et al.,
2010, Saur et al., 2015). Detailed investigation of differentially phosphorylated forms of
Pto led to a dimerization-based model for complex activation (Ntoukakis et al., 2013).
In its resting state, autophosphorylated Pto associated with Prf acts as a sensor domain in
a multimeric receptor complex, with different Pto moieties brought into close proximity
to each other through Prf dimerization. Upon AvrPto binding to Pto, disruption of the
Pto P+1 loop through the kinase-inhibiting function of AvrPto activates the second Pto
molecule (either directly or through Prf), which acts as ’helper’ moiety and subsequently
transphosphorylates the first Pto moiety to result in a fully activated complex, thus acting
as a ’helper kinase’. Taken together, this model postulates the evolution of an intricate
’bait-switch’ type of receptor complex acting as a ’molecular trap’ of effector molecules
(Ntoukakis et al., 2014).
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1.4.3 Limits of classification
Obvious limitations Recent reviews pointed out limitations to the classical ’zig-zag’
model postulating two distinct branches of plant innate immunity (PTI and ETI), as it fails
to describe cases such as necrotrophic pathogens benefiting from host cell death, neglects
DAMPs, postulates a staggered sequence of events that occur on vastly different spatial
and time scales, and marks a quantitative nature to defense response outputs that cannot in
reality be constrained to monolithic perception categories (Pritchard and Birch, 2014).
Danger signal continuum Additionally, as briefly mentioned previously, the classifi-
cation of a danger signal as either ’MAMP’ and ’effector’ is problematic by itself (Boller
and Felix, 2009, Thomma et al., 2011): Whenever a pathogen molecule harboring a
MAMP motif contributes to the virulence of the pathogen, it might be labeled an ef-
fector, as in the case of cytolytic NLPs (Böhm et al., 2014a). Detection of molecules
classically labeled as effectors is not limited to the intracellular space, as in the case
of bacterial harpins, which are targeted and perceived extracellularly; additionally they
are widely conserved in different bacterial clades (as in the the classical definition of a
MAMP) and lead to immune responses similar to classical ETI responses (Tampakaki
and Panopoulos, 2000, Chang and Nick, 2012, Choi et al., 2013).
Signalling networks It is hard to separate downstream responses as belonging solely
to PTI or ETI; for example, significant overlap exists between the responses induced
by flg22 or an apoplastic oomycete effector, Avr9 (Navarro et al., 2004); it has been
proposed that the observed differences in PTI and ETI responses arise from differential
input into the same downstream network (Tsuda and Katagiri, 2010, Gassmann and
Bhattacharjee, 2012), and quantitative differences might result from the ETI branch
removing negative regulation of the PTI branch (Cui et al., 2015). Additionally, upstream
PTI and ETI components are partially confounded, as proteins generally linked to either
branch of immunity exist as physically associated complexes at the plasma membrane,
suggesting mechanistic integration (Qi et al., 2011).
Removing barriers Recently, in an effort to reduce category barriers in plant innate
immunity signalling, an inclusive ’invasion model’ has been proposed which aims to
strictly classify molecules according to their physiological role in the originator organism,
and summarize any perception in another organism as ’invasion pattern perception’
agnostic of the exact result of this perception, which might include different types of
defence response or symbiosis (Cook et al., 2014). In summary, while straightforward
descriptive models of the interplay between host and microbes are conceptually helpful,
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the underlying mechanisms governing such interactions are apparently too complex to be
accurately described by such models; and as the expanding body of research moves away
from a few intensely-studied model systems, the growing number of ’exceptions to the
rule’ only heightens the awareness of these conceptual limitations and illustrates the need
for more integrative models.
1.5 Microbial effectors: molecular agents of virulence
1.5.1 Effector evolution, networks, and interplay
Evolution shaping the ’effectome’ A pathogen’s effector repertoire is a critical deter-
minant of its virulence and thus, its success of host adaptation, as reflected through host
range and specificity (also see section 1.3.2). Effector genes have been found flanked
by mobile elements (Kim et al., 1998); horizontal gene transfer is an important mech-
anism for the evolution of effector repertoires (Nogueira et al., 2009), and pathogen
strains contain both recently acquired and evolutionary ancient effectors (Rohmer et al.,
2004). The fact that many pathogen effectors lack homology to other bacterial proteins
posed questions towards their origin, and indeed the similarity of several effectors to
bacteriophage proteins has led to the hypothesis that phages serve as important vectors
for the introduction of novel effectors into bacterial genomes (Stavrinides et al., 2008).
Beside horizontal transfer of novel effectors, pathoadaptation (clonal descent with modifi-
cations in classical Darwinian form) is a major drive to effector diversification, and can
mediate the ’arms race’ to avoid detection while conserving the virulence function (Ma
et al., 2006, McCann and Guttman, 2008). Conservation of a large part of effectors
in different P. syringae pathovars suggests the maintenance of a core set of effectors
to maintain general virulence (Sarkar et al., 2006). With the increasing availability of
sequenced genomes, this concept has been extended to other pathogens such as Xan-
thomonas campestris (Guy et al., 2013) and Ralstonia solanacearum (Ailloud et al.,
2015).
Virulence targets As the discovery of novel effector proteins has continued at a steady
pace, a variety of different virulence strategies has become apparent (Abramovitch and
Martin, 2004, Block et al., 2008, Deslandes and Rivas, 2012), occuring at all stages
of infection (Asai and Shirasu, 2015). Even limiting analysis to intracellular effectors
and the P. syringae model pathogen, the array of virulence functions is dazzling: var-
ious effectors interfere with host protein turnover (Nomura et al., 2006), subcellular
localization (Jelenska et al., 2014), transcription processes (Nicaise et al., 2013), hor-
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mone homoeostasis (Hann et al., 2014), and phosphorylation-dependent downstream
signalling (Zhang et al., 2007). Beside host proteins, some effectors target nucleic acids;
transcription-activator-like effectors (TALEs) mimic transcription factors and bind to
host promoter regions (Boch et al., 2009) to modulate gene expression to the pathogen’s
benefit (Kay et al., 2007, Römer et al., 2007). A large-scale genomic analysis has pro-
vided insight into the effector-effector target interactome, indicating that a wide variety of
effectors from multiple pathogen clades evolved to bind relatively few, highly connected
host targets (Mukhtar et al., 2011); an example would be the previously mentioned
RIN4 (Sun et al., 2014). From the pathogen’s viewpoint, this is highly advantageous as
targeting these ’hubs’ maximizes the amount of disruption to the host’s immune system
and results in difficulty for the plant to evolutionarily eliminate targeted proteins due to
their functional involvement in multiple pathways. Conversely, these findings conceptu-
ally support the guard hypothesis, as effector-targeted hubs are also good candidates for
guarding by R-proteins.
1.5.2 BAK1 as an effector target
One stone, many birds Due to its central role as a co-receptor in PRR signalling
(section 1.4.1.5), BAK1 would be a prime ’hub’ type target for pathogen effectors. Indeed,
prompted by the curious discovery that Arabiopsis plants constitutively expressing the
P. syringae effector AvrPto phenotypically mimic weak bri1 mutants, suggesting an effect
on a component involved in BR signalling, an interaction between AvrPto and BAK1
(but not BRI1) could be observed in vivo in immunoprecipitation assays (Shan et al.,
2008). Additionally, the same interaction could be observed for AvrPtoB. This provided
an elegant explanation for previous observations that AvrPto and AvrPtoB interfere
with multiple PRR pathways (He et al., 2006), although AvrPto was hypothesized to
additionally target BAK1-independent PRRs (Lu et al., 2010a).
More stones In additon to AvrPto and AvrPtoB, another P. syringae effector, Hrp outer
protein F2 (HopF2), an ADP ribosyltransferase previously shown to inhibit mitogen-
activated protein kinase (MAPK) cascades (Wang et al., 2010), was found to target BAK1
(Zhou et al., 2013). Taken together, these studies demonstrate a striking redundancy in
P. syringae’s effector arsenal indicative of a truly high-value target. Targeting BAK1 is
not limited to the P. syringae model pathogen – a recent study shows that Xoo2875, an
effector of the rice pathogen Xanthomonas oryzae with various conserved homologs in
Xanthomonas species, targets OsBAK1 (Yamaguchi et al., 2013).
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Targeting kinases – a common theme? Elucidation of the co-crystal structure of
AvrPtoB bound to BAK1 demonstrated similarities of the molecular determinants for both
AvrPtoB’s virulence, mediated through BAK1, and recognition, mediated through Pto
(Cheng et al., 2011). Importantly, this together with the previously mentioned studies
pointed to a common theme – the structural similarity of intracellular kinase domains
of RLKs might prompt the same effector to bind multiple targets, as demonstrated by
previous studies showing AvrPtoB-mediated degradation of FLS2 (Göhre et al., 2008)
and AvrPto binding to both FLS2 and EFR (Xiang et al., 2008). Recently, the effector
HopAO1, a tyrosine phosphatase (Underwood et al., 2007), was demonstrated to directly
reduce EFR tyrosine phosphorylation, an important regulatory switch in PRR signalling;
subsequent experiments also demonstrated interaction with FLS2, but notably, not with
BAK1 or CERK1 (Macho et al., 2014). The precise molecular mechanisms which
determine binding specificity of kinase-targeting effectors thus remain to be elucidated.
1.6 Aims of this thesis
Previous studies resulted in conflicting datasets regarding the virulence target of the
Pseudomonas syringae effector AvrPto in the model organism Arabidopsis thaliana,
either demonstrating interaction with FLS2 (Xiang et al., 2008, Xiang et al., 2011), but
not BAK1 (Xiang et al., 2011), or demonstrating interaction with BAK1, and qualitatively
weaker interaction with FLS2 (Shan et al., 2008, Zhou et al., 2013). A common aspect
of these studies was the reliance on experimental in vivo approaches for determining
protein-protein interactions, thereby precluding quantitative analysis, which is a hallmark
of in vitro techniques (Lalonde et al., 2008). The initial working hypothesis of this
thesis was that the conflicting datasets of the previous studies could at least partially be
explained if AvrPto binds to all previously reported plant RLK virulence targets (due to its
mechanistic background as a kinase inhibitor), but with differential affinity obscured by
the qualitative nature of the experiments. To address this issue, the aim of this thesis was
the use of in vitro approaches to describe the molecular interactions between AvrPto and
its putative virulence targets quantitatively, thereby permitting conclusions regarding the
effector’s evolutionary background and its primary mode of action in the establishment of
virulence.
CHAPTER 2
MATERIALS
2.1 Consumables
The following tables list suppliers of chemicals (table 2.1), commercial biologicals
(table 2.2), and miscellaneous consumables (table 2.3) which have been used in this work.
Table 2.1 Chemicals
Type Supplier (location)
Basic Chemicals Sigma Aldrich (Taufkirchen), Carl Roth (Karlsruhe), Fisher
Chemical (Schwerte), Merck (Darmstadt), VWR (Darm-
stadt), Serva (Heidelberg), Avantor (Griesheim), BD Bio-
sciences (Heidelberg), Nanotemper (München),
Antibiotics Carl Roth (Karlsruhe)
Pharmaceuticals Roche (Grenzach-Wyhlen)
Table 2.2 Commercial biologicals
Type Supplier (location)
Oligonucleotides Eurofins MWG Operon (Ebersberg)
Peptides GenScript (Piscataway)
Enzymes Thermo Fisher (Braunschweig), Duchefa (Haarlem),
Yakult (Tokyo)
Antibodies Sigma Aldrich (Taufkirchen), Thermo Fisher (Braun-
schweig), Chromotek (München)
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Table 2.3 Miscellaneous consumables
Type Supplier (location)
Consumables for Nu-
cleic Acid and Protein
Methods
Thermo Fisher (Braunschweig), Carl Roth (Karlsruhe), Sar-
torius (Göttingen), GE Healthcare (München), Nanotem-
per (München)
Laboratory Plastics MultiMed (Kirchheim/Teck), Eppendorf (Hamburg)
2.2 Microbiological media
All media (table 2.4) were prepared with the listed components dissolved in ultra-pure
water (Milli-Q® system, Merck Millipore). Unless stated otherwise, all given percentages
are weight per volume (w/v). Solid media were prepared by adding agar-agar to liquid
media at a concentration of 15 gL−1. All media were autoclaved (121 °C, 20 min) before
use. For resistance-based selection of microbes, antibiotics (table 2.5) were added at the
indicated concentrations after autoclaving.
Table 2.4 Microbiological media
Type Formulation
Component Concentration (gL−1)
Lysogeny Broth (LB) Tryptone 10
Yeast Extract 5
NaCl 10
Terrific Broth, High Density Tryptone 10
(TB-HD), pH 7.5 Yeast Extract 24
Glycerol 3.16
KH2PO4* 0.23
K2HPO4* 1.25
Super Optimal Broth (SOB) Tryptone 20
Yeast Extract 5
NaCl 0.5
KCl 0.19
Super Optimal Broth with same as SOB, but including:
catabolite repression (SOC) D-Glucose* 3.6
Components marked with an asterisk (*) were sterilized seperately and added after autoclaving
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Table 2.5 Antibiotics
Type Concentration (µgmL−1)
Carbenicillin 100
Chloramphenicol 34
Tetracyclin 15
Kanamycin 20
2.3 Plasmid constructs
Table 2.6 lists the plasmid constructs used in this work.
Table 2.6 Plasmids and synthetic constructs
Name Usage Reference
pet22-BAK1K bac. expression, AtBAK1 kinase domain N. Wagener
pet22-S286A bac. expression, AtBAK1 S286A mutant this work
pet22-K317E bac. expression, AtBAK1 K317E mutant this work
pet22-Y403F bac. expression, AtBAK1 Y403F mutant this work
pet22-T324G bac. expression, AtBAK1 T324G mutant this work
pet22-T324D bac. expression, AtBAK1 T324D mutant this work
pet22-BRI1K bac. expression, AtBRI1 kinase domain N. Wagener
pet22-FLS2K bac. expression, AtFLS2 kinase domain N. Wagener
pJC40-BAK1K bac. expression, AtBAK1 kinase domain this work
pJC40-mOAvrPto bac. expression, PsAvrPto-mOrange this work
pJC40-Pto bac. expression, SlPto this work
pUri bac. expression, AtUricase R. Willmann
pGWB17-BAK1 Protoplast expression, AtBAK1 this work
pFRK1-Luc Protoplast expression, AtFRK1 (Zheng et al., 2014)
pAvrPto Protoplast expression, PsAvrPto (Zheng et al., 2014)
2.4 Bacteria
Table 2.7 lists the bacterial strains used in this work. All listed strains belong to the
bacterial species Escherichia coli.
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Table 2.7 Bacterial strains
Name (Supplier) Genotype Usage
XL1-BLUE
(Stratagene)
endA1 gyrA96(nalR) thi-1 recA1
relA1 lac glnV44 F’[::Tn10
proAB+ lacIq ∆(lacZ)M15]
hsdR17(rK- mK+)
Molecular Cloning,
Plasmid Propagation
ROSETTA(DE3)PLYSS
(Novagen)
F- ompT hsdSB(RB- mB-) gal dcm
λ(DE3 [lacI lacUV5-T7 gene
1 ind1 sam7 nin5]) pLysSRARE
(CamR)
Bacterial Expression
BL21(AI)
(Thermo Fisher)
F- ompT galdcm lon hsdSB(rB-
mB-) araB::T7RNAP-tetA
Bacterial Expression
2.5 Plants
Table 2.8 lists the genotypes of Arabidopsis thaliana used in this work. All mutant
genotypes are in the Columbia (Col-0) background. Plants were used for the isolation of
protoplasts as described in section 3.2.2.
Table 2.8 Plant genotypes
Name Stock Name Reference
Col-0 N/A N/A
bak1-4 SALK_116202 Kemmerling et al., 2007
bak1-5 × bkk1-1 N/A Schwessinger et al., 2011
CHAPTER 3
METHODS
3.1 Microbiological methods
3.1.1 General handling of bacteria
3.1.1.1 Transformation of E. coli
Chemically competent E. coli of strains listed in Table 2.7 were created using a high-
efficiency protocol (Inoue et al., 1990).
To transform chemically competent bacteria, frozen aliquots (−80 °C) were thawed on ice
for 10 min. Plasmid DNA (c = 100−500 ngµL−1) was added to thawed cells followed
by an incubation period of 15 min on ice. After resuspension by careful swirling, cells
were subjected to a heat shock of 42 °C for 45 sec., then briefly cooled on ice. 250 µL of
sterile room-temperature SOC medium (see table 2.4) without antibiotic was added to the
cells. The cells were then incubated at 37 °C for 1 h to allow expression of plasmid-borne
resistance markers. After this growth period, cells were collected by centrifugation
(5000 ×g, 5 min) and resuspended in 50 µL of SOC medium. The cells were then plated
on LB-Agar plates containing the appropriate selection marker (see tables 2.4 and 2.5)
and incubated overnight at 37 °C.
3.1.1.2 Propagation and storage of E. coli
To propagate E. coli, freshly transformed single colonies were picked from a LB-Agar
plate and used to inoculate 20 mL of LB medium containing the appropriate antibiotic
for selection. The liquid culture was incubated in a shaker (37 °C, 200 rpm) until an
OD600 of 0.6 to obtain a vital culture in the mid-log growth phase. This liquid culture was
then used as a starter culture for further use in DNA or protein preparations (see sections
3.1.1.3 and 3.1.2.1).
For long-term storage of E. coli, an aliquot of 300 µL of a mid-log phase culture was
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mixed with sterile glycerol to a final glycerol concentration of 40 % and flash-frozen in
liquid N2. The frozen stock was then kept at −80 °C until further use.
3.1.1.3 Cultivation of E. coli for DNA extraction
To cultivate E. coli for DNA extraction, a mid-log phase starter culture was used to
inoculate either 5 mL (small-scale) or 500 mL (large-scale) of LB medium containing the
appropriate selection marker. The cultures were incubated for 16 h in a shaker (37 °C,
200 rpm). After incubation, cultures were spun down in a centrifuge (Sorvall RC-6+) and
either used directly or stored at −25 °C until further use. Subsequently, DNA extraction
was performed as described in sections 3.3.1.1 (small-scale) and 3.3.1.2 (large-scale).
3.1.2 Heterologous protein expression in bacteria
3.1.2.1 Cultivation of E. coli for protein extraction
For heterologous expression of proteins, synthetic constructs containing complementary
DNA (cDNA) coding for proteins of interest were cloned into plasmids suitable for
bacterial expression (see table 2.6 for an overview of all constructs). Plasmids were
transformed into E. coli strains ROSETTA or BL21AI (see table 2.7).
A single colony was picked from the transformation plate and used to inoculate a starter
culture of 20 mL of LB medium containing the appropriate selection marker. The starter
culture was then cultivated in a shaker (overnight; 22 °C, 240 rpm) until an OD600 of
0.6. At this point, the culture was used to inoculate 500 mL of pre-warmed selective
medium (LB for expression in ROSETTA, TB-HD medium for expression in BL21AI; see
table 2.4) and transferred to a larger cultivation vessel (Erlenmeyer flask, total capacity
2 L). Bacteria were incubated further until an OD600 of 0.6. At this point, the expression
culture was scaled up to its final volume by distributing the starter culture into 5 flasks
with a final volume of 400 mL of pre-warmed selective growth medium each. Cultivation
was then continued until an OD600 of 0.6 to allow induction of protein expression at
optimal cell vitality.
3.1.2.2 Induction of protein expression
To induce protein expression, inducer was added to mid-log growth phase cultures (OD600
of 0.6).
For expression in ROSETTA, Isopropyl β -D-1-thiogalactopyranoside (IPTG) was added to
a final concentration of 1 mM. After addition of IPTG, cells were transferred to 28 °C and
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incubation was continued at 250 rpm. After 4 h, cells were harvested by centrifugation
(8000 rpm, 15 min), shock-frozen in liquid N2 and stored at −80 °C until further use.
For expression in BL21AI, L-Arabinose was added to a final concentration of 0.05 %. Af-
ter addition of L-Arabinose, cells were transferred to 18 °C and incubation was continued
at 250 rpm. After 16 h, cells were harvested and stored as described above.
3.1.2.3 Optimization of expression parameters
In order to optimize expression of proteins of interest, parameters such as inducer concen-
tration, expression temperature, expression time, and presence of detergent during protein
extraction were analysed.
Inducer concentration To test optimal inducer concentrations, three identical small-
scale cultures (20 mL in Erlenmeyer flasks of 100 mL total volume) in mid-log growth
phase were induced in parallel with hundred-fold titrations of inducer. For IPTG, con-
centrations of 10 µM, 100 µM, and 1 mM were tested. For L-Arabinose, concentrations
of 0.005 %, 0.05 %, and 0.5 % were tested. Expression was performed (as described in
section 3.1.2), total soluble protein was extracted (as described in section 3.1.2.4) and
the amount of the protein of interest in raw extracts was visualized via Sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) followed by Coomassie brilliant
blue (CBB) staining (as described in section 3.4.4).
Expression time and temperature To test optimal expression time and temperature,
time-course experiments were performed. Two identical small-scale cultures were pre-
pared as described above. Just before induction, a sample of 1 mL was collected, spun
down in a microcentrifuge (10000 ×g, 1 min), and flash-frozen in liquid N2. After
induction, the flasks were incubated further at 28 °C and 18 °C, respectively. For the
culture grown at 28 °C, samples were collected as described above at time points 0.5 h,
1 h, 2 h, 3 h, 5 h, and 16 h. For the culture grown at 18 °C, samples were collected at time
points 3 h, 5 h, and 16 h. At each time point, the OD600 of the culture was measured to
normalize for cell number. After collection of all samples, total protein was extracted
as described in section 3.1.2.4. The amount of extraction buffer used for each protein
extraction was kept proportional to the amount of cells as measured by OD600. Total
amount of protein was visualized by SDS-PAGE followed by CBB staining as referenced
above.
Protein solubility To test the solubility of the protein of interest dependent on expres-
sion conditions, expression parameters were analysed as described above and soluble
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total protein extraction (as described in section 3.1.2.4) was performed. After soluble
protein extraction, the cell pellet was resuspended again in extraction buffer supplemented
with 1 % (w/v) Sodium lauroyl sarcosinate (sarkoysl). Protein extraction, SDS-PAGE
and CBB staining was then performed as referenced above.
3.1.2.4 Extracting total soluble protein from E. coli
To extract total soluble protein from E. coli, frozen cell aliquots were thawed on ice.
Then, pre-chilled extraction buffer (50 mM Tris pH 7.6, 150 mM NaCl) was added to
cell aliquots. The amount of extraction buffer used depended on the amount of liquid
culture at the end of expression time as listed in table 3.1. Cells were resuspended and
kept on a water-ice slurry for the remainder of the procedure. The resuspended cells were
then sonicated in burst mode (Bandelin Sonoplus, probe MS-72; sonication 1 s, pause
3 s) using the culture-dependent parameters listed in table 3.1.
Table 3.1 Conditions for extracting total protein from E. coli
Vculture (mL) Vbuffer (µL) Amplitude (%) Σ Energy (kJ)
1 100 20 0.05
500 20 65 1.5
≥ 2000 50∗ 65 3
∗sonicated as two consecutive aliquots of 25 mL
After sonication, cell suspensions were spun down in a pre-cooled centrifuge (12000 ×g,
15 min, 4 °C). The supernatant was separated from the pelleted cell debris and kept on
ice until further use.
3.2 Plant methods
3.2.1 Growth conditions for A. thaliana
General cultivation A number of seeds were sown in pots on commercial soil sup-
plemented with an Imidacloprid-containing insecticide (Confidor WG70, Bayer). To
synchronize germination times, the seeds were stratified by storing them in a cold room
(4 °C) for 24 h. The vernalized seeds were then transferred to a climate-controlled growth
chamber (Saia-Burgess, Murten) with the following conditions: photoperiod of 8 h, light
intensity of 110 mE m−2 s−1, relative humidity of 60 %. Approximately 14 days after
germination, seedlings were transplanted to single pots (⊘ 6 cm) for further cultivation.
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Seed production Conditions were analogous to those listed above but with a photope-
riod of 16 h to induce flowering. Upon inflorescence formation, flowering stems were
sealed into paper bags to collect seeds. Plants were allowed to dry, and seeds were
harvested ∼4 weeks after flower formation.
3.2.2 Protoplast methods
3.2.2.1 Isolation of A. thaliana leaf mesophyll protoplasts
For isolation of Arabidopsis thaliana leaf mesophyll protoplasts, a protocol slightly
modified from Yoo et al., 2007 was used. Plants were grown under short-day conditions
for 5 weeks as described in section 3.2.1. Plants were then transferred to a temperature-
controlled room (20 °C) for further processing. All further steps in the protoplast isolation
and transfection protocols were performed at 20 °C, unless specified otherwise.
Leaf harvesting Plants were pre-selected according to size (rosette diameter ∼5 cm
for Col-0 plants, ∼3.5 cm for bak1 mutant plants) and generally healthy phenotype. As a
second selection step, up to three of the most well-formed (regularly shaped, sufficient
size) leaves from each plant were cut near the base using a razor blade. Subsequently,
the leaves were cut into thin (∼0.5 mm) strips, excluding ∼2 mm from the leaf tip and
base each and taking care not to crush any tissue at the cutting site. The leaf strips were
then transferred to a Petri dish containing 10 mL of enzyme solution (see table 3.2) and
carefully submerged using a forceps. About 50 leaves per plant genotype were cut in
total, resulting in ∼150 leaf strips per 10 mL of enzyme solution.
Protoplast extraction In order to allow the enzyme solution to penetrate the leaf tissue,
the Petri dish containing the leaves submerged in enzyme solution was placed in a
darkened desiccator and vacuum-infiltrated for 30 min. The Petri dish was then removed
from the desiccator and incubated further in the dark for 3 h. After incubation, the enzyme
solution containing the leaf strips was gently transferred to a larger Petri dish and washed
by addition of 10 mL of W5 washing buffer (see table 3.2). Protoplasts were then released
from the leaf strips by gentle swirling. The suspension was filtered through nylon mesh
to separate the leaf strips from the protoplast suspension. Protoplasts were harvested
by centrifugation in round-bottom tubes (4 °C, 100 ×g, 2 min). The supernatant was
discarded and protoplasts were resuspended in 4 mL W5 washing buffer. An aliquot of
15 µL was taken for protoplast quantification, and protoplasts were incubated in the dark
on ice for 2 h.
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Protoplast quantification To quantify protoplast yield, 15 µL of protoplast solution
(see above) were transferred to a hemocytometer (type Fuchs-Rosenthal, Paul Marienfeld).
The number of vital protoplasts (i.e. intact, spheroid, even distribution of chloroplasts)
was counted in 4 grid squares and the average used for volumetric calculations.
Table 3.2 Buffers and solutions for protoplast isolation
Type Component Concentration
mM % (w/v)
Enzyme solution Mannitol 400
KCl 20
CaCl2 10
MES pH 5.7 20
Cellulase R10 1.5
Macerozyme R10 0.4
BSA 0.1
W5 washing buffer NaCl 154
CaCl2 125
KCl 5
MES pH 5.7 2
3.2.2.2 Transfection of A. thaliana leaf mesophyll protoplasts
Transfection of protoplasts was performed using a protocol slightly modified from Yoo
et al., 2007.
Preparation After the last incubation step in the protoplast preparation protocol (see
section 3.2.2.1), the supernatant was removed from the settled protoplasts. The protoplasts
were gently resuspended in a volume of MMG solution (see table 3.3) calculated to yield
a protoplast concentration of 2×105 mL−1.
Transfection Aliquots of 600 µL of protoplast suspension (resuspended in MMG as
described above) per transfection were added to round-bottom tubes containing plasmid
DNA for the desired transfections (prepared as described in section 3.3.1.2). The proto-
plast suspension was mixed with the plasmid DNA by gentle swirling, then 660 µL of
PEG solution (see table 3.3) was added. The transfection was stopped after 5 min by
addition of 2.64 mL of W5 washing buffer. Protoplasts were harvested by centrifugation
(4 °C, 100×g, 2 min) and resuspended in 600 µL of W5 washing buffer. Protoplasts were
then ready to be used for a pFRK1-Luciferase assay as described in section 3.8.1.
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Table 3.3 Solutions for protoplast transfection
Type Component Concentration
mM % (w/v)
MMG solution Mannitol 400
MgCl2 15
MES pH 5.7 4
PEG solution Mannitol 200
CaCl2 100
PEG 4000 40
3.3 Nucleic acid methods
3.3.1 Plasmid preparation from bacteria
3.3.1.1 Small-scale preparation of plasmids
Small-scale preparation of plasmids was carried out using the GeneJET® kit (Thermo
Fisher) according to the manufacturer’s instructions, using a culture size of 5 mL.
3.3.1.2 Large-scale preparation of plasmids
Large-scale preparation of plasmids was carried out using the NucleoBond® Xtra Midi
kit (Macherey-Nagel) according to the manufacturer’s instructions, using a culture size of
500 mL.
3.3.2 DNA quantification
The amount of DNA in liquid preparations was determined using the built-in nucleic acid
quantification protocol of a NanoDrop 2000 spectrophotometer (Thermo Fisher).
3.3.3 DNA sequencing
For DNA sequencing, the LIGHTRUN™ service by GATC Biotech (Konstanz) was used
according to the service provider’s instructions. Sequencing data was analysed using the
CLC Main Workbench suite (CLCbio / Qiagen).
3.3.4 Agarose gel electrophoresis and DNA visualization
Dissolved DNA samples were separated into their constituent molecular species by
agarose gel electrophoresis.
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Gel preparation Agarose was suspended in 1× TAE buffer (40 mM Tris pH 8.5, 1 mM
EDTA), the agarose concentration being dependent on the required resolving range as
summarized in table 3.4.
Table 3.4 Agarose concentrations for resolving DNA species of differential size
%Agarose(w/v) Resolving Range (kbp)
0.5 1 – 30
0.7 0.8 – 12
1.0 0.5 – 10
1.2 0.4 – 7
1.5 0.2 – 3
Gel casting Suspended agarose was heated until boiling to facilitate dissolving, then
allowed to cool to 50 °C. Ethidium bromide was then added to the agarose solution at a
final concentration of 0.5 µgmL−1 before casting the gels. After solidifying, agarose gels
were transfered to a horizontal electrophoresis chamber (BioRad) containing 1× TAE
buffer.
Sample loading To prepare DNA samples for gel electrophoresis, the samples were
mixed with 5×DNA loading buffer (10 mM Tris pH 7.5, 60 mM EDTA, 60 % (v/v)
glycerol, 0.25 % bromphenol blue) to a final 1× concentration. Subsequently, samples
were loaded into the agarose gel and electrophoresis was performed at 100 V until the
dye front reached the lower edge of the gel.
DNA visualization After electrophoresis, stained DNA bands were visualized by UV
illumination in an E-BOX gel documentation system (Peqlab).
3.3.5 DNA extraction from agarose gels
For preparative DNA extraction from agarose gels, the GeneJET gel extraction kit
(Thermo Fisher) was used according to the manufacturer’s instructions.
3.3.6 Polymerase Chain Reaction (PCR) methods
3.3.6.1 Primer design for molecular cloning
To design primer pairs for the amplification of cDNA inserts for molecular cloning,
regions of template suitable for hybridisation were chosen manually to yield annealing
temperatures between 50 °C and 60 °C, with a maximum internal divergence of 4 °C per
pair. Melting temperatures were calculated using the salt-adjusted algorithm of the online
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tool OligoCalc (Northwestern University, Evanston), which uses the following equation
(Nakano et al., 1999):
Tm = (wA+ xT ) ·2+(yG+ zC) ·4−16.6 · log(0.050)+16.6 · log([Na+]) (3.1)
where w,x,y,z are the number of the bases A,T,G,C in the sequence, respectively.
Other molecular features such as stop codons, tags, spacers, linkers, and recognition sites
for type-III restriction enzymes were added in-frame to the target template hybridizing
region. Finally, the primers were tested in silico using the predefined PCR tools of the
CLC Main Workbench Suite (CLCbio / Qiagen).
3.3.6.2 Generation of cDNA inserts for molecular cloning
For the generation of cDNA inserts for molecular cloning, PCR reactions were set up as
summarized in the following table 3.5.
Table 3.5 Standard PCR reaction mix, Σ 50 µL
Component Volume (µL)
H2O (MILLIQ) 36
10× Polymerase buffer 5
10× dNTP mix (2 mM each) 5
Primer (fw) (50 µM) 1
Primer (rv) (50 µM) 1
Template DNA (∼1 ngµL−1) 1
DNA Polymerase (5 U µL−1) 1
To achieve maximum fidelity, Pyrococcus furiosus (Pfu) DNA polymerase (Thermo
Fisher) and its corresponding buffer stock was used for the generation of cDNA inserts.
Amplification was carried out in a thermocycler (Peqlab Primus 96advanced) using a
protocol summarized in table 3.6.
Table 3.6 Standard PCR amplification parameters
Step No Temperature (°C) Duration (min) Cycle Purpose
1 95 5 Initial Melting
×25
{
2 95 0.5 Melting
3 (Tm−4) 0.5 Primer Annealing
4 72 x Elongation
5 72 5 Final Elongation
where x = Length(template sequence in kb)×2 min.
After amplification, PCR reactions were stored at −20 °C until further use.
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3.3.6.3 Colony PCR for analytical purposes
To analyse successful ligation of an insert into a vector backbone, colony PCR was used.
Ligated plasmids were transformed into chemically competent XL1BLUE as described in
section 3.1.1.1. Single colonies were picked from the resulting transformation plate and
streaked on fresh selective agar plates. To provide plasmid template for the colony PCR,
the pipette tips which have been used for streaking the colonies were briefly dipped into
the reaction mixture. The remainder of the PCR mix and protocol are analogous to the
ones given in tables 3.5 and 3.6, respectively, with the following differences: Thermus
aquaticus (Taq) DNA polymerase (recombinant, home-made) and its corresponding buffer
(67 mM Tris pH 8.8, 16 mM (NH4)2SO4, 2.5 mM MgCl2, 0.01 % Tween-20) were used,
and elongation cycle duration was Length(template sequence in kb)× min.
To detect whether the insert has been cloned in the correct topology, the forward primer
was chosen to be vector-specific and the reverse primer to be insert-specific. After
amplification, PCR products were separated by agarose gel electrophoresis, followed by
visualization via UV illumination as described in section 3.3.4. Appearance of clear bands
at the expected size indicated successful ligation. Single colonies from the agar plates
which have been used as template were then used for inoculation of small-scale liquid
cultures as described in 3.1.1.3 and the subsequent isolation of plasmids as described in
3.3.1.1.
3.3.6.4 Site-Directed Mutagenesis (SDM) PCR
In order to generate point mutations in DNA to result in specific amino-acid exchanges
in coding sequences, a protocol modified from the commercial Quikchange 2 XL kit
(Agilent technologies) was used. This approach is a linear PCR technique based on
full-circle amplification of plasmids carrying the desired mutation.
Primer design The online tool provided by Agilent for use in the Quikchange 2 XL
kit was used to generate primer sequence pairs with Tm between 78 °C and 81 °C and a
minimal amino-acid exchange mutation in the center of the primer.
SDM protocol The PCR mix used for SDM PCR was identical to the standard PCR
mix which is listed in table 3.5. Pfu DNA polymerase was used. Table 3.7 lists the
amplification parameters for SDM PCR.
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Table 3.7 SDM PCR amplification parameters
Step No Temperature (°C) Duration (min) Cycle Purpose
1 95 1 Initial Melting
×18
{
2 95 0.833 Melting
3 60 0.5 Primer Annealing
4 68 x Elongation
5 68 5 Final Elongation
where x = Length(plasmid sequence in kb)×2 min.
After amplification, the PCR mix was supplemented with 0.5 µL of DpnI restriction
enzyme (10 U µL−1) and incubated for 1 h at 37 °C to specifically cleave methylated
DNA (template plasmid). After DpnI digestion, 10 µL of the reaction was transformed
into 100 µL of chemically competent XL1BLUE cells as described in section 3.1.1.1.
Analysis of SDM Mutagenesis was evaluated by sequencing 3 clones per reaction as
described in section 3.3.3 with suitable primers upstream of the mutated site and aligning
the DNA sequences with the wild-type template sequence.
3.3.7 Molecular cloning
Depending on the vector backbone used, cDNAs were cloned via either restriction-ligation
(section 3.3.7.1) or the commercial GATEWAY system (section 3.3.7.2).
3.3.7.1 Restriction-ligation cloning
Insert preparation For restriction-ligation type cloning, inserts were generated by PCR
as described in section 3.3.6 with primers containing the appropriate type-III restriction
enzyme recognition sites. Recognition sites were chosen in a way that excluded them both
from the insert coding sequence and from the vector backbone outside of the multiple
cloning site. To generate 3’ overhangs for cloning, PCR products were gel-purified as
described in sections 3.3.4 and 3.3.5, followed by restriction with the appropriate enzymes
(double digest). A sample restriction digest mix is summarized in table 3.8.
3.3 Nucleic acid methods 44
Table 3.8 Standard restriction reaction mix, Σ 100 µL
Component Volume (µL)
H2O (MILLIQ) 25
10× Restriction enzyme buffer 10
Restriction enzyme No 1 (10 U µL−1) 5
Restriction enzyme No 2 (10 U µL−1) 5
Gel-purified PCR product 50
Notes: Restriction enzyme buffer was chosen to provide the best possible performance for
both restriction enzymes and to avoid star activity. Relative amounts of both restriction
enzymes were varied according to their activity in the chosen buffer, e.g. double amount
of a restriction enzyme was chosen if it was expected to exhibit a 50 % reduction of
activity in the buffer used.
Following restriction digest, restriction enzymes were heat-inactivated according to
the supplier’s instructions and the restriction fragments were separated by agarose gel
electrophoresis as described in section 3.3.4. The target band corresponding to the
digested insert fragment was then excised as referenced in section 3.3.5.
Vector preparation Plasmid DNA was extracted from E. coli cultures as described
in section 3.3.1.1. The plasmids were then digested (with the same restriction enzymes
used to prepare the insert) to linearize the plasmids via double strand breaks, excise the
fragment of multiple-cloning-site between the restriction enzyme recognition sites, and
create 3’ overhangs suitable for ligation, analogous to the process described above. The
plasmid DNA was then separated and gel-purified as referenced above.
Ligation To ligate the previously prepared insert and vector DNA, a ligation mix was
prepared as summarized in table 3.9. The ligation reaction was incubated for 12-16 h at
16 °C, followed by heat-inactivation of ligase (80 °C, 15 min).
Table 3.9 Standard ligation reaction mix, Σ 20 µL
Component Volume (µL)
H2O (MILLIQ) 13
10× T4 DNA ligase buffer 2
T4 DNA ligase (5 Weiss U µL−1) 1
Vector DNA 2
Insert DNA 2
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Note: The ratio of vector DNA to insert DNA was varied according to their relative length
(in bp) to provide a 1:1 molar ratio of cohesive ends.
Following ligation, the reaction mixture was digested with a restriction enzyme cho-
sen to only cut any original (’empty’) vector DNA still present to optimize transformation
of the ligation mix. This was achieved by selecting a recognition site present in the piece
of multiple-cloning site that was expected to be eliminated during vector preparation.
Restriction was performed by adding 1 µL of the corresponding restriction enzyme (10
U µL−1) directly to the heat-inactivated ligation mix and incubating at 37 °C for 30 min.
Following restriction, the restriction enzyme was heat-inactivated according to the sup-
plier’s instructions. An aliquot of 1 µL of the ligation mix was then used to transform
chemically competent XL1BLUE as described in section 3.1.1.1.
3.3.7.2 GATEWAY® cloning
Cloning using the GATEWAY® system (Thermo Fisher) was performed according to the
manufacturer’s instructions.
3.4 General biochemical methods
3.4.1 Storage and handling of purified protein samples
Unless specified otherwise, purified protein samples were kept on ice at all times during
use. For short-term storage (up to 16 h), samples were stored at 4 °C. For long-term
storage, samples were divided into single-use aliquots, flash-frozen by immersion in
liquid N2 and then stored at −80 °C. For use, stored samples were thawed quickly by
addition of room-temperature buffer solution and vortexing (thawing by hand if no further
dilution of sample was desired). As soon as the sample was thawed completely, it was
transferred to ice for further use.
3.4.2 Dialysis
Buffer exchange was achieved by dialysis. Dialysis tubing of suitable molecular weight
cut-off and internal diameter was chosen and rinsed with H2O (MILLIQ) for 10 min,
followed by equilibration in target buffer for another 10 min. The dialysis tubing was
then closed on one end by clamping, filled with sample, and closed on the other end as
well. The tubing was transferred to a suitably large vessel (volume at least 1000× sample
3.4 General biochemical methods 46
volume) filled with pre-chilled (4 °C) buffer solution. Dialysis was performed for 16 h
(4 °C, stirring-rod agitation).
3.4.3 Protein quantification
Crude extracts and partially purified proteins Estimative quantification was per-
formed by separation on SDS-PAGE as described in section 3.4.4, followed by CBB
staining. For reference, a titration of bovine serum albumin (BSA) standard (1 µgmL−1,
10 µgmL−1, 100 µgmL−1, 1 mgmL−1) was included on the same gel. Sample protein
amount was estimated by comparing band intensity with the BSA standard.
Purified proteins (≥90 %, ≥100 µgmL−1) Purified protein stock solutions of suffi-
ciently high concentrations were quantified using the built-in methods of a Nanodrop 2000
spectrophotometer, taking into account the calculated molecular weight and molecular
extinction coefficient at a wavelength of 280 nm (Gill, SC; von Hippel, 1989). These
parameters were calculated based on protein sequence using the ProtParam online tool
of the ExPASy bioinformatics resource portal (Swiss Institute of Bioinformatics), which
uses the following equation for calculation of the extinction coefficient:
εProtein = N(Tyr)× ε(Tyr)+N(Trp)× ε(Trp)+N(Cystine)× ε(Cystine) (3.2)
where ε(Tyr) = 1490, ε(Trp) = 5500, ε(Cystine) = 125.
Purified proteins (≥90 %,≤100 µgmL−1) Estimative quantification of dilute purified
protein samples was performed using the commercial Roti® -Nanoquant system (Carl
Roth) according to the manufacturer’s instructions.
3.4.4 SDS-PAGE
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE, Laemmli,
1970) was used to separate proteinaceous samples under denaturing conditions. 12 %
polyacrylamide (PAA) gels were prepared to the specifications summarized in table 3.10.
Gel casting Separating gels were cast between glass plates in a vertical casting rack
(BioRad) and the top surface was covered with thin layer of isopropanol. After polymer-
ization of the separating gel, the isopropanol was discarded and the stacking gel was cast
on top of the separating gel. A comb for creating pockets for sample loading was inserted.
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Table 3.10 Gel composition for SDS-PAGE. SDS, Sodium dodecyl sulfate; AA, Acrylamide;
BAA, Bisacrylamide; APS, Ammonium persulfate; TEMED, Tetramethylethylenediamine
Type Component Concentration Volume (mL)
Resolving gel

H2O (MILLIQ) 3.2
Acrylamide mix 30 % (AA) 4
0.8 % (BAA)
Tris pH 8.8 1.5 M 2.6
SDS 10 % 0.1
APS 10 % 0.1
TEMED 0.004
Stacking gel

H2O (MILLIQ) 2.975
Acrylamide mix 30 % (AA) 0.67
0.8 % (BAA)
Tris pH 6.8 0.5 M 1.25
SDS 10 % 0.1
APS 10 % 0.05
TEMED 0.002
After polymerization of the stacking gel, the casting rack was disassembled and the gels
were either used directly or stored at 4 °C for up to 7 days.
Sample preparation Samples were mixed with 5 × loading buffer (250 mM Tris
pH 6.8, 10 % (w/v) SDS, 50 % (w/v) gylcerine, 5 % (w/v) β -mercaptoethanol, 0.002 % (w/v)
bromphenol blue) and incubated at 95 °C for 5 min. Samples were then loaded into the
sample pockets of the stacking gel.
Electrophoresis Gels were placed in a vertical electrophoresis chamber (BioRad), and
the chamber was filled with SDS running buffer (190 mM Glycine, 25 mM Tris pH 8.3,
1 % (w/v) SDS). Electrophoresis was then performed with a limiting current of 25 mA
per gel.
Staining of PAA gels After electrophoresis, gels were stained by immersion in Coomassie-
Brilliant-Blue (CBB) staining solution (1 gL−1 CBB, 50 % isopropanol, 10 % acetic acid)
for 0.5−2 h. To increase band contrast, gels were de-stained after staining by immersion
in de-staining solution (50 % isopropanol, 10 % acetic acid) for 0.5−4 h.
3.5 Protein purification
General considerations For protein purification, ÄKTA systems (ÄKTA Explorer,
ÄKTA Pure; GE Healthcare) were used. Temperature for all purification steps was 4 °C.
Before starting a purification procedure, the systems were prepared and washed according
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to the manufacturer’s instructions. Standard flow rates for all purification steps were 1
mLmin−1. All buffers used for purification were filtered, degassed and pre-chilled before
use.
3.5.1 Affinity Chromatography (AC)
Affinity chromatography was performed as a first step to purify tagged proteins. For
purification via hexahistidine tag (His-tag, Hochuli et al., 1988), Immobilized Metal ion
Affinity Chromatography (IMAC) columns containing Ni2+ ions bound to a sepharose
matrix (HisTrap FF 1 mL, GE Healthcare) were used.
Sample loading Total soluble protein was extracted from E. coli as described in sec-
tion 3.1.2.4, using extraction buffer containing a low amount of imidazole to decrease
unspecific absorption to the column during loading (50 mM Tris pH 7.6, 150 mM NaCl,
20 mM imidazole). The same buffer was used as a running buffer during purification
(buffer inlet A). Raw extracts were then loaded using the system’s sample pump at a
flow rate of 1 mLmin−1. To maximize the loaded sample amount, the sample tubing
was flushed with an aliquot of buffer directly after sample application (while still being
connected to the column) until UV absorption at 280 nm returned to baseline levels.
Sample elution After sample loading, an imidazole gradient was established by using
the system’s mixing unit to mix running buffer (see above) with elution buffer (50 mM
Tris pH 7.6, 150 mM NaCl, 500 mM imidazole). A two-step gradient was then performed,
consisting of a pre-wash step using a maximum imidazole concentration of 70 mM
(90 % (v/v) running buffer, 10 % (v/v) elution buffer), followed by an elution step using a
maximum imidazole concentration of 500 mM (100 % elution buffer). Figure 3.1 shows
a schematic representation of a typical elution profile. During the elution gradient step,
fractions (V = 1 mL) were collected continuously and stored at 4 °C. After elution was
completed, the column was washed with running buffer, and the purification procedure
was completed.
Fraction handling After collection, fractions were analysed for purity and yield by
SDS-PAGE and CBB staining as described in section 3.4.4. Depending on purity, fractions
were then either used as input for further purification procedures (e.g. size exclusion
chromatography (SEC), see section 3.5.2) or dialysed into protein storage buffer (50 mM
Tris ph 7.6, 150 mM NaCl) as described in section 3.4.2.
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Fig. 3.1 Typical elution profile for IMAC. The pre-elution washing gradient step was performed
between time points 0 min and 7 min, the elution gradient step between time points 7 min and
17 min. Elution is continued at 100 % buffer B to elute any strongly bound material prior to
column storage.
3.5.2 Size Exclusion Chromatography (SEC)
Size exclusion chromatography was performed using a gel filtration column filled with a
matrix of cross-linked agarose and dextran, with a total bed volume of 120 mL (HiLoad
16/600 Superdex 75 PG, GE Healthcare). The column was equilibrated with 240 mL (2
column volumes, CV) of running buffer (50 mM Tris pH 7.6, 150 mM NaCl) before use.
Sample loading Samples were loaded manually into an injection loop of suitable
diameter (250 µL to 25 mL) using a syringe. The contents of the loaded injection loop
were injected into the column after equilibration.
Sample elution Fractions (V = 1 mL) were collected continuously starting 120 mL
(1 CV) after sample injection.
Fraction handling Fractions were analyzed for purity and yield, and then processed
further, as described in section 3.5.1.
3.6 Kinase activity assays
Kinase activity assays were performed using a protocol modified from Horn and Walker,
1994. Recominbinant proteins with hypothetical kinase activity were expressed and
purified as described in sections 3.1.2 and 3.5.
Labelling reaction A total amount of 1 µg per sample protein was incubated in kinase
assay buffer (50 mM HEPES pH 7.6, 20 mM MgCl2, 1 mM DTT, 10 µM ATP, 10 µCi
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γ-AT32P). The reaction was incubated at room temperature for 1 h, then stopped by
addition of 5 × SDS sample buffer (see section 3.4.4).
Gel processing Samples were incubated at 90 °C for 15 min, then separated by SDS-
PAGE, stained and destained as described in section 3.4.4. The gels were then dried
by placing them on filter paper (Whatman, GE Healthcare) and incubating them in a
vacuum/heat gel drying apparatus (VWR) at 80 °C for 3 h.
Autoradiography visualization After drying, gels were placed on top of a storage
phosphor screen (BAS, GE Healthcare) and incubated inside an autoradiography cassette
for 16 h. After incubation, the screen was removed from the cassette in the dark and
transfered to a laser-based fluorescent image scanning unit (Hitachi FMBIO® III) and
exposed according to the manufacturer’s instructions.
3.7 In vitro interaction assays
Sample preparation In vitro interaction assays have been performed with aliquots of
purified proteins. Recombinant proteins were expressed and purified as described in
sections 3.1.2 and 3.5. Prior to each experiment, protein stock solutions were quantified
as described in section 3.4.3. All subsequent dilutions were made in interaction assay
buffer (50 mM Tris pH 7.6, 150 mM NaCl, 0.01% Tween-20), which is identical to protein
storage buffer except for the addition of detergent to suppress unspecific interactions.
3.7.1 Microscale Thermophoresis
3.7.1.1 Background
Molecular principle Microscale thermophoresis (MST) assays are based on the motion
of particles in a temperature gradient (thermophoresis; also called thermodiffusion or
Ludwig-Soret effect, Ludwig, 1856). This effect applies to particles ranging in size from
macroscopic colloids and aerosols to single ions in solution. Although thermophoresis
has been known for a long time, the precise molecular mechanisms governing this motion
remain largely elusive. For typical biomolecules in aqueous solutions, important factors
include size of the molecule, charge, and extent of the hydration shell; the complex
interplay of these and other factors make accurate prediction of thermophoretic behaviour
of biomolecules difficult. Experimentally, biomolecules may exhibit positive (movement
from hot to cold) or negative (movement from cold to hot) thermophoresis. Taking
general molecular diffusion into account, a steady-state situation will be reached for any
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given temperature gradient when the thermophoretic force acting on a particle equals the
diametric force of back-diffusion (see figure 3.2 for an illustration).
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Fig. 3.2 Molecular principle for thermophoresis. Top: Compartment representation. Particles
(black dots) are evenly and randomly distributed in a solution. Upon establishment of a temperature
gradient (grey), particles move due to thermophoresis until a steady-state has been reached. Upon
abolishment of the temperature gradient, particles redistribute in the solution by diffusion. The
eye symbolizes an external observer. Bottom: Apparent particle concentration over time (dashed
line) as seen by the observer .
Application to protein-protein interactions When biomolecular interactions take
place, the complex that is being formed exhibits thermophoretic behaviour that is different
to that of its isolated constituent molecules. MST assays take advantage of this by tracking
the movement of a specific biomolecule through fluorescence and using the differential
thermophoretic behavior of its possible states (i.e. isolated vs. complex-bound) to infer
the amount of complex formation (figure 3.3 A). In practise, quantitative determination
of binding affinities is possible for pairs of biomolecules by using a titration approach.
While the concentration of the observed molecule is held constant, the second molecule
is titrated over a broad range of concentrations. By setting the amount of complex being
formed into relation with the concentration of the second molecule, the affinity of the
interaction can be determined (figure 3.3 B, C).
Instrument technical background Instruments for MST assays as have been used in
this study (NT.115 platform, Nanotemper) use coupled optical systems to induce tem-
3.7 In vitro interaction assays 52
  
time
co
nc
en
tr
at
i o
n
time
co
nc
en
tr
at
i o
n
time
co
nc
en
tr
at
i o
nA
B
C
co
n c
en
tr
at
i o
n
time
co
nc
en
tr
at
i o
n
time
co
nc
en
tr
at
i o
n
time
co
nc
en
tr
at
i o
n
time
co
nc
en
tr
at
i o
n
time
co
nc
en
tr
at
i o
n
time
Fig. 3.3 Complex formation and thermophoresis. Thermophoresis-induced concentration shifts
(dashed lines) are depicted analogous to figure 3.2. One of the biomolecules (black shape) can be
observed through fluorescence, while the other (shaded diamond) can not. A, Complex formation
is reflected by a shift in thermophoretic mobility. B, Titration of the nonobserved molecule leads
to concentration-dependent shifts in apparent thermophoretic mobility for any given affinity of the
interaction. C, At a single constant concentration of the non-observed molecule, differences in
affinity are visible as differences in thermophoretic mobility.
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perature gradients (infrared laser) and measure fluorescence (UV-vis detector, excitation
by LED, emission filtering using RGB color channels) in glass capillaries of 10 µL total
internal volume. The temperature gradients induced by the infrared laser are spheroid
with a radius of ∼200 µm between the center point (highest temperature) and a 70 %
temperature drop point (Jerabek-Willemsen et al., 2011). Temperature gradients are
typically on the order of 2 to 6 °C (depending on the user-adjustable instrument infrared
laser power). Typical time scales for a single capillary measurement are about 60 s with a
laser-heated phase of 30 s and continuous fluorescence signal recording. The intensity of
the fluorescence signal can be manipulated by the adjustment of excitation LED power
and the choice of a specific emission filter set. Measurements over multiple capillaries
(typically 8 to 16 capillaries per interaction) are used to calculate thermophoretically
induced signal shifts dependent on concentration of the unlabeled molecule.
3.7.1.2 Assay development and experimental procedure
Instrument and consumables Thermophoresis measurements were performed using
a NT.115 instrument (Nanotemper) with a red/green filterset. Capillaries with various
coatings (uncoated, hydrophilic, hydrophobic) and capillary trays were obtained from the
same manufacturer.
Optimization of fluorescence signal For binary interactions between the bacterial
effector protein PsAvrPto and A. thaliana RLK kinase domains, PsAvrPto was used
as the observed molecule. To this end, PsAvrPto was expressed and purified with a
fused C-terminal mOrange fluorescence tag (Shaner et al., 2004). The green filter of
the instrument and hydrophilically coated capillaries were chosen for optimal signal
of mOrange fluorescence. Using a concentration of labeled PsAvrPto of 50 nM, a
fluorescence signal of ∼ 500 counts was observed (LED power 80 %), which is within
the linear range of the instrument and was chosen as the experimental concentration.
Titrations and sample preparation Serial titrations over a total of 16 capillaries were
used. Titrations were performed in PCR tubes in a specific manner to minimize artefacts
due to pipetting inaccuracies. To each tube except the first one, 10 µL of interaction buffer
(see section 3.7) were added. An aliquot of 20 µL of the unlabelled protein at two times
the highest experimental concentration was added to the first tube. From the first tube,
an aliquot of 10 µL of protein solution was then taken, mixed with the volume of buffer
in the second tube using the same pipette tip, and transferred to the next tube, where the
same procedure was repeated. The procedure was then repeated continuously until the
last tube, after which the remaining 10 µL of sample dilution were discarded, yielding 16
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tubes with 10 µL of serially diluted unlabelled protein each. To each of the tubes, labelled
protein was then added at two times the final experimental concentration using a fresh
pipette tip for each tube. Samples were mixed by flicking, spun down (1000 ×g, 30 s)
and transferred to capillaries by directly immersing the capillaries into the tubes. The
capillaries were then transferred to an aluminium rack (figure 3.4) and inserted into the
instrument.
Fig. 3.4 Serial dilution capillary setup for MST. Equal volumes of two protein solutions are used.
The labelled protein is used at the same concentration in each capillary (shaded part of capillary),
while the unlabelled protein is diluted over the range of capillaries (grey-scale gradient, with
darker colors corresponding to higher concentration). Note: the two different protein solutions are
in reality homogeneously distributed in each capillary; an artificial division in the center of each
capillary was used for illustrative purposes.
Measurement Capillaries were measured for total fluorescence using the automated
capillary scan method of the NT.115 control software. Thermophoresis measurements
were initiated if the variance in total fluorescence between all capillaries was below 10 %
for at least 15 out of 16 capillaries (measurements with single outliers were performed
discarding the outlier capillary). Measurements were performed twice for each sample
set at 20 % and 40 % infrared laser power, respectively.
3.7.1.3 Data evaluation
Affinity determination Data evaluation was performed using the NT.115 analysis
software provided by the manufacturer. For each measurement curve, normalized flu-
orescence values of a two-second window immediately before IR laser heating (cold
fluorescence) were divided by normalized fluorescence values of a four-second window
immediately before the end of IR laser heating (hot fluorescence). These values were
then plotted against the concentration of the unlabelled molecule. Curve fitting was
then performed using the built-in algorithms for a 1:1 binding model, which determines
normalized fluorescence values for the corresponding bound and unbound molecular
states and calculates the KD using the inflection point of the sigmoidal dose-response
curve.
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Normalization To account for different signal amplitudes between individual experi-
ments, fluorescence values were normalized by dividing maximum fluorescence (corre-
sponding to the unbound state) by minimum fluorescence (corresponding to the bound
state) and plotting these normalized values as fraction bound.
3.7.2 Surface Plasmon Resonance
3.7.2.1 Background
Molecular principle Surface Plasmon Resonance (SPR) is the most widely used
method to quantitatively determine protein-protein interaction parameters (Myszka,
1997). Using an optical biosensor approach, the total molecular mass accumulated
on a sensor surface can be quantified in real time with a maximum molecular weight
resolution of∼200 Da. Molecular interactions can be studied by fixing one of the binding
partners (termed ’ligand’) on the sensor surface and injecting the other binding partner
(termed ’analyte’) in a time-controlled manner. Binding events between these molecules
then lead to accumulation of mass on the sensor surface which can be detected directly. In
SPR assays, data is obtained as curves of system response (plotted as arbitrary resonance
units, RU) over time. The signal is proportional to mass, with 1 RU corresponding to
∼1 pgmm−2 of molecules (Stenberg et al., 1991). For a detailed description of the
physical background of the method, see Mayo and Hallock, 1989.
System overview SPR instruments consist of a microfluidics system with automated
sample injection mechanisms and constant flow regulated through a peristaltic pump (flow
rates 10 µLmin−1 to 30 µLmin−1). The reaction chamber (flow cells, see figure 3.5 A) is
created by docking a sensor chip to the instrument, which closes the internal microfluidics
system. The reaction chamber is enclosed in a temperature-controlled jacket (temperature
accuracy ± 0.005 °C) in order to achieve a stable environment for kinetic measurements.
Sensor surface molecular environment One of the most commonly used types of
sensor chip (type CM5, GE Healthcare) was used in this study. CM5 chips (figure 3.5)
consist of a thin gold surface on a glass substrate to which a carboxymethylated dextran
hydrogel matrix has been covalently attached by the manufacturer to a thickness of
∼100 nm, which corresponds to 0.2 % of the flow cell height (Myszka et al., 1998).
For immobilization of proteinaceous ligands, an amine coupling chemistry can be used
which covalently links the N-terminus and lysine ε-amino groups of the ligand to the
matrix carboxyl groups. This type of coupling results in a random, flexible, and three-
dimensional distribution of ligand molecules within the dextran matrix (figure 3.5 B),
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Fig. 3.5 Sensor chip for SPR measurements (not to scale). A, each sensor chip is made up of two
flow cells (black boxes) which are gold-coated microscopic cavities etched into the glass substrate
(shaded). Upon inserting the chip into the instrument, these cavities dock with corresponding
cavities in the instrument to create the reaction volumes. System flow runs sequentially through
both flow cells. By convention, flow cell 1 (FC1) is used as a reference flow cell, while flow cell 2
(FC2) is used as the sample flow cell. B, Simplified view of a single flow cell. The ligand (white
spheres) is attached to flexible dextran chains (black sticks), which are in turn covalently fused to
the gold surface (shaded area).
increasing the sensor’s binding capacity compared to that of a purely planar surface and
minimizing potential steric hindrance by decreasing the apparent ligand density in the
flow system (Johnsson et al., 1991). However, in context of analyte diffusion across this
third dimension, the thickness of the dextran layer can usually be neglected for practical
experimental considerations (Karlsson and Fält, 1997, Wofsy and Goldstein, 2002).
Analyte injections and binding events Injecting analyte into the system’s flow cell
(see figure 3.6) causes the total surface response signal to increase rapidly due to the
presence of the analyte molecules in the laminar flow close to the surface. This does not
necessarily indicate binding events. In the absence of binding the signal will return to the
baseline value rapidly after the analyte sample flow has been switched off and the flow
cell has been emptied of non-bound analyte (figure 3.6 A). However, if a binding event
takes place, the signal will initially remain at a high value after the analyte sample flow
has been switched off and decrease more slowly. The following signal decrease is then
due to dissociation of the complex, and the rate of this signal decrease is directly linked
to the binding reaction’s dissociation rate constant (figure 3.6 B).
Kinetic analysis Under certain circumstances, quantitative determination of binding
parameters is possible using sensorgram data generated by analyte injection. Taking
the predefined concentration of the analyte into account, an idealized binding event
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Fig. 3.6 Compartment representations (top) and sensorgrams (bottom) for analyte injections. A, if
no interaction takes place between ligand (white spheres) and analyte (black shapes), the signal
will rise temporarily during injection but fall back to baseline levels after injection has finished. B,
if an interaction takes place between ligand and analyte, the signal decrease after injection is more
gradual and depends on the rate of dissociation between ligand and analyte. Note: axis labels are
shown on first sensorgram only.
corresponding to a theoretical model (e.g. a simple 1:1 Langmuir binding of the analyte
(A) to a given ligand (B), see equation 3.3) can be predicted.
A+B
ka−−⇀↽ −
kd
AB (3.3)
By varying flexible parameters in the model iteratively (e.g. association rate constant, ka,
and dissociation rate constant, kd), the data can be fitted to the model until a minimum
deviation is achieved (see figure 3.7 A). At this point, the quality of the fit can be evaluated
using tools such as residual plots and uniqueness (U) values (see section 3.7.2.3 for details
on the exact procedure).
Kinetic titration On recent SPR platforms (such as the Biacore X100 that has been
used in this study), kinetic analysis via single-cycle titration is possible. In this work
flow, the analyte is injected consecutively at increasing concentrations (see figure 3.7 B).
In between injections, the analyte partially dissociates from the ligand. Although one
injection of analyte at a known concentration would yield enough data to determine the
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kinetic constants, using a titration series increases the robustness of the fit by cancelling
out artefacts potentially arising at certain analyte concentrations. For best resolution,
the titration should be performed around the expected KD of the interaction, i.e. analyte
should be injected at concentrations both below and above the expected KD. Analysis
is then performed on the entire sequence of injections (global analysis, see Rich and
Myszka, 2000).
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Fig. 3.7 Exemplary SPR interaction kinetics analysis. A, data for a single analyte injection
(grey curve, noisy) is being fitted to a mathematical model describing the interaction (black
curve, smooth). B, kinetic titration experiment. Multiple injections of increasing concentration
(c1,c2,c3,c4) have been performed during the same experimental run. The kinetic fit has been
performed over the timeframe of the whole experiment. Note: only the fit curve is shown for
clarity.
3.7.2.2 Assay development and experimental procedure
Instrument and consumables For SPR measurements, a Biacore X100 system (GE
Healthcare) was used. Sensor chips and all kits for sensor chip preparation were obtained
from the same manufacturer.
Sensor chip preparation To prepare a sensor chip for ligand capture purposes, a
fresh, unmodified sensor chip (carboxymethylated dextran covalently attached to gold
surface, type CM5) was inserted into the instrument and equilibrated with 1 × PBS
buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4) for 1 h (flow
rate 10 µLmin−1). The chip surface was then activated in both flow cells using an
amine coupling kit (GE healthcare) according to the manufacturer’s instructions with
an activation time of 7 min. Following activation, an α-RFP nanobody (RFPtrap®,
Chromotek) was injected to both chip flow cells at a concentration of 50 µgmL−1 in
10 mM acetate, pH 5.5., for 7 min. After nanobody injection, the surface was deactivated
for another 7 min. This protocol resulted in total nanobody amounts of ∼3000 response
units (RU) per sensor surface flow cell. After deactivation, the buffer was switched
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to interaction assay buffer (see section 3.7), the system was primed and subsequently
equilibrated for another 2 h before starting a ligand capture protocol.
Ligand capture Ligand was captured by injecting mOrange-tagged purified protein at
a concentration of 100 nM to the second (sample) flow cell of a chip coupled with an
α-RFP nanobody (as described above). Injection was performed using the instrument
control software’s built-in RU target method to a set amount of 250 RU. The system was
then equilibrated (flow rate 30 µLmin−1) until signal decrease due to ligand dissociation
reached the linear baseline phase with dissociation rates of less than 1 RU min−1 (∼3 h),
indicating negligible dissociation of ligand from the nanobody. Actual ligand binding
levels at the end of equilibration varied between approx. 180 and 220 RU.
Kinetic titration experiment Kinetic titration experiments were performed using a
single-cycle kinetics assay workflow. The sensor chip was loaded with ligand on the
sample flow cell and equilibrated as described above. The flow rate was set to 30 µLmin−1
to minimize the extent of the unstirred solvent layer effect above the dextran matrix and
therefore potential mass-transfer limitations (Goldstein et al., 1999). Before analyte
injection, a blank run was performed by injecting buffer for 4 to 5 times (120 s each).
Then the analyte was injected as a series of 4 to 5 injections (120 s each) at increasing
concentrations, with partial dissociation phases (120 s each) between each injection event.
Analyte concentrations were chosen from a set of threefold serial dilutions (12.3 nM,
37 nM, 111 nM, 333 nM, 1 µM, 3 µM, 9 µM) according to the expected affinity of the
interaction to provide a maximum concentration of at least ten-fold the expected KD.
After analyte injection, a replicate blank run was performed as before.
Alternative setup using α-his antibody As an alternative to using the mOrange moiety
to capture ligand molecules, a α-his antibody was used to capture ligand via fused his tag.
α-his antibody (GE Healthcare) was loaded onto both surfaces of a CM5 chip according
to the manufacturer’s instructions. As all the purified proteins used for interaction study
carried his-tags, a blocking step was necessary between ligand loading and analyte
injection (see figure 3.8). The aim of the blocking step was to suppress secondary binding
events occurring between the analyte his-tag and the α-his antibody on both flow cells. As
a blocking protein, his-tagged Arabidopsis thaliana Uricase (Willmann, 2011) was used
for its convenience in recombinant expression and purification. Uricase was expressed
in E. coli (BL21AI) as described in section 3.1.2 and purified as described in section
3.5. Purified Uricase was diluted to 1 mgmL−1 and injected manually into both flow
cells (contact time 600 s) after ligand loading. Injections were repeated until no further
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increase in signal could be observed, indicating a saturation of α-his binding sites in both
flow cells. The remainder of the assay protocol was performed as described before.
Y Y Y Y
Y Y Y Y
loading 
ligand
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Y Y Y Y
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blocking
Fig. 3.8 Alternative SPR setup using an α-his antibody (black Y shapes). The sensor chip surface
is symbolized by shaded rectangles. Top, reference surface; bottom, sample surface. After
loading the ligand (black diamonds), excess antibody binding sites on the sample surface as well
as all binding sites on the reference surface are blocked by injecting a non-interacting his-tagged
protein (shaded circles).
3.7.2.3 Data evaluation
Curve fitting Using the system’s evaluation software, single-cycle kinetics curves were
processed by subtracting the signal from the reference flow cell from the signal of the
sample flow cell. Systemic baseline drift and injection artifacts were taken into account
by subtracting the averaged values of the two blank runs from the values of the analyte
run (Rich and Myszka, 2000). Sample data were then fitted to a 1:1 binding model using
the built-in methods of the system’s analysis software.
Quality control Residual plots including upper and lower thresholds for acceptable
deviations were generated using the built-in methods and examined for relevant signal
deviations. To examine the mathematical robustness of the fit, iteratively calculated
uniqueness values (U values, Önell and Andersson, 2005) were determined for all pos-
sible combinations of parameter pairs using the built-in methods. Only curve fittings
passing stringent quality control (non-artifact residual deviations within the lower cal-
culated threshold, U-values < 15) were used for determination of kinetic constants and
KD.
3.8 In vivo interaction assays
In-vivo interaction assays have been performed to see whether the binding events which
have been characterized quantitatively in vitro can also be observed in a more natural
system. To this end, an A. thaliana leaf mesohpyll protoplast system which has originally
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been established to characterize effector function via transient expression (Yoo et al.,
2007, Zheng et al., 2014) has been adapted.
3.8.1 A. thaliana protoplast system to study effector interactions
Basic principle Using the adapted A. thaliana leaf mesohpyll protoplast system, inter-
action between effectors and their putative targets is observed indirectly by monitoring the
effector’s ability to suppress immunity signalling. Plants carrying a knock-out mutation
for a certain effector target gene are complemented by transient expression of the knocked-
out wild-type protein or a corresponding mutational construct. By co-transforming an
effector, a repression of immunity signalling is expected if the effector is able to bind its
natural target. If this is not the case (e.g. because mutations in the target protein decrease
its affinity to the effector), effector expression is expected to have a far lower (or no)
effect on repression of immunity signalling (see figure 3.9 for a schematic overview of
the basic principle).
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Fig. 3.9 Protoplast system adapted to study effector-target interactions. A, Wild-type plants
respond normally to PAMP (P) treatment (raised arrow in box). B, Effector target mutant
protoplasts (shaded circles) show decreased response to PAMP treatment. C, Effector target
mutant protoplasts complemented with the wild-type effector target (T) show restored response
to PAMP treatment. D, Effector target mutant protoplasts complemented with the wild-type
effector target and cotransformed with the effector (E) show strongly decreased response to PAMP
treatment. E, Effector target mutant protoplasts (outlined circles) complemented with a mutant
effector target which shows less binding activity to the effector (outlined T) and cotransformed
with the effector show higher response to PAMP treatment (compared to wild-type target with
effector expression).
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pFRK1-Luciferase assay A. thaliana protoplasts were isolated as described in section
3.2.2.1 and transfected as described in section 3.2.2.2 with one or more plasmid(s)
encoding for the following (see table 2.6 for details):
• The firefly luciferase (Luc) reporter gene under control of the flg22-induced
receptor-like kinase 1 (FRK1) promoter (pFRK1) to monitor immunity signalling
• The Pseudomonas syringae effector protein AvrPto (PsAvrPto)
• The A. thaliana immunity-related co-receptor BAK1 (AtBAK1), either in its wild-
type or in a mutated form
After transfection, protoplast suspensions were supplemented with the luciferase substrate
D-Luciferin to a final concentration of 200 nM and mixed carefully. For each sample, six
aliquots of 100 µL protoplast suspension each were then transferred to individual wells of a
96-well microtiter plate and incubated overnight (∼15 h, 20 °C). After this incubation step,
the microtiter plate containing the protoplast suspensions was transferred to a luminometer
(Berthold) and luminescence was measured for each well (initial luminescence). After
measuring initial luminescence, the plate was incubated in the dark for 30 min. After
this incubation step, the six wells per sample were divided into two groups of three wells
each. To the first group, 1 µL of flg22 solution (10 µM, 0.1 % (v/v) dimethylsulfoxide
(DMSO)) was added, yielding a final flg22 concentration of 100 nM. To the second group,
1 µL of 0.1 % (v/v) DMSO was added as a control. Then luminescence was measured as
before. After this measurement, the plate was shaken gently and incubated in the dark
for 90 min before the next measurement. Measurements were then continued in 90 min
intervals until 6 h after addition of flg22.
Data evaluation Measurements were plotted as relative light unites (RLU) vs. time
after PAMP treatment. To calculate relative induction, averaged RLU values of DMSO-
treated sample replicates (controls) were substracted from averaged RLU values of the
corresponding PAMP-treated sample replicates for each time point. To calculate fold
induction, averaged RLU values of PAMP-treated sample replicates were divided by
averaged RLU values of control replicates.
3.9 Bioinformatics
3.9.1 Structural modeling of proteins
Structural homology modelling was performed using an enhanced version of the Vector
Alignment Search Tool (VAST+; Madej et al., 2014), a tool which uses geometric
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datasets based primarily on crystal structures annotated in the Molecular Modelling
Database (MMDB; Madej et al., 2012). Partial structural alignments were generated in a
sequence-agnostic way by searching for conserved so-called "biounits" using the VAST+
algorithm, which is based on position specific scoring matrices (PSSMs, Kann et al.,
2005). Aligned biounits were visualized using the Cn3D tool (Wang et al., 2000). Non-
aligned biounits were then added to the visualization by pulling the respective geometric
datasets from the MMDB structural data.
3.10 Statistics
Unpaired Student’s t test was performed using the GraphPad QuickCalc t test calculator
(GraphPad Software, La Jolla, USA).
CHAPTER 4
RESULTS
4.1 Heterologous expression and purification of target proteins
from E. coli
4.1.1 Synthetic constructs for heterologous expression
Synthetic constructs containing cytoplasmic domains (CDs) of A. thaliana BAK1, BRI1,
and FLS2 with C-terminal His-tags for purification in the bacterial expression vector
pet22 have been provided by N. Wagener (unpublished data, figure 4.1). A synthetic
construct linking full-length S. lycopersicum Pto with a N-terminal His-tag for purification
(figure 4.2) has been cloned into the bacterial expression vector pJC40 as described
in section 3.3.7. As MST experiments need a fluorescent label to monitor protein-
protein interactions (see section 3.7.1.1), a synthetic construct for expressing P. syringae
(DC3000) AvrPto linked to an mOrange fluorescent tag (figure 4.3) has been generated
as described before. Table 4.1 summarizes the molecular properties of all synthetic
constructs and introduces the short-hand construct nomenclature that will be used for the
remainder of this chapter.
Table 4.1 Molecular properties for synthetic expression constructs
Construct No AAs MW (kDa) pI Organism of origin
BAK1-CD 353 39.8 5.81 A. thaliana
BRI1-CD 340 37.8 6.49 A. thaliana
FLS2-CD 330 36.9 5.65 A. thaliana
Pto 345 39.2 6.51 S. lycopersicum
mO-AvrPto 432 48.4 6.56 synthetic / P. syringae
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Fig. 4.1 A. thaliana RLK-CD his-tagged constructs (amino acid sequence). A, BAK1-CD, B,
BRI1-CD, C, FLS2-CD. Functional domains are indicated by shading. Dark grey, His tag
(purification tag); white, CD. Amino acids are given in single-letter code. Note: numbering is
specific to the synthetic construct and does not correspond to any database annotated residue
numbers.
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Fig. 4.2 Pto his-tagged construct (amino acid sequence). Functional domains are indicated by
shading. Dark grey, His tag (purification tag); white, Pto. Amino acids are given in single-letter
code. Note: numbering is specific to the synthetic construct and does not correspond to any
database annotated residue numbers.
Fig. 4.3 mOrange-AvrPto fusion construct (amino acid sequence). Functional domains are
indicated by shading. Dark grey, His tag (purification tag); white, mOrange (fluorescence tag);
black, flexible linker (domain separator); light grey, AvrPto (effector). Amino acids are given in
single-letter code. Note: numbering is specific to the synthetic construct and does not correspond
to any database annotated residue numbers.
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4.1.2 Expression analysis
Time course experiments Expression analysis of A. thaliana RLK-CD clones (figure
4.4) was performed as described in section 3.1.2.3. In the case of BAK1-CD, phosphoryla-
tion can be observed indirectly in a CBB-stained gel as an apparent shift in migration size
(Peck, 2006; the shift is indicated by solid arrow in figure 4.4). Prolonged expression time
increased the ratio of phoshorylated to unphosphorylated BAK1-CD with a maximum at
2-3 h post induction. This phosphorylation-dependent shift in apparent migration size is
not visible for BRI1-CD at the attained expression levels, although kinase activity assays
demonstrated autophosphorylation activity (see section 4.1.4). Consistent with previous
reports that FLS2 is a weak kinase with undetectable autophosphorylation activity in vitro
(Schwessinger et al., 2011), the expression product migrates as a single band. In contrast
to BAK1-CD and BRI1-CD, maximum expression levels were obtained by expressing for
16 h at 18 °C (figure 4.4, C). Very low soluble expression levels and a severe reduction
in bacterial growth rates were obtained using expression strain ROSETTA, indicating
toxicity of the expression product to E. coli; this problem could be partially abrogated by
the use of strain BL21AI, which provides more stringent repression of expression in the
non-induced state by controlling expression through the arabinose-inducible araBAD pro-
moter (Chao et al., 2002). However, expression levels for FLS2-CD remained relatively
low compared to those obtained for all other proteins used in this work.
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Fig. 4.4 A. thaliana RLK-CDs expression time course experiment (expression strain ROSETTA,
total cell extracts loaded on gel). SDS-PAGE with CBB staining. Expression temperature was
28 °C for time points 0 - 3 h p.i. and 18 °C for time points 16 h p.i. Solid arrow, phosphorylated
form of BAK1-CD, dashed arrow, unphosphorylated form. h p.i., hours post expression. Note:
composite image, not quantitative; individual image brightness has been adjusted.
Expression product is only partly soluble To test the amount of soluble vs. insoluble
protein that resulted from heterologous expression in E. coli, protein extraction was
performed as described in section 3.1.2.4 but in the presence of varying amounts of sodium
lauroyl sarcosinate (sarkosyl) to facilitate the solubilization of inclusion bodies (Frankel
et al., 1991). Figure 4.5 shows a pilot experiment demonstrating that a large amount
of BAK1-CD is retained in the insoluble fraction and can be solubilized using sarkosyl.
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However, due to the fact that the solubilized protein was shown to lack autophoshorylation
activity (see section 4.1.4, figure 4.10 B), the amount of BAK1-CD in the soluble fraction
was increased by varying expression parameters; optimization experiments showed that
while prolonged expression (>3 h) increased the total amount of expressed protein, the
maximum amount of soluble protein was obtained using short expression times (1–3 h at
28 °C); this correlated with a high amount of autophosphorylation activity as observed in
the appearance of a slower-migrating phosphorylated state (as described previously).
1 2 3 4 5
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Fig. 4.5 Extraction of A. thaliana BAK1-CD from E. coli (expression 16 h at 18 °C) in the absence
or presence of sarkosyl. SDS-PAGE with CBB staining. 1, whole cell lysis; 2, soluble extract
(buffer without sarkosyl); 3, 0.1 % (w/v) sarkosyl; 4, 1 % (w/v) sarkosyl; 5, 10 % (w/v) sarkosyl.
Equal amounts (by volume) were loaded onto the gel for each lane.
Expression of mOrange-AvrPto Expression conditions for the synthetic mOrange-
AvrPto fusion construct were optimized (section 3.1.2.3), indicating little soluble ex-
pression at higher temperatures (≥28 °C, data not shown) and using expression strain
ROSETTA, but high amounts of soluble expression after 16 h at 18 °C using expression
strain BL21AI, as shown in figure 4.6. In induced cells, the appearance of a double
band can be observed (Figure 4.6 C) with the main target band corresponding to a size
of 45 kDa. A secondary band at an apparent size of ∼30 kDa likely corresponds to a
truncated version or a degradation product (for more detail, see section 4.1.3).
Summary of optimized conditions Table 4.2 gives a brief overview of the optimized
bacterial expression conditions for the synthetic constructs used in this work.
Table 4.2 Optimized bacterial expression conditions
Construct Strain cinducer t (h) T (° C)
BAK1-CD ROSETTA 1 mM 3 28
BRI1-CD ROSETTA 1 mM 3 28
FLS2-CD BL21AI 0.05 % 16 18
Pto BL21AI 0.05 % 16 18
mO-AvrPto BL21AI 0.05 % 16 18
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Fig. 4.6 Bacterial expression (BL21AI) of mOrange-AvrPto fusion construct. Cells were har-
vested after 16 h of expression at 18 °C. A, orange color originating from the mOrange moiety
fluorescence can be observed in cell pellet after expression (right tube). B, the color is retained in
the soluble crude extract. C, soluble crude extract of noninduced (left) and induced (right) cells in
SDS-PAGE with CBB staining.
4.1.3 Purification
A. thaliana CDs and Pto Optimization of purification procedures was performed using
BAK1-CD as described in section 3.5, using affinity chromatography (AC) and size
exclusion chromatography (SEC) steps, followed by SDS-PAGE to examine yield and
purity, and in vitro kinase activity assays (section 4.1.4) to determine biochemical func-
tionality of the purified protein. The resulting optimized work flow was limited to a
single AC step, as subsequent further purification steps resulted in reduced yield and
post-purification concentration of protein resulted in loss of observable kinase activity
(see section 4.1.4, figure 4.10, B). A representative purification is shown in figure 4.7.
Purification procedures for mutagenized variants of BAK1-CD, BRI1-CD, FLS2-CD, and
Pto was performed analogously to that of BAK1-CD.
mOrange-AvrPto Affinity chromatography purification of mOrange-AvrPto (figure
4.8, A, B) consistently resulted in the presence of secondary bands migrating at a lower
molecular weight than the predicted target protein size in addition to the dominant band
(figure 4.8, C). Further attempts of purification by size exclusion chromatography (SEC)
failed to show an effect, as the different apparent molecular sizes could not be resolved.
The chromatogram shows two prominent peaks (figure 4.9, A), which both contain
the same molecular species (figure 4.9, B; the first elution peak likely corresponds to
higher-order complexes of mOrange-AvrPto).
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Fig. 4.7 Purification of BAK1-CD. A, affinity chromatography (AC; GE Healthcare HisTrap, 1
ml), complete run. Initial signal peaks are washing steps. Bacterial crude extract was applied to the
column at cumulative volume of ∼25 mL, and sample loading was stopped at cumulative volume
of ∼125 mL. Elution (imidazol gradient) was started at cumulative volume of ∼130 mL. A final
wash is performed after the main elution peak at a cumulative volume of ∼143 mL Black curve is
total absorption at 280 nm, indicating amount of protein. Dotted curve is conductance, indicating
elution gradient (imidazol). The numbers indicate the corresponding lanes in (C). B, enlargement
of elution step. Curves are as described above. The numbers indicate the corresponding lanes in
(C). C, SDS-PAGE on different steps of purification procedure. 1, raw extract; 2, flow-through
(non-bound material during column loading); 3, 4 and 5 correspond to different time points during
elution, as seen in (B). Each lane was loaded with 20 µL of the indicated sample.
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Fig. 4.8 Purification of mO-AvrPto. A, affinity chromatography (GE Healthcare HisTrap, 1 ml),
complete run. Initial signal peaks are washing steps. Bacterial crude extract was applied to the
column at cumulative volume of ∼15 mL, and sample loading was stopped at cumulative volume
of∼70 mL. Elution (imidazol step gradient: 50 mM, 250 mM, 500 mM) was started at cumulative
volume of ∼72 mL. Black curve is total absorption at 280 nm, indicating amount of protein.
Dotted curve is conductance, indicating elution gradient (imidazol). B, enlargement of elution
step. Curves are as described above. The numbers indicate the corresponding lanes in (C). C,
SDS-PAGE on AC elution fractions. 1, 2 and 3 correspond to different time points during elution
(steps of gradient), as seen in (B). Each lane was loaded with 2 µL of the indicated sample.
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Fig. 4.9 Attempted further purification of mO-AvrPto. A, size exclusion chromatography (SEC;
GE Healthcare HiLoad 16/600, Superdex 75). Peak fractions were harvested from 42 to 62 ml.
Cumulative volume is relative to sample injection. Numbers indicate the harvested fraction as
analysed in (B). B, SDS-PAGE on SEC elution fractions. SEC fraction lanes were loaded with
20 µL of sample each. The input (AC faction) is given for comparison purposes. Note: picture is
a composite image consisting of lanes run on different gels (SEC fractions / input), and is only
intended for visual comparison of band patterns.
4.1.4 In vitro kinase activity assays
Viability of in vitro kinase assays It has been demonstrated before that autophospho-
rylation of purified BAK1-CD can be observed in vitro (Wang et al., 2008). Similar
findings have been obtained for BRI1-CD; in contrast, FLS2-CD kinase activity seems to
be hardly detectable in vitro using the same assay format (Schwessinger et al., 2011). In
this study, kinase activity assays have been performed mainly to validate the molecular
function of purified proteins, in order to establish streamlined expression, purification,
and handling procedures for subsequent use of protein samples in interaction assays.
Kinase activity assays for purified BAK1-CD To test the influence of different han-
dling steps in protein purification on kinase activity, several aliquots were treated dif-
ferently and tested in the same format. Figure 4.10 shows autoradiographs obtained
from various aliquots of purified BAK1-CDs which were either stored under different
conditions (figure 4.10 A) or have undergone treatments to optimize soluble protein con-
centration (figure 4.10 B). Storage of BAK1-CD for 7 d at 4 °C has a detrimental effect on
autophosphorylation, while short-term storage for 1 d at 4 °C or a single freeze-thaw-cycle
result in similarly high amounts of autophosphorylation. Precipitating purified BAK1-CD
with ammonium sulfate and re-suspending the precipitate in a smaller volume of buffer to
increase soluble concentration results in a complete loss of autophosphorylation activity.
Similarly, purifying BAK1-CD from the insoluble fraction of bacterial expression using
sarkosyl detergent also results in a complete loss of autophosphorylation activity. Due
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to these results, the standard work flow adopted for all subsequent protein purification
procedures consisted of a single affinity chromatography step, immediately followed
by dialysis (16 h, 4 °C) to remove the imidazol used for elution, and subsequent flash-
freezing (liquid N2) of single-use aliquots; no post-purification attempts at increasing
protein concentration were performed due to their negative effect on BAK1-CD kinase
activity. All purified proteins used for downstream interaction assays were prepared in
the same manner for reproducibility.
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Fig. 4.10 Kinase activity assay of A. thaliana BAK1-CD using different treatments post-
purification. A, influence of storage conditions. 1, BSA (5 µg); 2, BAK1-CD stored for 7 d
at 4 °C (5 µg); 3, BAK1-CD stored for 7 d at 4 °C (10 µg); 4, BAK1-CD stored for 1 d at 4 °C (5
µg); 5, BAK1-CD stored for 1 d at 4 °C (10 µg); 6, BAK1-CD frozen and thawed once (5 µg);
7, BAK1-CD frozen and thawed once (10 µg). B, influence of treatments for optimizing concen-
tration. 1, BAK1-CD without further treatment (10 µg); 2, BAK1-CD concentrated threefold by
ammonium sulfate precipitation (10 µg); 3, BAK1-CD solubilized from inclusion bodies using
sarkosyl (10 µg); 4, bovine serum albumin (BSA, 10 µg).
Kinase activity assays for purified BRI1-CD In vitro autophosphorylation of recom-
binant BRI1-CD has been demonstrated before (Wang et al., 2005). To test whether
the BRI1-CD purification procedure resulted in kinase-active protein, a kinase activity
assay using BRI1-CD (and BAK1-CD for comparison purposes) has been performed
(figure 4.11). Purified BRI1-CD shows a strong autophosphorylation that is similar in
magnitude to that of purified BAK1-CD, despite the apparent lack of a distinct second,
slower-migrating band due to phosphorylation-induced mobility shift in SDS-PAGE
(section 4.1.2). These results indicate that purification of BRI1-CD results in similarly
kinase-active protein as BAK1-CD, confirming the suitability of the expression and
purification work flow for RLK cytoplasmic domains.
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Fig. 4.11 Kinase activity assay of purified A. thaliana BAK1-CD and BRI1-CD. 1, BAK1-CD
aliquot 1 (5 µg; 2, BAK1-CD aliquot 2 (5 µg); 3, BRI1-CD aliquot 1 (3 µg); 4, BRI1-CD aliquot 2
(5 µg). Bovine serum albumin (BSA, 5 µg) was used as a control.
Influence of AvrPto on BAK1-CD kinase activity AvrPto was described as an in-
hibitor of Pto kinase activity in previous studies (Xing et al., 2007) and was shown
to lower FLS2-CD autophosphorylation in vitro (Xiang et al., 2008). On the other
hand, AvrPto was previously reported to be phosphorylated in planta by a Pto- and
Prf-independent kinase activity (Anderson et al., 2006). To test the influence of AvrPto
on in vitro BAK1 phosphorylation, a titration experiment has been performed using equal
amounts of BAK1-CD and varying amounts of AvrPto (figure 4.12). The presence of
purified mOrange-AvrPto is seen as the appearance of a double band with the upper
band corresponding to the full-length construct with an apparent size of ∼45 kDa and
a secondary lower band with an apparent size of ∼30 kDa. Total signal corresponding
to labeled phosphates remains approximately constant in all lanes; upon increasing the
concentration of mOrange-AvrPto, phosphorylation slightly decreases on BAK1-CD and
increases on mOrange-AvrPto. No similar transphosphorylation is seen on the BSA
control. A very similar effect has been observed before for the interaction of a different
effector protein, AvrPtoB, with BAK1-CD (Cheng et al., 2011). While transphosphory-
lation of mO-AvrPto by BAK1-CD is readily apparent, it is more diffcult to determine if
the effect on BAK1-CD autophosphorylation is truly indicative of mO-AvrPto-mediated
inhibition of autophosphorylation activity. The total magnitude of BAK1-CD autophos-
phorylation signal intensity shift during the mO-AvrPto titration (figure 4.12, lanes 2-5),
considering the amount of mO-AvrPto used, is rather low (roughly, <50 %); together
with the fact that the ’BAK1-CD + BSA’ sample (lane 6) shows less autophosphorylation
signal than BAK1-CD alone (lane 1), although the amount of BAK1-CD loaded onto the
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gel was the same (CBB staining), these results preclude quantitative analysis. Although
not strictly comparable due to different experimental formats, it should be noted previous
studies based on protoplast Co-IP did not show a difference in (BL-stimulated) BAK1
and BRI1 phosphorylation in the presence or absence of AvrPto (Shan et al., 2008,
supplemental).
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Fig. 4.12 Kinase activity assay of A. thaliana BAK1-CD with different concentrations of mOrange-
AvrPto (mO-AvrPto). 1, BAK1-CD (2 µg); 2, BAK1-CD (2 µg) + mO-AvrPto (10 ng); 3, BAK1-
CD (2 µg) + mO-AvrPto (100 ng); 4, BAK1-CD (2 µg) + mO-AvrPto (1 µg); 5, BAK1-CD (2 µg)
+ mO-AvrPto (2 µg); 6, BAK1-CD (2 µg) + BSA (2 µg).
4.2 Determination of steady-state binding affinities for AvrPto
/ RLK interactions
4.2.1 AvrPto interacts with BAK1 in MST experiments
Steady-state affinity for binary interactions between mO-AvrPto and BAK1-CD was
determined by MST, using fluorescently labelled mO-AvrPto at fixed concentrations of
50 nM and titrations of BAK1-CD over four orders of magnitude (between approximately
0.5 nM and 5 µM). Averaged affinity for the interaction (at 40 % gradient intensity,
n = 3 experiments) was 45 (±8) nM. Experimental data allowed fitting to an idealized
steady-state binding model with good fidelity, with a clear inflection point and both
baseline (no complex formation) and saturation (full complex formation) levels being
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reached (figure 4.13). Notably, the steady-state affinity of BAK1-CD to AvrPto is higher
than any formerly reported affinity of AvrPto to other putative interactants as determined
in previous studies (see section 4.2.3, figure 4.16 for quantitative comparisons and
corresponding citations).
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Fig. 4.13 Steady-state affinity determination for the interaction pair BAK1-CD and mOrange-
AvrPto. The fraction bound was plotted in dependence of BAK1-CD concentration in each
capillary. Each data point was averaged from 3 independent experiments. Error bars are SD.
4.2.2 Temperature gradient strength does not significantly influence
binding
To test whether the affinity is influenced by the intensity of the experimentally induced
temperature gradient, experiments were additionally performed at 20 % and 80 % gradient
intensity, yielding affinities of 33 (±17) nM and 39 (±4) nM, respectively (figure 4.14;
n = 3 experiments), which are insignificant differences (p = 0.50 and 0.18, respectively)
compared to the value obtained for experiments using a 40 % gradient intensity.
4.2.3 Pto and FLS2 show weaker interaction with AvrPto
Full-length Pto and FLS2-CD were tested for interaction with mOrange-AvrPto analogous
to BAK1-CD. Affinities determined (at 40 % gradient intensity) were 239 (±82) nM for
FLS2-CD (figure 4.15 A, n = 3 experiments) and 133 (±46) nM (figure 4.15 B, n = 3
experiments) for Pto. There is a noticable increase in systematic noise at low protein
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A B
Fig. 4.14 Steady-state affinity determination for the interaction pair BAK1-CD and mOrange-
AvrPto at different temperature gradient settings. A, 20 % gradient intensity; B, 80 % gradient
intensity. The fraction bound was plotted in dependence of BAK1-CD concentration in each
capillary. Data is averaged from 3 independent experiments. Error bars are SD.
concentrations compared to the experiments including BAK1-CD, which is due to an
overall lower magnitude of fluorescence shift for these experiments. Due to solubility
issues, higher concentrations of FLS2-CD could not be obtained, which decreases the
fidelity of the determination of the lower bound of steady-state affinity, as it is difficult to
determine whether the saturation phase of the reaction has truly been reached (note fitting
curve at high FLS2 concentrations, figure 4.15, A). Figure 4.16, A shows a comparative
overview of the different steady-state affinities as determined by MST. These results
demonstrate that compared to the interaction with BAK1-CD, the interaction of mO-
AvrPto with FLS2-CD is approximately 5 times weaker, and the interaction with Pto is
approximately 3 times weaker. For comparison purposes, previous experimental data for
AvrPto binding affinities obtained by other groups is given in figure 4.16, B, indicating
generally good agreement of these datasets to the results obtained in this study.
4.2.4 No interactions can be observed for AvrPto with BRI1 and
negative controls
Using the same experimental setup as in the previously described MST experiments, no
interaction could be observed for the interaction pair mO-AvrPto with BRI1-CD (Figure
4.17, A). Two additional interaction pairs were studied as negative controls: mO-AvrPto
was tested for interaction with bovine serum albumin (BSA, figure 4.17, B) and BAK1-
CD was tested for interaction with mOrange (lacking the AvrPto moiety; figure 4.17, C).
No interaction could be observed for the negative controls (n = 2 experiments each).
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BA
Fig. 4.15 Steady-state affinity determination for the interaction pairs FLS2-CD and mOrange-
AvrPto (A), as well as Pto and mOrange-AvrPto (B). The fraction bound was plotted in dependence
of unlabeled protein concentration in each capillary. Data is averaged from 3 independent
experiments. Error bars are SD.
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Fig. 4.16 A, Overview of steady-state affinities as determined by MST. Black bar, BAK1-CD;
grey bar, FLS2-CD; white bar, Pto. Only the lower margin of error is shown for FLS2-CD, as
determination of the upper bound was not possible with sufficient certainty using this assay setup.
B, Previously determined affinities of AvrPto to FLS2-CD (Xiang et al., 2008), and AvrPto to Pto
(Xing et al., 2007). These experiments were performed using SPR in a steady-state configuration.
4.3 Kinetic characterization of AvrPto / RLK interactions 79
A B C
Fig. 4.17 Steady-state MST experiments for interaction pairs which showed no binding; A,
BRI1-CD / mO-AvrPto, as well as control experiments B, BSA / mO-AvrPto; and C, BAK1-
CD / mOrange. The normalized response values (calculated as in experiments with binding
response) were plotted in dependence of unlabelled protein concentration in each capillary. Data
is averaged from 2 independent experiments. Error bars are SD. Note: The ordinate axis has been
omitted in these diagrams as plotting a fraction bound (as in the experiments including a fitting
curve) would not be meaningful in this context.
4.3 Kinetic characterization of AvrPto / RLK interactions
As MST experiments give information only on steady-state affinities for any given inter-
actions, surface plasmon resonance (SPR) experiments were performed to elucidate the
kinetic background of all interactions described in this study. Additionally to the kinetic
characterization, these experiments represent an fundamentally different methodology to
arrive at quantitative affinity data.
4.3.1 BAK1 binds AvrPto with high affinity due to fast complex
formation
Kinetic parameters To determine kinetic parameters of the mO-AvrPto–BAK1-CD
interaction, a single-cycle kinetics titration approach was used. In this experimental set-
up, mO-AvrPto was transiently captured on a α-RFP nanobody (RFP-Trap, Chromotek)
with very high affinity (< 1 RU min−1 baseline signal slope); subsequently, BAK1-CD
was serially injected in increasing three-fold concentration steps, with continuous signal
recording. Blank- and FC1- referenced experimental cycles were then used for kinetic
analysis (for details on referencing methodology, see section 3.7.2.2). Data curves were
fitted using a 1:1 Langmuir binding model via the instrument’s evaluation software, result-
ing in generally good fitting according to quality control (section 3.7.2.3); this indicates
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that the interaction corresponds reasonably well to a simple 1:1 binding stoichiometry
without rate-limiting conformational changes or excessive complexity, although minor
complexity not accounted for by the model was generally visible as systematic deviations
within the quality control thresholds. Kinetic parameters were determined from fitting
curves; in turn, affinity was determined from kinetic parameters, yielding non-steady state
affinity data. Figure 4.18 shows a representative kinetic experiment with model fitting
(KD = 40 nM, pane A) and the corresponding quality control using a residuals plot, wich
shows deviations of experimental data from the model (pane B). Averaging values from
three individual experiments, the association rate constant (ka) for the mO-AvrPto with
BAK1-CD interaction was determined as 4.5 ×104 (± 2.0 ×104) mol−1 s−1, while the
dissociation rate constant (kd) was determined as 1.45 ×10−3 (± 2.7 ×10−4) s−1. The
affinity (KD) inferred from kinetic parameters was 36 ± 13 nM.
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Fig. 4.18 Interaction kinetics of mO-AvrPto and BAK1. A, data (black curve) and global kinetic
fit to a 1:1 binding model (red curve; χ2 = 0.115 RU2, U-value = 1). Injected concentrations
were 12.3 nM, 37.5 nM, 111 nM, and 333 nM. B, residuals plot showing deviations between data
and model. Quality control levels are indicated by the dotted line (inner threshold) and dashed
line (outer threshold). The experiment was repeated 3 times with similar results.
Alternative capturing system Due to the difficulties in using an α-RFP nanobody in
the FLS2-CD experiments (see section 4.3.3), and to test the dependence of the interac-
tion on ligand/analyte status for the interactants, kinetic experiments were alternatively
performed using an α-his antibody for ligand capture (see section 3.7.2.2). The roles
of ligand and analyte were switched compared to the α-RFP experiments by using
BAK1-CD as ligand and mO-AvrPto as analyte. Using this alternative system yielded
kinetic parameters similar to those obtained for α-RFP mediated capture (Figure 4.19,
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ka = 5.9 ×104 mol−1 s−1 , kd = 1.5 ×10−3 s−1, KD = 25 nM), indicating that the inter-
action occurs similarly independent of setting each interactant as either ligand or analyte.
This reinforces the notion that the parameters governing the interaction dynamics can be
described with reasonable accuracy by a simple 1:1 binding model, as the surface topology
and environment of the flow cell does not seem to be influencing binding parameters in
a significant way. Note that although the kinetic fitting curve visually appears to better
correspond to the data in figure 4.19 A compared to figure 4.18 A, this is a secondary
effect of the higher total signal amplitude in the former experiment and has no relevance
for the actual fitting quality, as observable in the corresponding residual plots (B panes),
which show very similar acceptable deviations in both cases.
B
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Fig. 4.19 Interaction kinetics of mO-AvrPto and BAK1 (alternative setup). A, data (black curve)
and global kinetic fit to a 1:1 binding model (red curve; χ2 = 0.744 RU2, U-value = 1). Injected
concentrations were 12.3 nM, 37.5 nM, 111 nM, and 333 nM. B, residuals plot showing deviations
between data and model. Quality control levels are indicated by the dotted line (inner threshold)
and dashed line (outer threshold). The experiment was repeated 2 times with similar results.
4.3.2 Pto / AvrPto complex formation is slow but very stable
Kinetic paramters Kinetic parameters for mO-AvrPto / Pto interaction were deter-
mined using the same experimental setup as described before for the mO-AvrPto / BAK1-
CD interaction pair. The association rate is an order of magnitude slower compared to
BAK1-CD, with a ka determined as 3.1 ×103 (± 1.9 ×103) mol−1 s−1. However, the
dissociation rate is slower as well, with a kd determined as 2.2 ×10−4 (± 1.2 ×10−4)
s−1, indicating an exceptionally stable molecular complex. The affinity as determined
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from the kinetic parameters was 119 ± 21 nM. Figure 4.20 shows a representative kinetic
experiment (KD = 90 nM).
B
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Fig. 4.20 Interaction kinetics of mO-AvrPto and Pto. A, data (black curve) and global kinetic fit
to a 1:1 binding model (red curve; χ2 = 0.55 RU2, U-value = 3). Injected concentrations were
12.3 nM, 37.5 nM, 111 nM, and 333 nM. B, residuals plot showing deviations between data and
model. Quality control levels are indicated by the dotted line (inner threshold) and dashed line
(outer threshold). The experiment was repeated 3 times with similar results.
4.3.3 FLS2 / AvrPto complex dissociates rapidly
FLS2-CD shows strong background binding to the α-RFP nanobody Using the
same assay setup as described before for the mO-AvrPto / BAK1-CD and mO-AvrPto /
Pto interaction assays resulted in FLS2-CD binding to both sample and reference flow
cells, with slightly higher amount of binding in the reference flow cell (figure 4.21).
This indicates that FLS2-CD binds to the α-RFP nanobody which is used to capture
mO-AvrPto in this assay setup. Corresponding to these circumstances, the observed
binding in the sample flow cell is slightly lower due to partial covering of the nanobody
surfaces with mO-AvrPto during ligand injection. Therefore, kinetic evaluation was not
possible under these conditions.
FLS2-CD binding to AvrPto can be observed in alternate system To handle the
issue of background binding in the α-RFP nanobody capture system, an alternative system
using an α-his antibody for capture was used (see section 3.7.2.2, figure 3.8). Analogous
to the alternative setup experiment with BAK1-CD (see section 4.3.1), FLS2-CD was
used as ligand, mO-AvrPto as analyte. Figure 4.22 shows the result of a representative
experiment. Although there are clear binding events occurring, the data does not fit to a
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Fig. 4.21 SPR: FLS2-CD background binding. Black curve is reference-subtracted sample data.
Injections were 111 nM, 333 nM, 1 µM, and 3 µM. Grey curve is buffer injection.
simple 1:1 binding model with sufficient quality over the whole range of injections (see
residuals plot, figure 4.22 B), making a quantitative kinetic evaluation by global kinetic
fitting impossible. Attempts to facilitate kinetic evaluation by loading a smaller quantity
of FLS2-CD (Önell and Andersson, 2005) did not result in improved data quality for
global kinetic analysis (data not shown). It should be noted that this alternate system has
inherent drawbacks, as binding of his-tagged analyte to the α-his antibody cannot be
ruled out completely despite prior blocking and reference subtraction (also see section
3.7.2.2).
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Fig. 4.22 Interaction kinetics of mO-AvrPto and FLS2-CD (alternative setup). A, data (black
curve) and global kinetic fit to a 1:1 binding model (red curve; χ2 = 31 RU2, U-value = 15).
Injected concentrations were 12.3 nM, 37.5 nM, 111 nM, and 333 nM. B, residuals plot showing
deviations between data and model. Quality control levels are indicated by the dotted line (inner
threshold) and dashed line (outer threshold). Note: the kinetic fit is shown only for descriptive
purposes, as the fit quality is not sufficient to infer meaningful kinetic data.
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Analysis of dissociation phases Removing complexity from the experiment by restrict-
ing analysis to the dissociation phases results in acceptable fitting quality (see figure 4.23),
which allows isolated estimation of the dissociation rate constant. Kinetic fitting was
performed for three individual concentrations of mO-AvrPto. It should be noted that the
reliability of a single parameter determination is inherently less robust than global kinetic
analysis, as reflected in the higher U-values in figure 4.23. Dissociation rate constants
estimated from this analysis were 0.04 s−1 (111 nM mO-AvrPto injection, figure 4.23 A),
0.07 s−1 (333 nM mO-AvrPto injection, figure 4.23 b), and 0.06 s−1 (1 µM mO-AvrPto
injection, figure 4.23 C), respectively. While not allowing determination of a kinetics-
based affinity due to lack of reliable association-phase data, these data indicate that the
complex of mO-AvrPto with FLS2 dissociates far more rapidly than those of mO-AvrPto
with either BAK1-CD or Pto, which argues for a much weaker complex formation (thus,
lower affinity), which is in line with the previously determined steady-state data.
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Fig. 4.23 Kinetic analysis (top) and residuals plot (bottom) of mO-AvrPto / FLS2-CD interaction,
dissociation phases only. Black curves in top panels show data, red curves show kinetic fit to a
1:1 binding model. Shown are three different injected concentrations of mO-AvrPto: A, 111 nM
(fit: χ2 = 0.102 RU2, U-value = 12); B, 333 nM (fit: χ2 = 0.604 RU2, U-value = 2); C, 1 µM
(fit: χ2 = 12.4 RU2, U-value = 9). Quality control levels are indicated by the dotted line (inner
threshold) and dashed line (outer threshold) in the lower panels.
4.3.4 BRI1 and BSA do not bind AvrPto
Using the same assay setup as for the characterization of mO-AvrPto / BAK1-CD and
mO-AvrPto / Pto interactions yielded no apparent binding for the BRI1-CD (figure 4.24,
A). The same was true for the BSA control (figure 4.24, B). Loading the sensor surface
with free mOrange (without an AvrPto moiety) and injecting BAK1-CD as has been done
in mO-AvrPto / BAK1-CD experiments has a similar effect (figure 4.24, C). These data
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recapitulate the corresponding steady-state data as measured in MST experiments (section
4.17).
A
B
C
Fig. 4.24 SPR experiments for A, BRI1-CD; B, BSA; and C, BAK1-CD with mOrange alone.
Injected concentrations were 37 nM, 111 nM, 333 nM and 1 µM for BRI1-CD, 111 nM, 333 nM,
1 µM and 3 µM for BSA, and 12.3 nM, 37 nM, 111 nM, and 333 nM for BAK1-CD, respectively.
Curves are reference-substracted data. The experiments were repeated 2 times with similar results.
Note: large signal spikes are injection artefacts.
4.3.5 Comparison of binding kinetics
Quantitative comparison Figure 4.25 shows an overview of kinetic constants as deter-
mined by SPR analysis. The affinities calculated from kinetic constants (figure 4.25 C,
solid bars) agree with steady-state affinities as have been measured in MST experiments
(figure 4.25 C, shaded bars; also see section 4.2).
Qualitative comparison Figure 4.26 shows an overlay of the kinetic experiments using
the alternate SPR setup (section 3.8) for the mO-AvrPto / BAK1-CD and mO-AvrPto /
FLS2-CD interaction pairs. Both experiments were conducted under identical conditions,
allowing a qualitative comparison of the respective kinetic profiles (as has been noted
before, the kinetic experiment for FLS2-CD does not allow quantitative global kinetic
fitting). The higher dissociation rate constant for the mO-AvrPto / FLS2-CD interaction
pair is readily apparent in the dissociation segments. The lower affinity of the interaction
is also visible as a proportionally lower relative response at lower injected mO-AvrPto
concentrations.
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Fig. 4.25 Comparison of kinetic parameters obtained from SPR experiments. A, association rate
constant (ka); B, dissociation rate constant (kd); C, affinity (KD; steady-state affinities (shaded
bars) are provided for reference). Note: logarithmic scales in (A) and (B). The dissociation rate
constant given for FLS2-CD is taken from the fitting with the smallest U-value, as described in
section 4.3.3, and should be considered estimative. This value is based on a single experiment; all
other values are based on three independent experiments.
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Fig. 4.26 SPR: Comparison of kinetic profiles for mO-AvrPto / BAK1-CD and mO-AvrPto /
FLS2-CD interactions. Consecutive injections were mO-AvrPto at concentrations of 12.3 nM,
37 nM, 111 nM, 333 nM, and 1 µM, respectively. Only the data points are shown. Data was
normalized as % of maximum response (at end of 1 µM mO-AvrPto injection).
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4.4 Putative interaction-mediating residues of BAK1
Relevant crystal structure data Previous studies reported extensive high-quality crys-
tal structure data on AvrPto (Wulf et al., 2004, Xing et al., 2007), Pto (Xing et al., 2007,
Dong et al., 2009), BRI1 (LRR domain, Hothorn et al., 2011), BAK1 (cytoplasmic
domain, Cheng et al., 2011), and FLS2 (LRR domain, Sun et al., 2013a). Of particular
interest for the scope of this study is the availability of co-crystallization data for the
interaction pairs AvrPto / Pto (protein data bank (PDB) identifier 2QKW, Xing et al.,
2007), AvrPtoB / Pto (PDB identifier 3HGK, Dong et al., 2009), and AvrPtoB / BAK1
(PDB identifier 3TL8, Cheng et al., 2011).
Hypothesis of shared interaction interfaces Although the effectors AvrPto and AvrP-
toB are sequence-unrelated, they share one of two proximate interaction interfaces on
the Pto molecule (Dong et al., 2009). Also, BAK1 is very similar to Pto both in primary
sequence as well as in solution structure, and was demonstrated to interact with AvrPtoB
as well (Cheng et al., 2011). Therefore, it seemed plausible that there may be significant
local overlap between the previously determined AvrPto-interacting region in Pto and a
putative AvrPto-interacting region in BAK1.
4.4.1 BAK1 kinase domain can be homology modelled to Pto
Using the VAST+ tool (Madej et al., 2014, also see section 3.9.1), BAK1-CD was
homology-modelled to Pto based on geometric criteria inferred from the previously
cited BAK1-CD / AvrPtoB and Pto / AvrPto co-crystal structural datasets, yielding
267 aligned residues with a root-mean-square deviation (RMSD) of 2.27 Å. (figure
4.27). It should be noted that the RMSD is calculated over the complete superposition
of all attempted alignments in the query structures (thus including AvrPto / AvrPtoB
alignments), indicating that this number underestimates the quality of the BAK1-CD / Pto
alignment. This alignment ranked second position out of a total number of 3745 geometric
alignments in the database query (based on number of aligned residues), position one
being the alignment with the second Pto crystal structure in the database (PDB identifier
3HGK, as cited before).
4.4.2 AvrPto / BAK1 geometrical analysis
Addition of the AvrPto structure to the aligned BAK1-CD / Pto superimposition (figure
4.28 A) shows that the relevant local structures are geometrically well aligned, indicating
three spatially adjacent putative interaction interfaces (figure 4.28 B). Although these
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Fig. 4.27 Structural superimposition of BAK1-CD (blue) to Pto (yellow) without side chains,
based on geometric alignment.
putative interaction interfaces are located close to each other in the three-dimensional
structure, their sequence-based location reaches across approximately the first half of the
intracellular kinase domain (figure 4.28 C).
4.4.3 Selection of point mutations
In an effort to understand the structural basis for the strong interaction between BAK1-
CD and AvrPto, a series of single point mutations was introduced into BAK1-CD. The
selection of point mutations was based on three general approaches, which are briefly
summarized below.
Global phosphorylation status For the first approach, mutations were introduced that
lock BAK1-CD either in an unphosphorylated or in a phosphorylated form, with the aim
to test whether global phosphorylation status of the BAK1-CD has any influence on its
affinity to AvrPto. Previous reports indicated that Pto activation loop phosphorylation,
which leads to the active conformation, is necessary for kinase activity and interaction
with AvrPto (Xing et al., 2007), and similarly, a kinase-inactive mutation of FLS2 was
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Fig. 4.28 Putative AvrPto / BAK1 interaction interfaces. A, Structural superimposition of BAK1-
CD (blue) to Pto (yellow) with added AvrPto structure (orange). B, enlargement of contact area.
Numbers indicate three putative interaction interfaces on the aligned BAK1 structure (direction
of counting from N to C terminus). C, location of interaction interfaces (black residues) in the
BAK1 amino acid sequence (N-terminally truncated). Big numbers correspond to interaction
interface numbering in (B). Grey and black diamond-shaped residues indicate phosphorylation
sites annotated in the UniProt database (The UniProt Consortium, 2015). Small numbers
indicate annotated residue numbers as retrieved from the UniProt database. Amino acids are given
in single-letter code.
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found to abolish its interaction with AvrPto (Xiang et al., 2008). Additionally, structural
studies investigating the interaction of BAK1-CD with AvrPtoB indicate that the active
conformation of BAK1 is necessary for this interaction (Cheng et al., 2011). Taken
together, these studies indicate that phosphorylation status may be a significant parameter
governing the interaction between AvrPto and its putative virulence targets (Zong et al.,
2008).
Local environment The second approach was based directly on geometrical analysis
of the interaction interfaces; mutations were introduced in amino acids which were both
physically close to the putative interaction interfaces and whose modification would have
a large direct impact on their immediate vicinity; for this reason, residues were selected
which had the potential to be phosphorylated, as presence or absence of phosphorylation
marks a strong change in a protein’s local environment. To simulate the effects of a
phosphorylated state, phosphomimetic aspartate substitutions were used on threonine
and tyrosine residues; to simulate the effects of an unphosphorylated state, glycine and
phenylalanine substitutions were used on threonine and tyrosine residues, respectively.
Conservation in interactants The third approach was based on previous experiments
in this study which indicated that AvrPto was able to bind BAK1-CD, FLS2-CD and Pto,
but not BRI1-CD. Therefore, alignments were generated and residues were determined
which were conserved in all the interactants, but not in BRI1-CD. Subsequently, the
corresponding BRI1 residue was introduced into BAK1-CD. Again, as in the previous
approaches, focus was placed primarily on amino acids which have the potential to be
phosphorylated.
4.5 Influence of BAK1 and AvrPto point mutations on inter-
action characteristics
4.5.1 BAK1 global phosphorylation status and kinase activity
4.5.1.1 Constitutively phosphorylated BAK1 binds AvrPto with wild-type affinity
S286A mutant BAK1 residue S286 has an important regulatory function for global
phosphorylation status, acting as a major negative regulatory switch (Wang et al., 2008),
and phosphorylation at this residue likely occurs in response to BAK1-FLS2 interaction
(Wang et al., 2014a). Therefore, an S286A mutation was introduced to create a con-
stitutively phosphorylated version of BAK1-CD. As expected, the mutation results in a
strong shift towards the BAK1-CD phosphorylated form during bacterial expression, as
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can be seen in the migration pattern during SDS-PAGE (figure 4.29 A). In SPR analysis
the association constant (ka) was determined as 5.4 ×104 (± 5.3 ×103) mol−1 s−1, while
the dissociation rate constant (kd) was determined as 1.2 ×10−3 (± 1.3 ×10−4) s−1. The
affinity (KD) inferred from kinetic parameters was 24 ± 6 nM. Figure 4.29 shows a repre-
sentative kinetic experiment (KD = 28 nM). These results indicate that the S286A mutant
interacts with AvrPto similarly to WT BAK1-CD, and suggests that the constitutively
phosphorylated state of residues which result from forced BAK1 autophosphorylation
pose no obstacle to interaction with AvrPto.
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Fig. 4.29 Interaction kinetics of mO-AvrPto and the S286A mutant. A, SDS-PAGE of soluble
extracts from E. coli (ROSETTA) expressing (1) no protein, (2) BAK1-CD S286A mutant, or (3)
BAK1-CD WT form. Arrows indicate phosphorylated and unphosphorylated form of BAK1-CD
as indicated. Note: picture is a composite image consisting of non-adjacent lanes of the same
gel, and is only intended for visual comparison of band patterns. B, data (black curve) and
global kinetic fit to a 1:1 binding model (red curve; χ2 = 3.19 RU2, U-value = 2). Injected
concentrations were 12.3 nM, 37.5 nM, 111 nM, and 333 nM. C, residuals plot showing deviations
between data and model. Quality control levels are indicated by the dotted line (inner threshold)
and dashed line (outer threshold). The experiment was repeated 2 times with similar results.
4.5.1.2 Kinase-inactive BAK1 does not bind AvrPto
K317E mutant BAK1 K317E is a well-characterized point mutation resulting in com-
plete loss of kinase activity (Li et al., 2002, Bajwa et al., 2013). Injection of the BAK1
K317E mutant using the same SPR assay setup as has been used for analysis of wild-type
BAK1-CD and other SDM mutants resulted in a pure baseline signal (data not shown).
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Subsequently, maximum concentration of K317E in the assay was raised to 3 µM in an
attempt to increase the observation window for binding events. Figure 4.30 shows the
result of a representative experiment; there is no binding visible that would allow kinetic
evaluation; the very slight binding event occurring at the highest concentration is due to
unspecific background absorption to the reference flow cell, as indicated by the negative
magnitude of the response. These findings support previous data by other groups (as cited
before) that the active conformation of kinase interactants is crucial for their interactions
with AvrPto.
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Fig. 4.30 Interaction kinetics of mO-AvrPto and the kinase-inactive K317E mutant. A, SDS-PAGE
of purified protein; (1) BAK1-CD WT, (2) BAK1-CD K317E mutant. Arrows indicate phos-
phorylated and unphosphorylated form of BAK1-CD as indicated. Note: picture is a composite
image consisting of lanes run on different gels, and is only intended for visual comparison of
band patterns. B, data curve for K317E injections. Injected concentrations were 111 nM, 333 nM,
1 µM, and 3 µM. The experiment was repeated 2 times with similar results.
4.5.2 The BAK1 Y403F mutation has no influence on its affinity to
AvrPto
Y403 identification The BAK1 residue Y403 was identified by looking for potential
functionally relevant single amino acid divergences in conservation among the interactants
(also see section 4.4.3). Y403 is conserved as a tyrosine in BAK1, FLS2, and Pto, but not
in BRI1 (figure 4.31, B).
Y403 as putative effector target? Interestingly, the homologous position in A thaliana
EFR, Y836, was recently described to be required for EFR activation and downstream
immunity signalling, as well as to be targeted by another P. syringae effector protein,
HOPAO1. This effector acts as a tyrosine phosphatase and suppresses immunity signalling
by dephosphorylating EFR Y836 (Macho et al., 2014).
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Y403F analysis Y403 is located distal to the putative AvrPto / BAK1-CD interaction
interfaces (4.31, A). SPR analysis shows that the Y403F mutation has no significant effect
on its binding to AvrPto (figure 4.31 shows a representative experiment), as both kinetics
and affinity for the interaction are similar to WT BAK1-CD (ka = 2.1×104 (±9.3×103)
mol−1 s−1, kd = 7.3×10−4(± 5.7×10−5) s−1, KD = 35 (±14) nM), indicating that the
single amino acid divergence at the Y403-equivalent position in BRI1-CD is not the
determinant for AvrPto interaction specificity.
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Fig. 4.31 Y403F analysis. A, The Y403 residue (green) is located distal to the putative BAK1-CD
(blue) / AvrPto (orange) interaction interfaces (aligned Pto is not shown for clarity). B, alignment
showing conservation of Y403 (numbering corresponds to BAK1 only). C, SPR analysis, data
(black curve) and global kinetic fit to a 1:1 binding model (red curve; χ2 = 0.50 RU2, U-value= 1).
Injected concentrations were 12.3 nM, 37.5 nM, 111 nM, and 333 nM. D, SPR analysis, residuals
plot showing deviations between data and model. Quality control levels are indicated by the dotted
line (inner threshold) and dashed line (outer threshold). The experiment was repeated 2 times with
similar results.
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4.5.3 BAK1 T324 mutations significantly alter its affinity to AvrPto
due to altered interaction kinetics
T324 identification The second putative interaction interface (see figure 4.28, B, C)
contains a single phosphorylatable residue, T324. T324 locates centrally in this interface,
with the residue and its corresponding phosphate group (the crystal structure used to build
the model exhibited phosphorylation at this residue) extended into the direction of the
putative location of the AvrPto structure (figure 4.32, A). Besides location, this residue
was also chosen because of its conservation status. FLS2 and Pto contain a serine, another
phosphorylatable residue, at the homologous position of BAK1 T324. However, in the
BRI1 sequence, the homologous residue is a glycine instead (figure 4.32, B).
T324G associates rapidly Surprisingly, mutating BAK1-CD T324 to a glycine to
mimic the situation in BRI1-CD resulted in increased affinity to mO-AvrPto in SPR
experiments, with a KD of 6.3±1.2 nM (figure 4.32, C shows a representative experiment,
KD = 7 nM), an approximately six-fold increase compared to WT BAK1-CD. Kinetic
analysis reveals that the increased affinity of the T324G mutant to mO-AvrPto is due to
an increased association rate of the complex (ka = 1.2× 105 (±3.0× 104) mol−1 s−1),
which is about 3 times faster than that of WT BAK1-CD. In contrast, the dissociation rate
is about as fast as that observed for WT BAK1-CD (kd = 7.7×10−4 (±1.2×10−5) s−1).
T324D dissociates quickly To further analyse the observed effect of the T324G mu-
tant, the functionally opposed phosphomimetic mutation was introduced to BAK1-CD
(T324D). Correspondingly, the affinity of T324D to mO-AvrPto was significantly lower
than that of WT BAK1-CD or the T324G mutant (KD = 170.0±40.0 nM). In regards to
kinetics, this mutation has the opposite effect to T324G as well: while the association
rate for complex formation with mO-AvrPto is about the same as that of WT BAK1-CD
(ka = 2.8×104 (±1.2×104) mol−1 s−1, the dissociation rate for the complex is about 5
times faster (kd = 4.9×10−3 (±1.8×10−3) s−1).
T324 as ’interface marker’ T324 has not been reported as a BAK1 in vivo phos-
phorylation site previously in A. thaliana (’Arabidopsis2010’ database, Clouse et al.,
2008). However, it can be subject to autophosphorylation during heterologous expression
in the E. coli system, as has been demonstrated in a phosphoproteomics study (Wu
et al., 2012), and the homologous residue in tomato BAK1 (SlBAK1) was also shown
to autophosphorylate in vitro (Bajwa et al., 2013). As the T324G mutations results in
increased affinity to AvrPto, the initial hypothesis that the non-phosphorylatable single
amino acid divergence of the T324-homologous position in BRI1 may be a contributor to
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Fig. 4.32 T324 analysis. A, The T324 residue (green) is located in the middle of the second
putative BAK1-CD (blue) / AvrPto (orange) interaction interface (aligned Pto is not shown for
clarity). B, alignment showing conservation of T324 (numbering corresponds to BAK1 only).
C, T324G SPR analysis, data (black curve) and global kinetic fit to a 1:1 binding model (red
curve; χ2 = 0.53 RU2, U-value = 1). Injected concentrations were 12.3 nM, 37 nM, 111 nM,
and 333 nM. D, T324G SPR analysis, residuals plot showing deviations between data and model.
Quality control levels are indicated by the dotted line (inner threshold) and dashed line (outer
threshold). The experiment was repeated 3 times with similar results. E, T324D SPR analysis,
data (black curve) and global kinetic fit to a 1:1 binding model (red curve; χ2 = 0.95 RU2, U-value
= 3). Injected concentrations were 37 nM, 111 nM, 333 nM, and 1 µM. Note: Injection artefacts
were removed at the beginning and end of injections. F, T324D SPR analysis, residuals plot (as
described above). The experiment was repeated 3 times with similar results.
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the differential RLK-CD interaction specificity of AvrPto can be ruled out. However, it
seems plausible that the differential effects on AvrPto/BAK1 binding affinity and kinetic
behaviour resulting from the T324G and T324D mutations may be due to steric hindrance
of a phosphate group at this position; this would in turn reinforce the notion that the
BAK1 loop containing this residue indeed forms part of the interaction interface and thus
substantiate the initial hypothesis that the interactions between AvrPto and either BAK1
or Pto occur similarly on a structural level (section 4.4.2).
4.5.4 AvrPto mutation Y89D strongly diminishes interaction with
BAK1
Y89D in literature AvrPto Y89D has previously been described as a mutant which
abolishes binding of AvrPto to Pto and loses wild-type AvrPto’s negative effect on Pto au-
tophoshorylation (Xing et al., 2007). Very similar findings have been reported regarding
the Y89D mutant’s effects on putative virulence targets FLS2 and EFR; interaction with
these proteins was strongly diminished and no effect on FLS2 or EFR autophosphorylation
could be observed, in contrast to wild-type AvrPto (Xiang et al., 2008).
Y89 analysis AvrPto Y89 extends towards the putative AvrPto / BAK1-CD interfaces
(figure 4.33, A). The effect of AvrPto Y89 on interaction with Pto has previously been
described as mediating hydrophobic contact with Pto V51; however, in BAK1, the
homologous residue is a glycine (G299; figure 4.33, B, C). These residues are located
in the corresponding BAK1 and Pto loops forming the first putative interaction interface
(also see figure 4.28). Interestingly, residue T324 (which is located in the BAK1 loop
forming the second putative interaction interface) extends towards AvrPto Y89 (figure
4.33, D). Mutating Y89 to a phosphomimetic aspartate has a strong effect on interaction
with BAK1, reducing binding to a very low residual level (figure 4.33, E). It seems likely
that the strong reduction in binding occurs mechanistically analogously to the situation in
the Pto/AvrPto interaction (Xing et al., 2007), and that a phosphomimetic aspartate in
the Y89 position leads to strong steric hindrance. These findings can be set into relation
with the previously described T324 mutations, as in both cases aspartate mutations have
qualitatively (though not quantitatively) similar results, further substantiating the putative
alignment of the interaction interfaces.
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Fig. 4.33 Y89D analysis. A, AvrPto Y89 (green) extends towards the putative BAK1 (blue)
interaction interfaces. B, AvrPto Y89 faces residues V51 in Pto (red residue on yellow structure)
and G299 in BAK1 (cyan residue on blue structure), respectively. Only the relevant loops on the
Pto and BAK1 structures are shown for clarity. C, alignment showing conservation of Pto V51
(numbering corresponds to Pto only; colors correspond to pane B). D, AvrPto Y89 locates close
to both BAK1 G299 (yellow) and BAK1 T324 (red). E, AvrPto Y89D shows drastically reduced
interaction with BAK1-CD in SPR experiments. Injected BAK1-CD concentrations were 37 nM,
111 nM, 333 nM, and 1 µM, respectively. This signal was not sufficient for meaningful kinetic
evaluation. The experiment was repeated 2 times with similar results.
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4.5.5 Mutational analysis kinetics comparison
Quantitative comparison Figure 4.35 shows a quantitative overview of kinetic con-
stants for BAK1-CD mutant interactions with mO-AvrPto as determined by SPR ex-
periments and presents statistical analysis which compares the kinetic behaviour of the
mutants to wild-type BAK1-CD. There are no significant differences in kinetic behaviour
between wild-type BAK1 and the mutants S286A and Y403F. However, significant differ-
ences could be observed for both T324 mutants. The divergence in affinity of T324G and
T324D compared to wild-type BAK1 (which is higher, and lower, respectively (figure
4.35, C)); is reflected through markedly different interaction kinetics. While the T324G
mutant exhibits an approximately three-fold faster complex formation compared to wild-
type BAK1 and all other mutants (figure 4.35, A), the dissociation of the complex is
slightly slower compared to wild-type BAK1 (figure 4.35, B). The opposite is true for
T324D: formation of the complex occurs similarly as in wild-type BAK1 (figure 4.35, A),
while it exhibits an approximately five-fold faster complex dissociation (figure 4.35, B).
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Fig. 4.34 Comparison of kinetic parameters obtained from SPR experiments for BAK1 mutants. A,
association rate constant (ka); B, dissociation rate constant (kd); C, affinity (KD). Note: logarithmic
scales in (A) and (B). Values are given as means ± SD. The values are based on three independet
experiments, with the exception of the S286A and Y403F mutants, which are based on two
independent experiments. P values (unpaired Student’s t-test) are indicated above the error bars.
Qualitative comparison Normalizing the data obtained from kinetic experiments with
WT BAK1-CD and its corresponding T324 mutants as fraction of maximum response
and plotting an overlay of the respective kinetic curves visualizes the different kinetic
behaviours (figure 4.35).
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Fig. 4.35 Qualitative comparison of BAK1 mutant kinetics. Black, wild-type BAK1-CD; orange,
T324G mutant; blue, T324D mutant. Only data curves are shown for clarity. Injections were 12.3
nM, 37 nM, 111 nM, and 333 nM. Curves have been normalized as % of maximum response
(at the end of 333 nM injection) to facilitate comparison. Injection artefacts have been removed
from the T324D curve (note missing data points). Affinities (KD) are given in the inset box for
reference.
4.6 AvrPto interactions in planta using a protoplast system
Declaration of collaboration All in vivo experiments as described in the following
sections were performed in collaboration with T. Schmidt and have been included in
the corresponding M.Sc. thesis (Schmidt, 2015). The contribution of T. Schmidt was
as follows: Discussions concerning the planning of experiments, preparation of stock
solutions and isolation of plasmids for use in the experiments, sowing and care of plants
for use in protoplast isolation, manual assistance during protoplast isolation and the
performance of the experiments.
4.6.1 BAK1 SDM variants can functionally complement the bak1
mutant phenotype in flg22-triggered immunity signalling
To test whether the BAK1 point mutations generated for the in vitro study can still provide
the natural BAK1 function in vivo, wild-type BAK1 or its point mutated variants were
expressed in A. thaliana protoplasts as described in section 3.2.2. BAK1 function was
studied using a pFRK1-luciferase assay as described in sections 3.8.1 (also see figure
3.9, A to C for a schematic overview of the system and its use to study functional
complementation). Comparing protoplasts isolated from Col-0 plants with protoplasts
isolated from bak1-5 bkk1-1 mutant plants shows a significant (p≤ 0.05) reduction in
luciferase activity 3 h post induction (figure 4.36, A, p = 0.034). This phenotype can
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be rescued by transforming plasmids containing full-length BAK1 under control of the
35S promoter into the bak1-5 bkk1-1 protoplasts (figure 4.36, B). Except for the kinase-
inactive mutant K317E, which does not show a significant pFRK1 induction compared to
noncomplemented protoplasts (p = 0.19), all tested BAK1 point mutations could rescue
the phenotype, indicating that these point mutations do not impair natural BAK1 function
in context of immunity signalling (represented by flg22-triggered pFRK1 induction).
However, the resolution of the asssay does not allow conclusions in regard to quantitative
differences in the point mutants’ ability to rescue the bak1-5 bkk1-1 phenotype when
compared to complementation with wild-type BAK1.
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Fig. 4.36 Complementation of bak1-5 bkk1-1 mutant phenotype in flg22-triggered FRK1 induction
by transiently expressing BAK1 or point-mutated variants in protoplasts . A, bak1-5 bkk1-1 mutant
protoplasts are impaired in flg22-triggered immunity signalling (represented by pFRK1 induction).
B, wild-type BAK1 or BAK1 point mutations can complement BAK1 function when expressed
transiently in bak1-5 bkk1-1 mutant protoplasts. Point mutations are described by single-letter
amino-acid abbreviations and PDB annotated BAK1 sequence numbering. Fold change is given
as the quotient in luminescence of flg22-stimulated vs. unstimulated protoplasts 3 h after flg22
treatment. Values are given as mean ± SD; the number of independent experiments on which the
values are based are given below the data labels. P values (unpaired Student’s t-test) are indicated
above the error bars.
4.6.2 Differences in affinity as observed in vitro are not visible in the
functional assay
To test whether the differences in binding affinity between AvrPto and the different point-
mutated BAK1 variants that have been determined in vitro (see section 4.5) can also be
observed in vivo, the A. thaliana protoplast system was used to investigate AvrPto function
in bak1-5 bkk1-1 protoplasts which have been complemented with either wild-type BAK1
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or one of the point-mutated variants as described in section 4.6.1 (also see figure 3.9, C to
E for a schematic overview of the system and its use to study effector function). Addition
of plasmid enabling expression of AvrPto to bak1-5 bkk1-1 protoplasts complemented
with either wild-type BAK1 or one of its point-mutated variants results in reduction of
luciferase activity (figure 4.38). However, in the case of K317E and T324G mutants,
the observed difference between pFRK1 induction in samples without or with AvrPto
expression is not large enough for the difference to be significant (p = 0.51 and 0.08,
respectively). In this assay, the in vitro affinity differences between AvrPto and wild-type
BAK1, T324G, or T324D, respectively, are not reflected in a differential ability of AvrPto
to repress immunity signalling, likely due to the overexpression situation for both the
different BAK1 variants and AvrPto. Thus, while not achieving the necessary resolution to
reflect the differential binding specificity between AvrPto and BAK1 variants as observed
in vitro, this assay qualitatively demonstrates the physiological action of AvrPto in vivo.
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Fig. 4.37 AvrPto function in bak1-5 bkk1-1 mutant protoplasts complemented by transiently
expressing BAK1 or SDM variants. Dark bars, without AvrPto; light bars, with AvrPto. Point
mutations are described by single-letter amino-acid abbreviations and PDB annotated BAK1
sequence numbering. Fold change is given as the quotient in luminescence of flg22-stimulated vs.
unstimulated protoplasts 3 h after flg22 treatment. Values are given as mean ± SD; the number of
independent experiments on which the values are based are given below the data labels. P values
(unpaired Student’s t-test) are indicated above the error bars.
4.6.3 AvrPto additionally acts on BKK1 in the functional assay
In addition to the bak1-5 bkk1-1 double knockout mutant protoplasts, experiments have
been performed in bak1-4 mutant protoplasts to study the contribution of BKK1, which
has previously been found to interact with AvrPto through Co-IP experiments (Shan et al.,
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2008) and indirectly through phenotypical readouts such as stomatal patterning (Meng
et al., 2015). While expression of AvrPto in bak1-5 bkk1-1 protoplasts complemented
with the kinase-inactive K317E BAK1 mutant has no effect 3 h after flg22 treatment (as
there is no visible pFRK1 induction to begin with), there is visible pFRK1 induction in
bak1-4 protoplasts complemented with the K317E BAK1 mutant 3 h after flg22 treatment
and a corresponding reduction upon expression of AvrPto, likely mediated through BKK1.
However, this result is based on a single experiment only, and should be confirmed
through additional experiments.
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Fig. 4.38 AvrPto functional difference in bak1-5 bkk1-1 and bak1-4 mutant protoplasts com-
plemented by transiently expressing BAK1 K317E. Dark bars, without AvrPto; light bars, with
AvrPto. Fold change is given as the quotient in luminescence of flg22-stimulated vs. unstim-
ulated protoplasts 3 h after flg22 treatment. Values are given as mean ± SD; the number of
independent experiments on which the values are based are given below the data labels. P values
(unpaired Student’s t-test) are indicated above the error bars. The bak1-4 data is based on a single
experiment.
CHAPTER 5
DISCUSSION
This study provides novel insights into the virulence strategy of Pseudomonas syringae
mediated through the effector protein AvrPto, which has served as an important model for
the study of effector function in the plant immunity field. AvrPto was previously shown to
be involved in the suppression of multiple MAMP-induced defence pathways (He et al.,
2006), but a conflict in the literature has evolved over the molecular background of these
findings. A number of previous studies identified several putative virulence targets but
critically, failed to reach consensus on the identity, providing two conceptually different
explanations for the observed virulence phenomena – describing AvrPto as either targeting
various single PRRs or a common co-receptor (section 5.1). In contrast to the previous
experimental approaches, this work provides a novel way to address this conflict by using
comparative quantitative methodology to highlight critical differences in specificity and
binding kinetics for the interaction of AvrPto with its multiple virulence targets, as well
as with the well-studied avirulence target Pto (section 5.2). The insights gained from
quantitative elucidation of effector virulence mechanisms open up new directions for
future research extending quantitative analysis to other facets of the plant immunity field
(section 5.3).
5.1 AvrPto’s virulence targets: nuances of a spectrum?
5.1.1 Moving targets are harder to hit
AvrPto targets kinases The plasma membrane localization (Shan et al., 2000) and
virulence action at an early stage of immune signalling (He et al., 2006) gave important
clues towards the localization and mechanistic nature of AvrPto’s elusive virulence target.
As component of the classical gene-for-gene resistance pair avrPto / Pto (Ronald et
al., 1992, Martin et al., 1993, Rommens et al., 1995), it became clear that immunity
mediated through AvrPto recognition relies on the direct interaction between AvrPto and
an intracellular Ser/Thr kinase (Scofield et al., 1996, Tang et al., 1996). Taking these
separate findings together with the guard model (see section 1.4.2.2), it was reasonable
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to conclude that the virulence target of AvrPto should be a plasma membrane-localized,
intracellular kinase acting early in immunity signalling.
PRRs as virulence targets Thus it came at no surprise that the first study pointing
towards specific virulence targets identified the intracellular domains of two PRRs, FLS2
and EFR, as virulence targets using evidence of complex formation with the effector by
co-immunoprecipitation (Co-IP) experiments (Xiang et al., 2008). Importantly, the study
highlighted AvrPto’s virulence action on multiple PTI pathways and speculated towards a
larger array of yet-unidentified PRR-kinase virulence targets. From an evolutionary and
physiological point of view, this study reached a conclusion both important and intuitively
logical: AvrPto, a kinase inhibitor, binds to several, closely related PRR kinase domains
(likely due to their structural similarity) and thus inhibits more than one PTI pathway –
AvrPto thus acts as a multifunctional and effective tool evolved by P. syringae specifically
to shut down early PTI responses, a major factor determining the virulence of bacterial
pathogens (Macho and Zipfel, 2015), as most clearly underlined by the fact that ectopic
expression of AvrPto in Arabidopsis fully restores virulence of P. syringae hrp mutants
completely lacking the T3SS (Hauck et al., 2003).
Targeting PRR complexes The discovery of BAK1 as a central co-receptor in various
PTI pathways (section 1.4.1.5), however, changed the big picture of MAMP perception
in several important ways, one of them concerning the virulence strategy of effectors.
The virulence effects of AvrPto which have been observed in previous studies could now
be logically and parsimoniously explained by a mechanism other than that of targeting
various different PRRs – targeting the common co-receptor. This new concept was
taken up immediately in the second 2008 publication concerning itself with AvrPto’s
virulence targets (Shan et al., 2008); using a similar Co-IP approach to Xiang et al.,
2008, AvrPto was found to interact with BAK1. Curiously, association of AvrPto with
FLS2 was detected in some, but not all of the Co-IP experiments performed in the study;
when co-expressing BAK1 and FLS2 in protoplasts together with moderate amounts of
AvrPto, Co-IPs resulted in only BAK1 being pulled down with AvrPto. The authors thus
concluded that the binding event between AvrPto and FLS2, while observable in specific
circumstances, may be an artefact of overexpression. Mechanistically, binding of AvrPto
to BAK1 was shown to interfere with flg22-triggered BAK1/FLS2 association, and it
was postulated that this physical inhibition of complex formation between a MAMP
receptor and its co-receptor, rather than any influence on the target’s kinase activity,
was the basis of virulence. This finding was consistent with the previous observation
in other studies that AvrPto is a relatively weak kinase inhibitor (105 times less potent
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than PKI, Grove et al., 1987, Xing et al., 2007), and might not reach necessary levels
for its kinase-inhibiting activity to become physiologically relevant during infection
in the in vivo situation. Beside the direct evidence of BAK1/AvrPto interaction, Shan
and co-workers also found indirect evidence pointing towards involvement of BAK1
(rather than different PRRs) in AvrPto virulence action, as AvrPto-overexpressing plants
phenotypically resemble plants impaired in BR responses such as bri1 mutants (Shan
et al., 2008), a phenotype which could be explained due to the direct involvement of
BAK1 as a co-receptor for BL (Sun et al., 2013b).
Second thoughts The conflicting datasets obtained from the previously cited studies
prompted both groups involved to conduct follow-up experiments; however, these failed
to resolve the issue, instead broadening the divide between the previous observations.
Further Co-IP experiments using both protoplasts and seedlings, reinforced by bimolecu-
lar fluorescence complementation (BiFC) assays in protoplasts, demonstrated interaction
between AvrPto and FLS2; critically, no interaction of AvrPto with BAK1 could be
observed under the same circumstances (Xiang et al., 2011). To address the issue of
overexpression, a Co-IP was performed from plants expressing tagged AvrPto, but no
tagged targets; detection with antibodies raised against native FLS2 or BAK1 yielded
endogenous FLS2, but no BAK1, in the immunoprecipitate. The discrepancy of the
results was not limited to the identity of the putative virulence target; mechanistically, the
study showed that the flg22-triggered FLS2/BAK1 association occurred independently of
the presence or absence of AvrPto; instead, a direct inhibition of FLS2 kinase activity
was postulated and reasoned to be visible as a reduction in phosphorylation of BIK1, a
downstream substrate of FLS2 kinase activity, in FLS2 but not fls2 mutant protoplasts
(Zhang et al., 2010). However, this observation arguably does not rule out the direct
involvement of BAK1, as the same group previously showed that BAK1 is essential for
flg22-triggered BIK1 phosphorylation, consistent with its role as a co-receptor (Zhang
et al., 2010). Additional evidence against this line of reasoning stems from the fact that
BIK1 was previously shown by the Shan group to be directly phosphorylated by BAK1 in
vitro (Lu et al., 2010b), although in vivo this event occurs on flg22 treatment and depends
on the presence of both kinase-active FLS2 and BAK1 simultaneously, indicating that
transphosphorylation events between FLS2 and BAK1 are essential for subsequent BIK1
phosphorylation. In further response to the findings of Shan et al., 2008, Xiang and
co-workers provided an alternative explanation for the AvrPto overexpressor bri1-like
phenotype: AvrPto was shown to interact with two receptor-like cytoplasmatic kinases
implicated in BR signalling, the BR-signaling kinase 3 (BSK3), and constitutive differen-
tial growth 1 (CDG1), which are downstream substrates of BRI1 (Tang et al., 2008, Kim
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et al., 2011). As the follow-up study by Xiang and coworkers included a broader array
of interaction assays to characterize the AvrPto-FLS2 interaction, a similarly targeted
follow-up study by the other group analogously expanded the experimental procedures
for the AvrPto-BAK1 interaction, and additionally characterized the interaction of another
P. syringae effector, HopF2, with BAK1 (Zhou et al., 2013). BiFC experiments were
added, showing interaction of AvrPto with BAK1; additionally Co-IPs were performed
using protoplasts in the fls2 mutant background, again showing interaction with BAK1
and further indicating that this interaction occurs independently from FLS2. The previous
findings regarding developmental phenotype were reinforced; constitutive AvrPto overex-
pressor constructs (35S::AvrPto-HA) did not result in plants producing viable seeds in
the Col-0 or fls2 background; however, using a bak1-4 mutant background led to reduced
severity of the developmental phenotype and to plants producing viable seeds, indicating
BAK1 as the physiological virulence target of AvrPto.
AvrPto and stomatal patterning Additional phenotypical evidence leading to BAK1
(and other SERKs) as AvrPto’s virulence target was presented in a recent study by the
Shan group investigating the function of SERKs in stomatal patterning. Upon perception
of epidermal patterning factor (EPF) ligands (Lee et al., 2012), SERKs heterodimerize
with ERECTA family RLKs to regulate stomatal patterning independent of BR signalling
(Meng et al., 2015). Ectopic expression of AvrPto causes a stomatal clustering phenotype
which disrupts regular stomatal patterning (similar effects were observed for AvrPtoB).
This is likely due to AvrPto acting on all functional SERKs, as there is a remarkable
redundancy in SERK function in the context of stomatal patterning: single and any
double mutants do not show a phenotype, while only one triple mutant combination,
serk1-1/serk2-1/bak1-4 shows clustered stomata, indicating strong contribution of these
three SERKs and somewhat weaker contribution of SERK4. Consistent with these
data, AvrPto overexpressor plants show a stronger stomatal clustering phenotype than the
mentioned triple mutant (a quadruple null mutant is embryo lethal), indicating suppression
of residual functionality by AvrPto targeting SERK4.
Overview: new data in context How do the main findings described in this thesis fit
into the context of the previous literature? AvrPto was found to interact with BAK1, Pto,
and FLS2, with differential specificity ranked from strongest to weakest interaction in
the listed order. In brief, this supports the qualitative data obtained in both Shan et al.,
2008 and Xiang et al., 2008, as well as one of the direct follow-up studies, Zhou et al.,
2013, but not the data in Xiang et al., 2011, which ruled out interaction between AvrPto
and BAK1. Importantly, the quantitative data for all studied AvrPto interactions are fully
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compatible with previous quantitative characterizations as described in Xing et al., 2007
and Xiang et al., 2008 (section 4.2.3, figure 4.16, B). More detailed discussion about
quantitative implications of these findings adding new insights to previous studies is given
in section 5.2.
5.1.2 Target subpools and availability at the plasma membrane
The inner plasma membrane: AvrPto’s habitat AvrPto contains a myristoylation
motif on its second glycine (G2), targeting it to the interior surface of the plant plasma
membrane (PM) during secretion via the T3SS; this localization is critical for both its
recognition by Pto (Shan et al., 2000) and its virulence activity (He et al., 2006). As
AvrPto interacts with several proteins, which themselves might occur in differential
states at the plasma membrane, elucidation of AvrPto’s virulence strategy benefits from
knowledge about the dynamics of its putative virulence targets in order to determine their
spatio-temporal accessibility to the effector.
FLS2 at the PM As a classical model PRR, FLS2 has been the topic of several studies
dissecting trafficking and compartmentalization of MAMP receptors, laying the foun-
dation of our current understanding of PRR dynamics at the plasma membrane. FLS2
is in dynamic balance, undergoing ligand-induced endocytosis (Robatzek et al., 2006,
Beck et al., 2012) and secretory trafficking controlled by the endoplasmic reticulum (ER)
(Tintor and Saijo, 2014, Inada and Ueda, 2014) to maintain a signalling-competent
receptor pool at the cell surface (Robatzek and Kuhn, 2015). MAMP perception leads to
dynamic reorganization of protein composition at the plasma membrane, including many
PRRs (Keinath et al., 2010). Interaction of FLS2 with BAK1 upon ligand perception
results in a marked reduction in its membrane mobility; unelicited FLS2 however is
highly mobile (Ali et al., 2007, Schulze et al., 2010). However, localized redistributions
of PRRs in direct response to pathogens at the infection site may play a role, and has been
demonstrated for FLS2, although paradoxically in response to a fungal pathogen (Nielsen
and Thordal-Christensen, 2013); the functional relevance of these findings remains to
be seen. It is therefore hard to determine the distribution of PRR targets such as FLS2
encountered at the plasma membrane by AvrPto upon secretion into the plant cell; the
hypothetical physiological implications of receptor quantity for immunity suppression by
AvrPto are discussed in further detail in section 5.3.1.
Dynamic insights for BAK1 Molecular dynamics of BAK1 populations have been
elucidated mainly in the context of brassinosteroid signalling. However, due to the strik-
ing structural and mechanistic similarity of BAK1’s role in either BR or flg22-induced
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signalling, insights obtained from these studies may be relevant for transfer to BAK1-
related immunity signalling. Similar to FLS2, BAK1 is constantly recycled to maintain
a signalling-competent population at the PM; however, endocytosis of BAK1/BRI com-
plexes seems to be ligand-independent (Russinova et al., 2004). This is likely a result
of the different dynamic needs of stimulus perception – constant, slower response to
endogenous developmental signals vs. fast, flexible response to a MAMP (Geldner
et al., 2007). A recent study visualizing localizations of fluorescently tagged BAK1
and BRI1 in real time shows that the two proteins constitutively associate in absence
of ligand (’pre-formed complexes’), but only about 10 % of the total population of
BRI1 at the PM exists as a heterooligomer with BAK1 upon application of exogenous
ligand (Bücherl et al., 2013), which is in line with earlier semi-quantitative Co-IPs
showing that less than 5 % of total BAK1 is recruited by BRI1 upon ligand perception
(Albrecht et al., 2012). However, ligand perception leads to an increase of ∼50 % of
receptor heterooligomers, implicating a role for ligand-mediated receptor recruitment
(Bücherl et al., 2013). Comparing the studies investigating BAK1 dynamics with FLS2
and BRI1 strengthened the notion that BAK1 exists in distinct sub-pools which are not
freely interchangeable between developmental and immunity signalling; consequently,
the growth-inhibition effect of MAMP signalling does not occur due to any rate limiting
caused by BAK1 availability to either pathway, and uncoupling is likely mediated through
differential phosphorylation (Schwessinger et al., 2011, Belkhadir et al., 2014, Wang
et al., 2014a). However, AvrPto is likely able to bind BAK1 present in both pathways
(or at least a hypothetical ’precursor’ state of BAK1 feeding into both pathways) as
indicated by the growth phenotypes described before and the findings in the present
work that AvrPto binds to constitutively fully-phosphorylated BAK1-CD with the same
affinity as to the wild-type protein in vitro (see section 4.5.1.1). Although the exact
molecular determinants of the differential BAK1 states in developmental and immunity
signalling are not yet entirely clear, site-specific differential phosphorylation mediated
through BAK1-interacting RLKs was recently demonstrated (Wang et al., 2014b). In
addition to the direct evidence concerning specific phosphorylation states, a recent study
investigating the negative regulatory pseudokinase BIR2 demonstrated a crucial role for
BIR2 in segregating BAK1 into distinct pools which can be specifically adressed by the
corresponding ligand (Halter et al., 2014a).
Redundancy in BAK1 function Homology among members of the SERK family
leads to a large degree of functional redundancy in various pathways, including immunity
signalling (section 1.4.1.5). The degree in which the different SERKs can functionally
stand in for each other probably depends on the specific PRR involved; while EFR strongly
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interacts with all SERKs except SERK5, FLS2 seems to preferentially interact with BAK1
and to a lesser degree, SERK2, while the interaction with SERK1 and BKK1/SERK4
was limited (Roux et al., 2011). Consistent with observations that even in bak1 mutant
plants AvrPto was able to suppress MAMP signalling, AvrPto was found to associate with
BKK1/SERK4 and SERK5, and may thus be targeting the closest BAK1 homologues to
maximize its virulence effects (Shan et al., 2008); a later study expanded these findings
to SERK1 and SERK2 (Meng et al., 2015). These results could be confirmed in this
work in the functional assay, as AvrPto was able to suppress the residual flg22-triggered
FRK1 induction in bak1-4 mutant plant protoplasts, likely indicating its action on other
SERKs still functionally present in the protoplasts (section 4.6.2).
5.1.3 Biological significance of target spectrum
Intention or artefact? The notion that AvrPto is an exceptional example of a promis-
cuous effector, targeting a variety of proteins, is now well established in the literature and
has been confirmed through this work. The quantitative data obtained in this work add
crucial information to this picture and show that AvrPto is a not only a promiscuous, but
also relatively selective effector (Mandell and Kortemme, 2009), as there are signifi-
cant differences in binding affinity to its various targets. However, the question remains
whether this broad target range is of direct biological relevance or rather a secondary effect
of a relative lack of differentiation in regard to the structural determinants of interactions
between AvrPto and its targets. These issues are speculative, as it is difficult to design
meaningful experiments directly addressing this question and yielding data that would
conclusively rule out either one of these options. As crystallographic structural analysis of
the AvrPto-BAK1 and AvrPto-FLS2 interactions was outside the scope of this work, the
structural aspect is discussed briefly in section 5.1.4, while putative implications of the
novel quantitative data on AvrPto-target interactions obtained in this work are discussed
in detail in sections 5.2 and 5.3.1.
5.1.4 Molecular aspects of kinase binding
Structural insights The structural data available for AvrPto-Pto and AvrPtoB-BAK1
co-crystals enabled the homology-based modeling of a putative AvrPto-BAK1 complex
structure in this work (section 4.4). The viability of this approach was validated through
the determination of a single previously uncharacterised residue on BAK1, T324, which
can either increase or decrease the affinity of BAK1 to AvrPto when mutated to a
glycine or a phosphomimetic aspartate, respectively. In SPR experiments, these affinity
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differences were demonstrated to be caused by altered interaction kinetics (section 4.5.5,
figure 4.32). The T324 residue is central to a BAK1 loop extending towards the putative
location of the AvrPto structure, into close vicinity to AvrPto Y89 (figure 4.33, D).
The corresponding aspartate mutant of AvrPto, Y89D, has been previously described to
strongly suppress interaction with Pto (Xing et al., 2007) and FLS2 (Xiang et al., 2008),
a finding that could be independently verified through this work (section 4.5.4, figure 4.33,
E). Based on these data, it is most likely that steric hindrance of negatively charged groups
(either phosphorylated threonine or the phosphomimetic aspartate residue) mediates
the lowered affinity of AvrPto Y89D and BAK1 T324D mutants through electrostatic
repulsion. This demonstrates that the AvrPto-BAK1 and AvrPto-Pto interactions occur
similarly on a structural level, involving analogous interaction interfaces. The biological
significance of BAK1 phosphorylation on T324 is not clear yet, but this phosphorylation
was demonstrated in vitro for the BAK1-AvrPtoB co-crystal (Cheng et al., 2011), and
the BAK1 T324D mutant can still functionally complement flg22-triggered immunity
signalling in Arabidopsis protoplasts (section 4.6.2, figure 4.36, B).
Interaction determinants Consistent with previous findings that reached similar con-
clusions for FLS2 (Xiang et al., 2008) and Pto (Xing et al., 2007), this work demon-
strated that an active conformation of BAK1’s catalytic loop (which can be disrupted
through the K317E kinase-inactive mutation) is crucial for AvrPto interaction (section
4.5.1.2). In contrast to T324 and K317, no other single-point-mutated BAK1 variants
tested in this work showed a significant difference in AvrPto interaction compared to
wild-type BAK1 (section 4.5.5, figure 4.5.5), indicating that further mutational analysis,
possibly including higher order combinations of amino acid substitutions, may be neces-
sary to unravel the exact primary sequence determinants which allow BAK1 (in contrast
to, for example, BRI1) to interact with AvrPto. A putative future co-crystal structure of
AvrPto in complex with BAK1, once available, will significantly facilitate this task and
allow independent verification of the homology-based in silico model described in this
work.
Kinase inhibition? Elucidation of the AvrPto-Pto co-crystal structure (Xing et al.,
2007) demonstrated a significant structural similarity to the well-studied complex of
the cAMP-dependent protein kinase (also known as protein kinase A, PKA) and its
corresponding small inhibitory peptide, protein kinase A inhibitor (PKI, Bossemeyer
et al., 1993). These findings explain the autophosphorylation-inhibitory effect observed
in vitro by Xiang et al., 2008 for FLS2 and, in this work, for BAK1 (section 4.1.4, figure
4.12). The effect is likely based on competitive inhibition through a pseudosubstrate
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mechanism, as both PKI and the corresponding loop of AvrPto localize close to the
ATP binding pocket of PKA and Pto, respectively (Dalton and Dewey, 2006, Xing
et al., 2007), thus limiting access of ATP substrate. A similar reduction of BAK1
autophosphorylation has been shown for the interaction between AvrPtoB and BAK1
(Cheng et al., 2011). However, it has been shown that AvrPto is drastically less effective
in inhibiting Pto autophosphorylation when compared to the PKI/PKA pair (Kis of 11 µM
and 1 nM, respectively, a difference of 4 orders of magnitude; Xing et al., 2007, Shan
et al., 2008). Interestingly, while the interaction of AvrPtoB with BAK1 is significantly
weaker than that of AvrPto (steady-state affinity of 3.5 µM, or approximately 100-fold
lower than that of AvrPto to BAK1), its inhibitory effect on BAK1 autophosphorylation
is significantly stronger in relative terms (Cheng et al., 2011). It thus appears likely that
the inhibition of BAK1 kinase activity through AvrPto, while demonstrable, may be a
secondary effect of its complex localization, not its primary molecular virulence function.
5.2 A novel quantitative look at effector-target interactions
5.2.1 Methodology of this work compared with previous studies
Black, white, or grey? The collection of previous studies providing specific data to-
wards the identification of AvrPto’s putative virulence target (5.1.1) had one important
methodological aspect in common: the reliance on qualitative approaches such as Co-IP
and BiFC for describing bimolecular interactions. Compared to high-throughput screen-
ing methods such as yeast two-hybrid (Y2H) or affinity purification followed by mass
spectrometry (AP-MS), these methods provide lower rates of false negatives or positives,
thereby increasing the fidelity of the interaction data at the cost of throughput (Berggård
et al., 2007, Lalonde et al., 2008). Co-IP, when performed with specific antibodies, can
faithfully report the presence of a complex including two or more proteins of interest.
However, quantitative conclusions are very limited. While it may be possible to qualita-
tively rank affinities between multiple interaction pairs by carefully choosing expression
levels (as has been performed in Shan et al., 2008, demonstrating that compared to FLS2,
a larger amount of BAK1 can be co-immunoprecipitated with AvrPto), true quantitative
information such as dissociation constants (KDs) cannot be obtained. Moreover, it is
difficult to conclude that an interaction characterized by Co-IP is really indicative of
a binary, direct contact between two proteins, as a third (possibly undetected) protein
might mediate the physical association between the two proteins of interest. Very similar
limitations apply to BiFC analysis, as association of proteins at a distance of ∼7 nm can
reconstitute the fluorophore and thus lead to a positive signal (Hu et al., 2005, Fan et al.,
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2008); this distance scale is well within the range of higher-order protein complexes
(Erickson, 2009).
In vivo vs. in vitro The most significant conceptual advantage of these methods com-
pared to the main methods used in the present work is their higher similarity to native
biological conditions, as they can be performed inside living cells or complete organisms
mimicking the situation as it would occur in nature. However, it is impossible to achieve
truly native conditions in controlled laboratory experimental environments, and each
method necessarily includes deviations from the natural system (such as changes in pro-
tein expression levels or down-stream analytical manipulations); therefore, conceptually,
there are arguably no practically attainable ’native’ conditions, but rather varying degrees
of ’artificial’. Advancing along the scale towards more artificial conditions allows the con-
trol of an increasing number of experimental parameters. Under purely in vitro conditions,
protein-protein interactions can be studied quantitatively because the use of purified pro-
teins in aqueous buffer environments rules out a large number of (potentially, unknown)
complicating factors, and allows quantification of individual protein concentrations. Thus,
the critical advantage of in vitro methodology is the possibility of quantitative analyis.
It is important to carefully consider the advantages and disadvantages of each method;
ultimately, in vivo and in vitro methods ideally complement each other to yield different
types of information which then allow to characterize a protein-protein interaction in
greatest depth (Piehler, 2005).
5.2.2 Seeing both sides of a coin: steady-state affinity and kinetics
for quantitative characterization of an interaction
Steady-state affinity A common way to quantify the intensity of biomolecular interac-
tions is the determination of binding affinity – ultimately a thermodynamic description
of the sum of attractive and repulsive intermolecular forces that govern the interaction.
Fundamentally, biomolecular interactions can often be reasonably described by simple
binding models which are governed by the law of mass action; formation of a biological
complex can thus be described succinctly as the reversible formation of a product made up
of two reactants A and B: A + B−→ AB. Steady-state affinity determination assays take
advantage of the fact that such reactions eventually reach chemical equilibrium; that is,
the association and dissociation rates of the complex are equal and there is no net change
in the amount of complex. If the concentration of the reactants can be predetermined
and the amount of complex can be observed, experimental titration approaches allow
quantification of the interaction’s binding affinity. In this work, steady-state binding affini-
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ties were measured through microscale thermophoresis (MST), an optical technology
for quantitative interaction analysis (section 3.7.1.1 and figure 3.4 illustrate the titration
concept applied to MST). The most common way to describe affinity in context of bio-
logically relevant interactions is that of the dissociation constant, KD, which is defined
as the concentration of free A at which half of B is associated with A. It is important to
note that while often quantitatively linked, dissociation constants of functionally relevant
biomolecular interactions do not always reflect the actual functional output of the system
(e.g. as described by the EC50 of dose-response curves).
Kinetics Kinetic affinity determination reaches the same type of information via a
different pathway; instead of observing reactions that have reached chemical equilibrium,
the rates of association and dissociation of the complex are measured directly. Formation
of the complex AB is described by a forward reaction (A+B−→ AB), which is governed
by the association rate constant, ka. Conversely, dissociation of the complex AB is
described by a backward reaction (AB−→ A+B), which is governed by the dissociation
rate constant, kd. The affinity of the interaction (KD) can then be determined directly from
the association and dissociation rate constants: KD =
kd
ka
. Intuitively, a higher affinity
thus corresponds to a faster association rate and a slower dissociation rate of the complex.
Compared to steady-state analysis, kinetic analysis provides additional information to
characterize an interaction, as two interactions with the same affinity can have different
kinetic behaviours. In the present work, this is exemplified by the interactions between
AvrPto and either BAK1 or Pto: although the binding affinity of these interactions differs
by roughly a factor of 3, the interaction between AvrPto and BAK1 both associates and
dissociates roughly 10 times faster (figure 4.25). In this work, kinetic experiments have
been performed using surface plasmon resonance spectroscopy (SPR; section 3.7.2) in a
single-cycle kinetic titration approach (figure 3.7).
5.2.3 Quantitative differences in affinity: quo vadis?
Scales The highest affinity measured in the course of this work was that of AvrPto to
BAK1-CD, with KDs determined as 45 ±8 nM (steady-state, section 4.2.1) and 36 ±13
nM (kinetics, section 4.3.1), respectively. How does this affinity compare to that of other
well-known physiologically relevant biomolecular interactions? Botulinum neurotoxin
of Clostridium botulinum, the most acutely lethal toxin currently known with an LD50
of 1.3–2.1 ngkg−1 in rats (Arnon et al., 2001), binds its protein receptor with a KD of
∼34 nM (Jin et al., 2006), an affinity very similar to the AvrPto-BAK1 interaction. The
affinity ceiling in biological context is likely provided by two of the strongest currently
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known non-covalent protein-ligand binding events, the interactions of avidin or strep-
tavidin with biotin, which occur on a femtomolar affinity scale (Weber et al., 1989).
However, such exceedingly strong interactions seem to be the exception rather than the
rule, and most biologically relevant interactions, including protein-protein interactions,
occur at affinities between roughly 1 nM and 1 mM, with some rare exceptions in the
picomolar range (Houk et al., 2003, Wang et al., 2004, Chen et al., 2013). Specific
protein-protein interactions, as exemplified by mammalian antibodies binding their cog-
nate antigens, are typically in the nanomolar to low micromolar affinity range (Griffiths
et al., 1994). However, more transient protein-protein interactions, as they typically
occur in signalling, may be significantly weaker, often falling into the higher micromolar
range (Nooren and Thornton, 2003). Importantly, the affinity of the effector AvrPtoB
to BAK1 was previously determined as 3.5 µM in isothermal titration calorimetry (ITC)
experiments (Cheng et al., 2011), an affinity 100-fold lower than that of AvrPto to BAK1
as determined in this work. In this context, the affinity of AvrPto to its virulence targets
BAK1 and FLS2, as well as to the tomato avirulence target Pto, can generally be catego-
rized as relatively specific, high-affinity protein-protein interactions, based on the relative
affinity scale on which these interactions occur.
Factors The affinity difference between the interaction pairs AvrPto-BAK1 and AvrPto-
FLS2, as determined in equilibrium binding analysis, is approximately 5-fold (figure 4.16
A). What implications can a 5-fold difference in affinity have on biological context at the
cellular scale? Or, stated more provocatively, is this enough of a quantitative separation to
postulate meaningful physiological effects originating from such an affinity difference?
Unfortunately, there is little quantitative data regarding effector-target interactions, or
other similar interactions in the context of plant immunity; the greatest number of de-
tailed quantitative analyses of biological interactions has been performed in context of
medical and pharmaceutical science, especially cancer research. Studies investigating
the functionality of animal estrogen receptors (ERs)) indicate that ∼4-fold ligand affinity
differences between two receptor subtypes, ERα and ERβ , may be the molecular basis
for tissue-specific differential action of estrogens (Kuiper et al., 1997), thus highlighting
a relatively small difference in interaction affinity as a major factor encoding a phys-
iological output (albeit on a receptor-ligand level). The human Dicer protein, which
converts double-stranded RNA (dsRNA) substrates to small interfering RNA (siRNA)
products, is dynamically regulated through differential binding affinities on a similar
scale. Dicer is inhibited by processed siRNAs, which competitively bind the active site
of the enzyme, but with an affinity 5-11 times weaker than the substrate dsRNAs (Lima
et al., 2009). Obviously, the specificity factors necessary to achieve differential functional
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output in complex interaction networks depends largely on the relative levels of all the
interactants. To elucidate these quantitative relationships in complex interaction networks
is a daunting task, and even the most well-studied interactions (such as those including
the human epidermal growth factor receptors (EGFRs) are not fully understood yet on
the quantitative scale (Jones et al., 2006).
Selectivity Looking at the physiological consequences of kinase inhibition, the medical
literature provides some illustrative insights, as target selectivity of kinase inhibitors is
a major issue in drug design. A large scale study comparing target binding specificity
of a set of 38 pharmaceutical small-molecule kinase inhibitors to 287 human kinases
(∼ 55 % of the predicted kinome) show that selectivity varies significantly, with some
inhibitors acting very selectively, some promiscously, and many strongly binding a pri-
mary target and additionally various ’off-targets’ with differential specificity (Karaman
et al., 2008). Qualitatively, the latter situation is remarkably similar to that of the puta-
tive AvrPto interactome. The authors quantified selectivity relative to primary targets(
S = KD(off−target)KD(primary target)
)
and found that most small-molecule kinase inhibitors are quite
selective to their primary targets, but some have significant affinity (defined as S≤ 10)
to off-targets which are closely related to the primary target, and a few even to rela-
tively unrelated off-targets. This differential specificity has been identified as a highly
relevant factor in the design of anti-tumor and anti-angiogenic agents (Morin, 2000),
and can lead to tissue-specific functional implications of these kinase inhibitors (Sako
et al., 1988). Arguably, similar mechanisms could apply, in the context plant immu-
nity, to differential specificity of effectors targeting multiple kinases (such as AvrPto
and AvrPtoB). However, whether there is significant functional similarity between the
well-characterized pharmaceutically relevant small-molecule kinase-inhibitors of animal
kinases and macromolecular kinase inhibitors such as AvrPto is not known, and a lack of
comparative quantitative data on the selectivity of other proteinaceous kinase inhibitors
precludes direct comparisons. Thus, more quantitative studies on functionally similar
protein-protein interactions are needed to clarify this issue and establish the functional
importance of target selectivity in the context of effector virulence in plant immunity
signalling.
Efficacy, a missing link? Studies quantitatively probing receptor-ligand relationships
in depth, usually in the medical context of developing receptor antagonists in drug design,
demonstrated that efficacy is a critical link between two independently quantitative
elements, interaction affinity and physiological response (Kenakin, 2002). Efficacy can
be summarized as differential functional output a given ligand causes at a given state of
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receptor occupancy. Conceptually, the virulence effects of AvrPto could be described in
this manner by quantitatively linking its target occupation to observed virulence results
(effectively making AvrPto a ’ligand’ to its virulence target ’receptors’ in the nomenclature
of classical efficacy studies). However, such analysis is complicated by the lack of a
reliable physiological readout that is both close to native conditions and sensitive enough
to detect quantitative differences in affinity between AvrPto and its virulence targets. In
the present work, an adapted protoplast system using pFRK1 activation (and its repression
through AvrPto) as physiological readout (sections 3.8.1 and 4.6.2), while demonstrating
the in vivo effects of AvrPto virulence, did not achieve sufficient resolution to significantly
discriminate between∼4-fold differences in affinity (section 4.6.2), which was the highest
difference obtained for the tested BAK1 single point mutations (figure 4.35, C). Thus, the
putative quantitative relationship between virulence target binding affinity and gradated
physiological output (observed virulence effects) remains elusive at this point. Possibly,
further mutational analysis using BAK1 variants concurrently mutated in multiple sites
may achieve larger affinity shifts that may be reflected in the established pFRK1-Luc
protoplast assay.
5.2.4 Implications from kinetics
Time is of the essence Kinetic analysis adds a critical temporal dimension to quantita-
tive interaction analysis. While steady-state affinity is a very convenient measure to quan-
tify the strength of an interaction, it conceptualizes a ’frozen’ state of complex existence
which realistically does not often occur in nature, as physiological interactions between
biomolecules may never reach chemical equilibrium
(
ka× [A]× [B] = kd× [AB]
)
before
the corresponding biological event has already concluded – as has been succinctly stated
in a technical article on kinetic analysis, ’biological systems that have reached a state
of equilibrium are typically necrotic’ (Önell and Andersson, 2005). Many high-affinity
interactions dissociate slowly enough that quantitative disruption of a complex, once
formed, does not occur under physiological conditions. The most stable complex observed
in the course of this work was that of AvrPto with Pto, with a dissociation rate constant
2.2 ×10−4 (±1.2 ×10−4) s−1 (section 4.3.2). How long would meaningful complex
dissociation take under these circumstances? Calculating the half-life (first-order reaction
kinetics) of the complex yields:
t1/2 (AvrPto-Pto) =
ln 2
kd(AvrPto-Pto)
≈ 0.693
2.2×10−4 s−1 = 3150 s = 52.5 min (5.1)
5.2 A novel quantitative look at effector-target interactions 117
It appears reasonably unlikely that a significant amount of AvrPto could be liberated
once recognized by Pto, and depending on (currently unknown) relative effector/receptor
levels in the physiological context of infection, this interaction may be irreversible for
all practical purposes. The fact that tomato plants carrying the Pto/Prf R-gene system
are highly resistant to Pto DC3000 infection argues for the effectiveness of this ETI
defence pathway, and the idea that the robust induction of defence responses mediated
through Prf/Pto can easily overcome the virulence effects of PTI suppression. In contrast
to complex dissociation, the timing effects of complex association are harder to interpret,
as according to the law of mass action, they are second-order reactions and critically
depend on the actual concentrations of each individual interactant (termed ’A’ and ’B’ in
the following differential equation) at the onset of complex formation:
d[AB]
dt
= ka× [A]× [B]− kd× [AB] (5.2)
Thus, even relatively slow association rates may be practically overcome through interac-
tor abundance, and it appears reasonable to assume that this would be the case for Pto.
Possibly, future work investigating Pto and virulence target (SlFLS2, SlBAK1) protein
levels in tomato plants under physiological conditions might reveal the currently missing
concentration data components to predict the relative amounts of AvrPto-virulence target
and AvrPto-Pto complexes forming during infection, and thus provide further insights
into the Pto-mediated defence strategy evolved in tomato against AvrPto.
Evolutionary framework The interactions between AvrPto and its different binding
partners occur on a relatively narrow affinity scale (one order of magnitude), but the kinet-
ics are strikingly different – viewed qualitatively and relative to each other, AvrPto-BAK1
associates quickly and dissociates slowly, AvrPto-FLS2 associates slowly and dissociates
quickly, and AvrPto-Pto associates slowly and dissociates slowly (section 4.3.5). These
data intuitively fit into a theoretical framework which aims to explain how the function-
ally different interactions of AvrPto with its multiple binding partners originated on an
evolutionary level, possibly adressing the question of biological significance that was
proposed earlier (section 5.1.3). On the pathogen side, AvrPto likely evolved to quickly
and quantitatively associate with BAK1 upon injection and targeting to the plant plasma
membrane, thus effectively shutting down multiple early-timescale MAMP responses
simultaneously. AvrPto would encounter various off-targets, namely the intracellular
kinase domains of PRRs, due to their structural similarity with AvrPto’s primary target
BAK1. However, the specificity to BAK1 would be accomplished as binding to off-targets
appears to occur on slower time scales, and additionally, as the dissociation of AvrPto
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from PRR CDs is relatively fast, as exemplified by the FLS2 data. The AvrPto-FLS2
complex has a half-life of 9.9 s (calculated as shown before for the AvrPto-Pto complex,
equation 5.1); compared to the situation for the AvrPto-BAK1 complex, which has a
half-life of 477 s (7.95 min), this almost 50-fold difference in complex stability indicates
that binding events to off-targets would be relatively reversible and thus allow the effector
to preferentially bind its primary target with high fidelity. Thus, the evolutionary pressure
to abrogate binding to secondary targets might be rather low, and if any such evolutionary
modifications would also lower the affinity to AvrPto’s primary target (a likely possibility
considering the structural similarities between the BAK1-CD and PRR-CDs), it might
be opportune to sacrifice a certain amount of specificity to gain maximum affinity to the
primary virulence target.
5.3 Transferring insights to more complex systems
The quantitative interaction analysis performed in this work delivers insights that help
to evaluate the functional role of AvrPto in the origin of both virulence and avirulence
responses in plants. The next steps to further our understanding of effector biology
and virulence mechanisms now need to place these findings into physiological context.
Pathways in plant immunity are being elucidated mechanistically in ever-greater detail,
but critically, quantitative characterizations on an in vivo level remain rare. AvrPto acts
early during infection to suppress PTI responses, and the evaluation of its physiological
action, and thus, its virulence strategy, hinges heavily on information about the relative
abundance of the effector, its various putative virulence targets, and (if present), avirulence
targets.
5.3.1 Physiological consequences of protein levels
Dynamics of AvrPto delivery AvrPto gets secreted into the plant cell in a partially
unfolded state in order to physically fit through the inner diameter of the T3SS apparatus
(which is ∼2.5 nm, Blocker et al., 2001), and employs a pH-dependent folding switch
to attain its active form within the plant cytoplasm (Dawson et al., 2009). Experiments
quantifying effector delivery into host cells in real time using another bacterial model
organism, enteropathogenic E. coli, demonstrate that the translocation kinetics of effectors
can be strikingly different, resulting in a hierarchical delivery that may indicate timing
as a strategy to coordinate effector function; 40 min after infection, delivery of ’quick’
effectors may already have reached a steady-state while delivery of ’slow’ effectors may
be barely detectable, and effector concentration within the bacterial cell was found to
5.3 Transferring insights to more complex systems 119
be a main determinant for translocation kinetics (Mills et al., 2008). In absolute terms,
the kinetics for the effector translocation event can be very fast, as demonstrated by a
study showing insertion of the Salmonella invasion protein (SipA) into the host cell∼60 s
after bacterial docking; the delivery then continued linearly until complete exhaustion of
the intrabacterial effector pool (Schlumberger et al., 2005). The translocation kinetics
for AvrPto are still unknown; studies using an AvrPto fusion protein with a calmodulin-
dependent adenylate cyclase (Cya) reporter domain detected effective translocation at
the first time point of the experiment, which was 3 h after inoculation of tomato plants
with Pto DC3000 (Schechter et al., 2004), but the temporal resolution of this assay is
too low to determine accurate translocation kinetics. It is therefore currently unknown
which determinants govern the effective delivery of AvrPto into the plant cell, and the
time scales involved; experimental approaches dynamically tracking AvrPto delivery (e.g.
through observing fluorescently labeled AvrPto in planta) are needed to clarify this issue.
However, it is reasonable to assume that in early stages of infection, the absolute amount
of functional AvrPto able to interact with virulence targets in situ is rather low, as there
are multiple potential rate-limiting steps involved: pathogen attachment, AvrPto delivery
through the T3SS, pH-triggered AvrPto folding, and finally, diffusion towards the target
protein.
Target abundance It is logical to assume that this effector scarcity early in the infec-
tion process implies that overly abundant virulence targets may not be effectively (i.e.,
quantitatively) bound by AvrPto. At this point, any significant differences in target levels
would be crucial to determine the possible effectiveness of AvrPto; in extreme situations,
this factor could theoretically even outweigh affinity differences. If, for example, the
amount of immunity signalling-competent BAK1 present would outweigh the amount
of FLS2 by a factor of 100 before flg22-triggered complex formation, AvrPto binding
to FLS2 could have a greater effect despite its lower affinity, as a limiting amount of
effector could block a larger relative fraction of FLS2 than BAK1 to inhibit FLS2/BAK1
complex formation. However, current knowledge about both FLS2 and BAK1 amounts in
planta is relatively limited. A study highlighting functional variation of FLS2 across A.
thaliana ecotypes and close relatives quantified total FLS2 abundance via Western Blot
(using an antibody against sequence-identical epitopes), noting that FLS2 amounts vary
widely, are apparently not correlated to transcript levels, and that functional differences
in flg22 response observed in the various groups primarily depend on receptor levels, not
differential affinity of MAMP to receptor (Vetter et al., 2012). These findings indicate
that although the FLS2 perception system is generally well conserved, the actual amount
of receptor present is highly variable; furthermore, it is currently unclear how the apparent
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disconnection between transcript and protein levels observed by Vetter and colleagues can
be explained mechanistically and physiologically, as regulation of FLS2 transcript levels
has been observed in context of ethylene signalling (Mersmann et al., 2010). Another
phytohormone, salicylic acid (SA), was recently shown to directly control the abundance
of both FLS2 and BAK1 pools at the plasma membrane relative to non-plasma membrane
fractions through the Accelerated Cell Death 6 (ACD6) protein, which directly associates
with FLS2 and BAK1 and and likely acts on the secretory pathway to stimulate their
maturation and export from the ER (Zhang et al., 2014, Tateda et al., 2014). Taking
these findings together, it appears likely that hormonal modulation of plant immunity
responses can have direct effects on AvrPto’s effectiveness in PTI signalling suppression
by increasing receptor amounts at the plasma membrane, although current approaches
limit our understanding to relative, not absolute protein levels.
Sequestering by Pto? The binding event of AvrPto to Pto initiates ETI signalling in
a classical R-protein-mediated response (section 1.4.2.3). This effect is sufficient to
explain the resistance of plants carrying the Pto/Prf system to Pto DC3000. However,
the peculiar kinetics of the AvrPto/Pto interaction (figure 4.3.5, section 5.2.4) raise the
question whether physical sequestering effects may also play a significant role. As
formation of the AvrPto-Pto complex likely relies on significant amounts of available
Pto (in order to overcome the relatively slow association), this fact combined with the
exceptionally high complex stability may lead to a local depletion of AvrPto at the plasma
membrane, providing a conceptually independent approach to mitigate AvrPto’s virulence
effects in vivo. Importantly, this hypothesis is consistent with an interesting effect
observed by He and coworkers in an early study: ectopic expression of Pto in Arabidopsis
protoplasts lowered AvrPto’s ability to suppress flg22-triggered FRK1 activation (He
et al., 2006); this would likely be mediated through the postulated sequestering effects,
as these protoplasts lacked a signalling-competent Pto/Prf system. This putative double-
edged defence strategy by R-protein complexes could provide an intriguing perspective for
future research efforts, as there is currently no example for such a hypothetical ’bi-modal’
guarded effector target.
5.3.2 Putative unknown targets
A wide interactome? The possibility of multiple virulence targets was recognized
from the very beginning of investigations into AvrPto’s interactome (section 5.1.1).
Although an increasing amount of evidence (including this work) points towards the
central co-receptor BAK1 as the primary virulence target, AvrPto was previously shown
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to additionally interact with the kinase domains of other SERKs (Meng et al., 2015),
FLS2 (this work, Shan et al., 2008, Xiang et al., 2008), and EFR (Xiang et al., 2008).
Besides these relatively well-characterized PRR targets, there is a number of proteins for
which initial data also indicate association with AvrPto. Xiang and coworkers observed
that AvrPto interacts with several RLCKs (Xiang et al., 2011); additionally, the same
group previously found that AvrPto binds and inhibits the autophosphorylation of the
kinase domain of At2g23200, a yet uncharacterized Ser/Thr kinase of the Catharanthus
roseus receptor-like kinase (CrRLK1L) subfamily featuring malectin-like domains and
putatively involved in plant immunity (Xiang et al., 2008, Nissen et al., 2016).
Delimiting the interactome’s extent It thus appears highly likely that AvrPto is gener-
ally unselective enough to qualitatively (although probably not quantitatively) associate
with a large group of kinases independent of their exact physiological function, and
these probably represent ’off-targets’ as discussed previously in the context of selectivity
(section 5.2.3). It is possible that we are just beginning to gather targets of this remarkably
promiscuous effector, and have barely scratched the surface of its interactome. Although
the affinity of AvrPto to BAK1 is high enough to confidently state this interaction to
be highly specific and indicative of a primary target in evolutionary context, it cannot
be ruled out completely that AvrPto interacts with other, yet unknown proteins with
even greater specificity. At this point, the structural requirements that kinases need to
meet in order to interact with AvrPto are not clear yet (section 5.1.4), and it has been
shown previously that it is hard to predict these interactions based on sequence similarity
alone (Shan et al., 2008). As mentioned above, previous studies led to the discovery
of several AvrPto-interacting proteins in a case-by-case manner, but the hypothetical
interactome is large enough that other approaches may be necessary to fully understand
its boundaries. If future work can determine specific residues which confer interaction
with AvrPto to previously non-binding kinase targets (such as BRI1), it may finally be
possible to comprehensively predict the extent of AvrPto’s interactome based on sequence
and structural data.
SUMMARY
Pseudomonas syringae is a widespread and highly adaptable bacterial plant pathogen
that can infect both economically relevant crop plants and Arabidopsis thaliana, making
it a highly relevant model pathogen for investigating the origin of pathogenicity in the
plant immunity field. P. syringae uses a large and diverse arsenal of effector proteins
secreted into the host cell to suppress plant immune responses during the infection pro-
cess and thereby increase its virulence. One of these effectors, AvrPto, has historically
been studied in-depth as a part of a classical gene-for-gene resistance pair in tomato.
Though it has been the target of scientific inquiry for more than two decades, the virulence
mechanism of AvrPto remained largely elusive. AvrPto binds the intracellular kinase
domains of multiple plant plasma membrane pattern recognition receptors, and previ-
ous qualitative investigations into these interactions led to inconclusive and conflicting
hypotheses regarding AvrPto’s virulence target. This thesis provides insights into these
unresolved questions by using quantitative methodology to investigate differences in
binding specificity and interaction kinetics in AvrPto’s multi-faceted interactome. AvrPto
was shown to bind the intracellular domain of the PRR-interacting co-receptor AtBAK1
with high affinity, while binding the equivalent domain of the PRR AtFLS2 with demon-
strable, but significantly lower affinity. Quantitative investigation into the interaction of
AvrPto with SlPto, the guarded effector target forming the molecular basis for R-gene
mediated immunity in response to AvrPto recognition in tomato, show that the affinity
of this interaction ranks between those of AvrPto with either BAK1 or FLS2. These
data indicate that AvrPto likely evolved to bind BAK1 homologues in various host plant
species, and in turn, SlPto evolved in tomato to bind AvrPto and mediate its recognition.
In contrast, binding to FLS2 likely occurs due to its structural similarity to the primary
target BAK1. Importantly, additional kinetic analysis of these interactions provided
a conceptually different methodological approach to corroborate the affinity data, and
added temporal information consistent with the described evolutionary model. Although
the exact molecular determinants of AvrPto’s kinase binding specificity remain elusive,
mutational analysis on BAK1’s intracellular domain indicate that the interaction likely
occurs structurally similarly to that of AvrPto with Pto, an interaction which has already
been structurally elucidated.
ZUSAMMENFASSUNG
Pseudomonas syringae ist ein weitverbreitetes und hochgradig anpassungsfähiges pflanzen-
pathogenes Bakterium; da es sowohl wichtige Nutzpflanzen als auch den pflanzlichen
Modellorganismus Arabidopsis thaliana befällt, wurde es zu einem wichtigen Modell
für die Aufklärung von Virulenzmechanismen in der Pflanzenimmunitätsforschung. Von
herausragender Bedeutung für die Pathogenität von P. syringae ist ein großes Repertoire
verschiedener Effektorproteine, die in die Pflanzenzelle sekretiert werden und dort auf
mannigfaltige Weise die Immunantwort des Wirtes unterbinden können. Eines dieser
Effektorproteine, AvrPto, wurde in der Vergangenheit besonders intensiv untersucht, da
es Bestandteil eines Resistenzpaares im Rahmen der klassischen Gen-für-Gen Hypothese
der pflanzlichen vererbten Immunität ist. Trotz dieser Umstände verblieb die Identität des
pflanzlichen Zielproteins, das von AvrPto zur Virulenzsteigerung angegriffen wird, lange
ungeklärt. Dieser Arbeit vorangehende Studien konnten zwar zeigen, dass AvrPto in der
Lage ist, die intrazellulären Domänen verschiedener pflanzlicher Rezeptorkinasen zu
binden, allerdings verblieb die biologische Relevanz dieser Interaktionen ein bedeutsamer
Streitpunkt. Durch quantitative Methodik, die sich von den bisherigen Ansätzen unter-
scheidet, konnten im Rahmen dieser Dissertation neue Erkenntnise zu diesem Thema
gewonnen werden. Es konnte gezeigt werden, dass AvrPto die intrazelluläre Domäne des
PRR-Korezeptors AtBAK1 mit hoher Affinität bindet, während die äquivalente Domäne
des PRRs AtFLS2 deutlich schwächer gebunden wird. Im Vergleich dazu liegt die
Affinität von AvrPto zu SlPto, dem Protein aus Tomate welches die spezifische Erken-
nung von AvrPto vermittelt, dazwischen. Evolutionsgeschichtlich gesehen lassen sich
diese Umstände durch folgendes Modell erklären: AvrPto evolvierte wahrscheinlich,
um das in vielen Pflanzenspezies konservierte Zielprotein BAK1 mit hoher Affinität zu
binden, während in Tomate seinerseits das Protein Pto evolvierte, um AvrPto zu binden
und seine Erkennung zu vermitteln; die Bindung von AvrPto zu FLS2 hingegen beruht
vermutlich auf struktureller Ähnlichkeit zum Zielprotein BAK1. Kinetische Experimente
ermöglichten eine methodisch unabhängige Verifizierung der Affinitätsdaten und stützen
das beschriebene Evolutionsmodell durch dazu schlüssige zeitabhängige Aspekte der
Bindungscharakteristik. Obwohl derzeitig noch nicht abschließend geklärt ist, welche
molekularen Eigenschaften die Bindespezifität von AvrPto zu verschiedenen Kinase-
domänen vermitteln, konnte durch Mutagenese von BAK1 gezeigt werden, dass die
Bindung strukturell wahrscheinlich ähnlich zu der mit Pto stattfindet, für welche bereits
Kristallstrukturdaten vorliegen.
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APPENDIX: SYNTHETIC OLIGONUCLEOTIDES
The following tables lists synthetic oligonucleotides generated in this work, which were
used as primers for either cloning (table A1), sequencing (table A2), or SDM (table A3).
Table A1 Synthetic oligonucleotides: Cloning
Name Sequence (5’-3’) Target
BAK1-Nde1-fw ctgatccatatgtcggataattttagcaacaagaac BAK1
BAK1-XhoI-rv gtcgatctcgagttatcttggacccgaggggta BAK1
BAK1-BamHI-fw ctgatcggatcctcggataattttagcaacaagaac BAK1
BRI1-NdeI-fw ctgatccatatggaggcggagttggagatg BRI1
BRI1-XhoI-rv gtcgatctcgagttataattttccttcaggaacttc BRI1
BRI1-BamHI-rv gtcgatggatccttataattttccttcaggaacttc BRI1
FLS2-NdeI-fw ctgatccatatgacctgttgcaagaaaaaagaa FLS2
FLS2-XhoI-rv gtcgatctcgagttaaacttctcgatcctcgttac FLS2
FLS2-BamHI-rv gtcgatggatccttaaacttctcgatcctcgttac FLS2
Pto-HindIII-fw ctgatcaagcttatgggaagcaagtattctaag Pto
Pto-BamHI-rv gtcgatggatccttaaataacagactcttggag Pto
mO-HindIII-fw ctgatcaagcttgtgagcaagggcgaggagaat mOrange
mO-link-BglII-rv gtcgatagatcttccagatcctcctcccttgtacagctcgtccatgcc mOrange
AP-link-BglII-fw ctgatcagatctggctctggaggaaatatatgtgtcggcggatcc AvrPto
AP-XhoI-rv ctgatcctcgagtcattgccagttacggtacgg AvrPto
Table A2 Synthetic oligonucleotides: Sequencing
Name Sequence (5’-3’) Target
T7-fw taatacgactcactataggg T7 promoter
pJC40seq-rv tgttagcagccggatcag pJC40 MCS
Table A3 Synthetic oligonucleotides: Mutagenesis
Name Sequence (5’-3’) Target
Y89D-fw gacatgcagcatagggacatgacgggagcgt mO-AvrPto
Y89D-rv acgctcccgtcatgtccctatgctgcatgtc mO-AvrPto
S286A-fw gttttcattgcgtgaactacaagttgctgcggataattttagcaac BAK1
S286A-rv gttgctaaaattatccgcagcaacttgtagttcacgcaatgaaaac BAK1
K317E-fw ctgatggtactttagtggccgttgagaggctaaaagaggag BAK1
K317E-rv ctcctcttttagcctctcaacggccactaaagtaccatcag BAK1
T324G-fw gctaaaagaggagcgcggccaaggtggcgaactg BAK1
T324G-rv cagttcgccaccttggccgcgctcctcttttagc BAK1
T324D-fw gttttcattgcgtgaactacaagttgctgcggataattttagcaac BAK1
T324D-rv cagttcgccaccttggtcgcgctcctcttttagc BAK1
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